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Part I. INTRODUCTION AND
LITERATURE REVIEW

Chapter 1 Introduction
(12) Owp/er/
1. General remarks
The genetics or heredity of behaviour characteristics has puzzled manhood since ancient
times. It became a part of our culture and popular knowledge, in expressions like "it's in the
blood". Pseudo-scientific knowledge in this area led to well-known excesses in the 20th
century. In the second half of the 20th century more thorough scientific research in this Held
was performed. This led to the birth of a new science, behavioural genetics. Initially,
scientific research in this Held started from different sides. In quantitative genetics,
behavioural scientists tried to tease apart the role of heredity in psychiatric disorders and in
normal psychological characteristics, e.g. intelligence or personality trails. Molecular
geneticists looked for genes thut could underlie behavioural characteristics or disorders.
Clinical geneticists wanted to understand the pathways between genetic diseases and the
impact that some of them have on intelligence, development and other aspects of behaviour.
The ultimate goal has always been to find treatment opportunities that might reverse negative
effects of genes on behaviour. In recent years, the three disciplines have become much closer
as shown in organisations and conferences like the International Society of Psychiatric
Genetics [ISPG, 2002] and the Society for the Study of Behavioural Phenotypes [SSBP,
20021.
What the last 50 years of research have most clearly taught is the extreme complexity of the
pathways between genes and behaviour [Rutter et al., 1999b], While relatively simple
organisms like Drosophila (fruit fly) may show quite straightforward associations between a
gene mutation and a particular behaviour [Pflugfelder, 1998], this is rather the exception than
the rule in much studied mammalians like mice and men. Another common observation is that
the effect of identifiable genetic defects on behaviour varies widely. This is the phenomenon
of phcnotypical heterogeneity. Genetic heterogeneity on the other hand, implies that different
genetic disorders may cause a similar developmental disorder. This is seen in non-specific
mental retardation.
In the field of neuropsychiatric genetics, research has shown that heredity is important in
autism, schizophrenia, bipolar disorder, Attention Deficit Hyperactivity Disorder and Tourette
syndrome. Nevertheless, for none of these well-studied disorders a single gene defect has
been found that could explain at least a substantial part of the cases. Different alternatives for
the one-genc-one-disorder model have been proposed. A first model is that of the additive
effect of different genes: several gene defects add up to cause the clinical disorder. Each of
(.13)
them may have a different weight in the pathogenesis of the phenotype. A second model is
that separate gene defects may cause the disorder phenotype. independently from each other.
According to a third model, some neuropsychiatric disorders may be associated with
functional variants (polymorphisms) of particular genes, instead of being associated with gene
defects. Theoretically, these polymorphic genes may act independently from each other, or
combine and have additive effects. This model is supposed to cause the variation in normal
behaviour traits, like intelligence and temperament traits. However, studies, which show
associations between particular gene polymorphisms and behavioural traits or psychiatric
disorders, also demonstrate that these associations generally only explain a modest part of the
variation of the phenotype (for a review, see (McGuc and Bouchard, 1998]).
Genetic causes that may affect behaviour can roughly be classified in four categories: (I)
single gene defects; (2) defects or absence of multiple genes, as observed in (cryptic)
chromosomal abnormalities; (3) variations in single genes (polymorphism); (4) combinations
of polymorphism in multiple genes. The first two categories arc more manageable to research,
as in a number of cases the genes involved are known. Even then, the pathway between gene
and behaviour has proven to be complex. It can be influenced by molecular mechanisms at the
locus of the gene defect, by other genes, by the environment, and by stochastic effects. The
simplest model one can study is the behavioural effect of identifiable molecular defects in
single genes. The influence of other genes, environment and chance are left out. Even so, this
model may in itself explain a wide variance in the phenotype of several diseases. We have no
idea of the proportion of neuropsychiatric disorders that are caused by single gene disorders.
Yet, they offer us a particular opportunity to understand one aspect of the variability in the
phenotype of neuropsychiatric disorders.
2. Aims of this thesis:
The aim of our research has been to explore the behavioural effects of two single gene
disorders: Fragile X Syndrome and Myotonie Dystrophy (Steinert's Disease). The causal
mechanism in both diseases is an unstable trinucleotide repeat expansion, or dynamic
mutation. Dynamic mutations are of particular interest. Firstly, several disorders of the central
nervous system are caused by this recently discovered kind of mutation. Secondly, a dynamic
mutation consists of a range of expansion lengths that each may affect the phenotype to a
different degree, or even in a qualitatively different way. Thirdly, dynamic mutations have a
measurable variance at the molecular level, which can be correlated with variance at the
phenotypical level.
(14) C/wp/er/
The molecular mechanism in Fragile X Syndrome and Myotonie Dystrophy is at least
partially understood. The most common clinical aspects of both diseases have been well
described. We have focused on two issues: (I) some less well-known aspects of the
behavioural phenotype of both diseases, and (2) how variations at the molecular level
differentially affect (he behavioural phenotype.
3. Outline of this thesis
Part I consists of reviews and theoretical considerations on the behavioural phenotype in
single gene disorders, in particular in Fragile X Syndrome and Myotonie Dystrophy. In
Chapter 2, we outline a number of concepts and findings that are essential to understand the
subsequent research. Chapter III is an overview of possible causes of phenotypical variation
in single gene disorder. Chapter IV and V arc literature reviews on Fragile X syndrome and
Myotonie Dystrophy, with special interest for the behavioural phenotype of these disorders.
Pan II brings together a number of publications on the behavioural phenotype in Fragile X
syndrome und Myotonie Dystrophy, studied by the research groups in Leuven and Maastricht
in the period 1992-2002. The studies in Fragile X Syndrome describe (1) neurocognitive
characteristics in female fragile X full mutation carriers of normal intelligence (Chapter 6),
(2) neurocognitive characteristics in female fragile X premutation carriers (Chapter 8) and (3)
the effect of incomplete hypermethylation of the fragile X full mutation in boys (Chapter 7).
In the studies in Myotonie Dystrophy we focused on the behavioural phenotype of
adolescents and young adults with the juvenile onset type of the disease, in a stage of the
disease process where behavioural problems prove to be more disabling than the mild or
almost absent muscle symptoms. This research highlights the effect of the Myotonie
Dystrophy gene mutation on the central nervous system. Chapter 9 presents mainly the
cognitive and behavioural characteristics in juvenile Myotonie Dystrophy. In Chapter 10 the
findings on behaviour characteristics in childhood onset Myotonie Dystrophy are analysed
further in a new group of subjects.
In Part III, conclusion remarks and comments are made.
4. References:
All references have been compiled at the end of the thesis
Chapter 2 Introductory concepts
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1. Behavioural phenotype
I.I. Definition
When Langdon-Down first described Down's syndrome, he described particular behavioural
characteristics like cheerfulness and musicality in the subjects with this syndrome (Langdon-
Down. 1866. cited in (O'Brien, 1992)). Nyhan was probably the first to use the term
"behavioural phenotype" in the context of behaviour associated with genetic diseases in man,
when he described the compulsive self-injurious behaviour that is consistently found in
subjects with Lcsch-Nyhan syndrome [Nyhan, 1972).
Since then, (he term has acquired different meanings and interpretations. In their very
restrictive definition, Flint and Yule require two criteria to apply the term "behavioural
phenotype" to the association between a particular behaviour and a genetic disorder [Flint and
Yule. 1994). The first is that there must be "a distinctive behaviour that occurs in almost
every case of the condition and rarely (if at all) in other conditions". The second criterion is
that u genetic anomaly should be demonstrated, which has a direct relationship with the
observed phenotype. Both criteria are met in a very limited number of genetic disorders, like
Lcsch-Nyhan syndrome. However, for the majority of genetic disorders in which more or less
characteristic behavioural features have been described, the first condition will never be met.
Hyperexcitability and several other behavioural characteristics are present in many but by far
not all boys with the fragile-X syndrome. The same symptoms may occur in other subjects
with a moderate mental retardation without the fragile-X syndrome. Consequently, this
symptom does not meet the first criterion of Flint and Yule. The second criterion, of a
demonstrable genetic anomaly, is met for a growing number of genetic disorders, following
advances in molecular biology This definition of the term behavioural phenotype is
obviously loo narrow. It should be noted that a similar definition would also be of no use in
the categorisation of somatic phenotypes, where variability in the phenotype is more often the
rule than the exception.
At the other end of the spectrum of interpretations lie the loo global ones. Complex
behavioural or psychiatric syndromes, e.g. non-verbal learning disability or autism, have been
described as "the" behavioural phenotype of a particular genetic disorder. More than a decade
ago. it was claimed that fragile X syndrome was the underlying cause in up to 25% of
children with autism [Gillberg and Wahlstrom. 1985]. This view was refuted in a meta-
analysis including 5601 males with mental retardation and 1006 males with autism, all tested
/n/rtw/wcn'ow am/ ///erafwre re vj'etv (17)
for fragile X [Fisch. 1992]. The study showed that the prevalence of autism in males with
fragile X is not significantly higher than in males with the same level of mental retardation
without fragile X. An important problem in this kind of errors is that statements on
behavioural phenotypes are often made on small samples of subjects with a genetic syndrome
[Flint, 1998). This is partially understandable as the prevalence of many genetic syndromes is
very low. Collaboration between several research centres can circumvent this problem.
Another common error results from the way in which the behavioural phenotype is measured.
Firstly, with the best intentions classical behaviour questionnaires or neuropsychological tests
are used in groups of subjects with a genetic syndrome and mental retardation (MR). Children
with MR have on average a threefold prevalence of behaviour problems compared with
individuals with normal intelligence [Einfeld and Tonge, 1996]. Many neuropsychological
tests correlate with intelligence. The use of instruments that have only been validated for a
normal population will inevitably result in an abnormal prevalence of problems. Instruments
that are appropriate for the cognitive level of the subjects and/or control groups should be
used. Secondly, in some genetic syndromes, a subset of symptoms may be observed that are
also observed in a particular behaviour disorder, while the other characteristics of this
behaviour disorder are not present in subjects with the genetic syndrome under study. This
may erroneously lead to the conclusion that the behavioural phenotype of the genetic disorder
is a particular behaviour syndrome. Boys with fragile X have speech and language delays,
show repetitive behaviours, signs of hyperexcitability, like toe-walking and hand-flapping,
and abnormal eye contact. All these symptoms are often seen in autism [Reiss and Freund,
1992]. However, most subjects with fragile X have normal emotion recognition and social
empathy, while deficiencies in these abilities are core problems in autism (Maes et al., 1993;
Simon and Finucane, 1996]. Sometimes there is a stronger association between a genetic
disorder and a complex behaviour syndrome: 25-50% of subjects with tuberous sclerosis have
all the core symptoms of autism [Bolton P.F. and Griffiths, 1997; Smalley, 1998].
Finally, when using classical questionnaires, one may overlook some typical aspects of the
behavioural phenotype. Many boys with fragile X syndrome bite their thumb root when
excited, subjects with 17p-deletion (Smith-Magenis) syndrome show self-hugging and
poikiloembolomania (the habit of inserting objects in body orifices), and subjects with Prader-
Willi syndrome often pick their skin. These rare symptoms are not items of the usual
behaviour questionnaires. They require careful naturalistic observation of a number of
subjects with a particular genetic syndrome in order to develop specific questionnaires, with
(18)
which research on the behavioural phenotype of that syndrome can be conducted on a larger
scale.
Somewhere between a too restrictive and a too global definition of the term behavioural
phenotype, we can define the term behavioural phenotype of a genetic disorder as r/ie range
0 / foAavioK/- c/KW-ac/em//« /AÖ/ are .i/g/iz/ican/Zy awi>c/a/eJ w»7A f/ie tfoordirr. In fact, this
approach of the behavioural phenotype is quite similar to that of the somatic phenotype.
Which is not surprising, as in both cases gene defects arc the underlying cause of the
phenotype'' The pathways between molecular defects and the resulting observed somatic or
behavioural phenotype arc different, or at least partially different. Indeed, there may be
intcrtwinemeni of both at different levels. In Noonan syndrome, feeding problems are caused
by early orofacial dyspraxia inducing phobic avoidance [O'Brien. 1992]. In velo-cardio-facial
syndrome, anomalies and dysfunction of the soft palate may underlie feeding problems in
infancy |Swillcn ct al.. 2(XX)].
We will clarify three aspects of the proposed definition of the behavioural phenotype:
behaviour, range, and significantly associated.
In (his context, the term AeAaviour should be used in its broadest sense and include: (1)
specific and/or developmental delays, e.g. mental retardation, language development disorder;
(2) personality characteristics and general dimensions of behaviour, e.g. amiable, shy,
aggressive, hyperactive; (3) complex clusters of pathological behaviour like psychiatric
syndromes, e.g. cycloid psychosis in Prader-Willi syndrome (PWS) [Verhoeven el al., 1998,
2002aI; (4) other characteristic behaviours that cannot be classified in a psychiatric syndrome
and that may be syndrome-specific, e.g. gaze-avoidance in fragile X syndrome, skin-picking
in Prader-Willi syndrome. Developmental delays, personality characteristics and behavioural
dimensions should be assessed with psychomelrical instruments; psychiatric syndromes with
structured psychiatric interviews and standardised observation instruments; and unclassifiable
symptoms by means of observation lists based on earlier naturalistic observation [Dykens,
1995].
The concept of a ran;« o/fteAawo«n is delicate. It is based on what sound research teaches
on the individual variability of behaviour in genetic syndromes. In a large group of
individuals with a particular genetic disorder, statistical analysis and use of a control group
may show that a number of behaviour characteristics are associated with the syndrome. Some
subjects will display all these characteristics, while others will only partially exhibit the full
spectrum. The studies on fragile X syndrome and myotonic dystrophy in this thesis are
examples of this phenomenon. Other examples include studies on the behavioural phenotype
re v;>w
of velo-cardio-facial syndrome (VCFS) (Swillen et al., 1999; Verhoeven et al„ 2002b; Vogels
et al., 2002]. In Chapter 3 we will review causes of this variability.
The aspect s*g/i/yica/i//y arcoc/a/errf means that the characteristics and boundaries of a
particular behavioural phenotype have been obtained by quantitative and statistical analysis in
sufficiently large groups of subjects, where possible with the use of control groups.
1.2. Behavioural phenotype and psychiatric syndromes
As we learned from the hapless story of the supposed association between autism and fragile
X syndrome, a cautionary note is required when psychiatric syndromes are found to be part of
a behavioural phenotype. Our knowledge of the pathophysiological mechanisms underlying
psychiatric syndromes and the reasons why symptoms cluster together in such syndromes is
still limited. Until we have a complete understanding of their causes, the observed clusters of
symptoms remain syndromes and not diseases. Research on gene-behaviour relationships may
even show that the currently accepted clustering into syndromes and the boundaries between
them is rather arbitrary and should be re-evaluated in the future [Ruttcr ct al., 1999b) (see also
Chapter 3).
When a significant number of subjects with a particular genetic disorder display a cluster of
symptoms that can be categorised as a psychiatric syndrome, we can say that this psychiatric
syndrome is part of the behavioural phenotype. In such cases, the use of the term
"psychopathological phenotype" is appropriate, as proposed by Verhoeven and co-workers
[Verhoeven et al., 2000]. A major advantage is that affected individuals will receive the
necessary medical and psychological attention for the psychiatric problems. However, a
number of subjects with the genetic disorder may only display a number of the symptoms and
thus not fulfil the criteria for the psychiatric syndrome. It is then cautionary not to sec these
symptoms as a pars pro toto and diagnose the psychiatric syndrome for the erroneous reason
that this psychiatric syndrome was described as a part of the behavioural phenotype of that
genetic disorder. Moreover, genetic disorders may be associated with a set of psychiatric
symptoms that do not match well with existing categories. Consequently, different
investigators may come to disparate diagnoses in the same genetic disorder, depending on
their diagnostic perspectives [Verhoeven and Tuinier, 2001; Wang et al., 2000]. In this
respect, the psychopathological profile of VCFS is rather unique and lacks key symptoms to
meet the criteria for schizophrenia or for bipolar disorder and the term velo-cardio-facial
psychiatric syndrome has been proposed [Verhoeven et al., 2000; Vogels et al., 2002].
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Psychiatric syndromes observed in genetic syndromes are an epiphenomenon and
developmental product of the underlying genetic defect. Probably, when genetic defects that
are not associated with a known genetic disorder underlie a psychiatric syndrome, the types of
mechanisms between gene and behaviour are not fundamentally different from those when a
psychiatric syndrome is associated with genetic disorder and is a part of its phenotype: e.g.
panic and phobic disorders had been known since long when it was discovered that a
polymorphic genomic duplication on chromosome 15, not associated with distinct
dysmorphic signs, is a susceptibility factor for these disorders [Gratacos et al., 2001 ].
2. Mental retardation
Mental retardation (MR) is probably the most common behavioural feature associated with
genetic disorders affecting the central nervous system. The essential feature of MR is
significant sub-average general intellectual functioning that is accompanied by significant
limitations in adaptive functioning in several skill areas: communication, self-care, home
living, social skills, functional academic skills, work, and other. The onset must occur before
the age of 18 years, and generally much earlier [American Psychiatric Association, 1994].
General intellectual functioning is defined by intelligence quotient (IQ), obtained by
assessment with standardized intelligence tests. Significant sub-average general intellectual
functioning is defined as an IQ of at least two standard deviations below the average, which
corresponds with an IQ of 70 or less. The presenting symptoms are generally impairments in
adaptive functioning [American Psychiatric Association, 1994]. Adaptive functioning refers
to the way in which individuals cope with normal life demands and how well they meet the
standards of personal independence. Impairment in adaptive functioning can be measured
with scales, like the Vineland Adaptive Behaviour Scales [Sparrow et al., 1984]. In some
individuals, e.g. subjects with autism, there may be an important difference between
intellectual functioning and adaptive behaviour [Schatz and Hamdan-Allen, 1995]. Both
aspects should be taken into account when assessing an individual with developmental delays.
Different degrees of mental retardation can be specified, ranging from mild to profound
mental retardation, reflecting the level of intellectual impairment.
The prevalence of mental retardation is difficult to measure in large populations, but has
declined in Western countries from several percent to approximately 0.6%-1% [Richardson,
1989; Strommc and Valvatne, 1998; Szymanski and King, 1999]. Better nutrition is
considered to have contributed to this decline in prevalence.
/n/ro</uc/io/i review (21)
The causes of mental retardation are manifold: genetic causes, environmental causes like
malnutrition or toxins. Genetic causes are thought to account for approximately one third of
all detectable aetiologies [Szymanski and King, 1999). The prevalence of delectable genetic
causes increases with the severity of the MR. These genetic causes can be divided in different
subgroups (see Table I) |Chiurazzi. 2001a; Pronk et al., 1999].
Table I Genetic cause of MK and other neuropsychialric developmental disorder«.
Category
Chromosomal
abnormalities
Aneuploidies
Mosaicism
Deletions, duplications,
and re-arrangements
Single gene disorders
Polygenic inheritance
Subcategory
Autosomes
Sex-chromosomes
Partial trisomies &
duplications
Deletions &
microdeletions
Cryptic translations /
deletions / duplications
Autosomal recessive
Autosomal dominant
X-linked
mitochondria!
Examples, associated with mental retardation
or other developmental disorders.
Trisomy 21 /Down syndrome
47,XXY-Khnefclier syndrome; 45,X-Tumer
syndrome
Tetrasomy I2p-Pallisler-Kilhan syndrome
Distal 3p trisomy; inverted 8p duplication
syndrome
del(8p); del (22q)-velo-cardio-facial syndrome
Familial cases of MR with multiple congenital
anomalies
Phenylketonuna, essential microcephaly
Neurofibromatosis type 1, SfC///-gene mutation
with dysarthry, myotonic dystrophy
Fragile X syndrome; diverse syndromic and
non-syndromic forms of X-linked MR
Myoclonic epilepsy with ragged-red fibbers
Non-specific familial MR
MR with a genetic origin can be subdivided according to the associated physical, neurological
and biological signs (see Table 2).
In specific or syndromal MR, clinical, biochemical or other phenotypical findings are
associated with MR. The MR is then part of a broader phenotype. Some genetic anomalies are
associated with multiple congenital anomalies (MCA), among which facial and other
dysmorphic signs. This is the case in e.g. Down syndrome and velo-cardio-facial syndrome.
In phenylketonuna and other metabolic disorders, the MR is associated with biochemical
(22) •*• ' i "•*' w v> - fe«
findings, without visible clinical signs. In MASA-syndrome [Schrander-Stumpel et al., 1995;
Weiler and Gartner, 2001], Rctt syndrome [Amir et al., 1999) and X-linked infantile spasms
[Claes et al., 1997: Rugtveit. 1986), MR is associated with characteristic neurological signs.
This subdivision is somewhat arbitrary, however, as some genetic syndromes present with
signs from different subcatcgories. In Prader-Willi syndrome and Down syndrome, MR is
associated with MCA's and a neurological symptom, muscle hypotonia. • • • = -
In non-specific or non-syndromal MR, the MR is the only clinical finding and there are no
dysmorphic or other clinical signs. It is often thought that non-specific MR is either caused by
non-genetic factors, or, if genetic, by polygenic inheritance [Plomin et al., 2000; Rutteret al.,
1996). In a number of families with non-specific MR, a monogenic heredity has been found,
und the underlying gene defect could be identified. On the X-chromosome, at least 33 such
genes have alrcudy been cloned |Chiurazzi ct al., 2001). Autosomal forms of non-specific
MR. like 3p25-tcr syndrome [Higgins et al.. 2000), seem more seldom than X-linked MR
(XLMR) or are more difficult to identify.
Table 2 Clinical classifications of MR with • genetic origin, and a few examples.
• . •$ • • .
Specific MR
. ;•••• Multiple congenital anomalies Down syndrome, velo-cardio-facial
syndrome
Metabolic disorders Phenylketonuria
• * Neurological symptoms MASA-syndrome
Non-specific M R 3p25-ler syndrome; various non-specific
XLMR
The classification in specific and non-specific MR is also ambiguous: more in-depth analysis
of the phenotype of some so-called non-specific genetic causes of MR may eventually show
that more subtle phenotypical signs are associated with demonstrable causes of isolated MR,
but not with others. Such phenotypical signs may be specific neurocognitive deficits or other
neuropsychiatric symptoms. It has been suggested that MR due to a mutation in a gene of the
IL-reeeptor family located at Xq22. which is highly expressed in the hippocampus, might be
associated with specific problems of short-term memory [Carrie et al., 1999). Findings like
this underscore the importance of thorough analysis and classification of not only the somatic
phenotype, but also of the behavioural phenotype.
3. Other developmental disorders
Developmental disorders are chronic conditions where there is a disturbance in the acquisition
of cognition, language, motor, or social skills [Harris. 1998a]. Beside mental retardation,
these include a variety of neuropsychiatric conditions: e.g. autism, language developmental
disorder, motor coordination developmental disorder, and dyslexia. The taxonomy of these
developmental disorders is based on the observed phenotype, and not on causal mechanisms
|American Psychiatric Association, 1994]. During the last three decades, there has been an
increasing interest in the causal mechanisms of these disorders, as testified in textbooks on
developmental neuropsychiatry [Harris, 1998b] and psychopathology [Cicchetti and Cohen,
1995]. The role of genetics in the aetiology of developmental disorders is becoming
increasingly clear [Rutter et al., 1990; Rutter, 1994; Ruttcret al., 1999a]. . . . . >^ .. .
Basically, the same broad classification of causes can be made as for mental retardation.
Syndromal forms of autism exist. The autistic behaviour is then part of a broader clinical
phenotype that is associated with a genetic defect. Various chromosomal defects have been
found in individuals with autism [Gillberg, 1998]. The autism phenotype is also associated
with some monogenic disorders, e.g. tuberous sclerosis [Smalley, I998J. Non-syndromal
autism can be caused by monogenic inheritance, as has been suggested in a number of
families with multiple probands [Jamain et al., 2002]. In other subjects, a polygenic
inheritance most probably underlies the disorder [Bolton P. et al., 1994]. A similar
classification can be applied to the findings in other neuropsychiatric developmental
disorders. However, the relative importance of the different causes of these developmental
disorders is unknown and might be different from one disorder to the other. ,? ^ •.;;-,«>;
4. Dynamic mutations
The term "dynamic mutation" was introduced to distinguish the unique properties of
expanding, unstable DNA repeat sequences from other types of mutation [Richards R.I.,
2001] (see also Chapter 3, section 5). In 1991. this mechanism was discovered in fragile X
syndrome [Verkerk et al., 1991] and spino-bulbar muscular atrophy [La Spada et al., 1991]. In
1992, a similar mechanism was found in myotonic dystrophy [Aslanidis et al., 1992; Harley et
al., 1992a]. So far, at least 13 different dynamic mutations have been described, all affecting
the central nervous system [Richards R.I., 2001]. Amongst these are Huntington's chorea,
Friedreich ataxia, and a rare form of major psychosis associated with a dynamic mutation in
the 5C4Ä gene [Vincent J.B. et al., 2000]. . .*. • • . •--.•-•
(24)
Repeat sequences of (wo, three, four and sometimes more base pairs are common in the
genome. They arc generally stable in the population. For unclear reasons these repeat
sequence sometimes become unstable and expand. The mechanism of the expansion is far
from being elucidated Trinucleotide repeats, in particular the pairs CCG/CGG and CAG/CTG
are particularly prone to this phenomenon. Instability can occur from one generation to
another (gametic instability), and/or within the same individual (somatic instability). In
myolonic dystrophy both forms of instability occur, while in Huntington's chorea only
gametic instability has been observed. Instability can consist of an increase of the number of
repeats eg . (f'CKj)n—• (CCiG)n+m. as well as a decrease, e.g. (CTG)n—•(CTG)n-m. An
increase (amplification) is more frequently observed. Repeat number and composition of the
repeat (perfect repeat of the same trinucleotide, versus interruptions with other trinucleotides)
influence instubility of the repeat sequence. In general, alleles with higher repeat numbers and
ulleles that arc free of interruptions are more unstable than those with a lower copy number
and/or that contuin interruptions |Richards R.I., 2001]. In some dynamic mutations, there is a
parental gender bias in the amplification of the trinucleotide repeat from one generation to the
next. In fragile X syndrome, (he repeat number is stable in paternal inheritance, and often
unstable in maternal inheritance. In Hunlington's chorea paternal inheritance on average leads
to larger expansions than maternal inheritance [Norremolle et al., 1995].
Dynamic mutations are distributed across a range of relatively stable repeat lengths in the
normal population. Beyond a certain repeat number, the repeat becomes unstable and is then
associated with pathology in most of these diseases. This is then called a mutation. The
relationship between repeat length and phenotype varies from disease to disease. (I) There
may be a gradual correlation between repeat number and disease onset and/or severity. In
Huntington's chorea the disease will develop in individuals who have more then 37 CAG
repeats at the mutation site, and longer repeats are associated with earlier disease onset
(Duyao et al.. 1993]. (2) In some other dynamic mutation diseases, there is a bimodal
distribution of the phenotype. In fragile X syndrome, expansions between 55 and 200 CGG
repeats are unstable while subjects have a mostly normal phenotype. This is the fragile X
premutation. The fragile X full mutation consists of amplifications of more than 200 repeats
and is associated with the classical fragile X phenotype. In the SC4£-gene expansions
between 107-127 CTG repeats are associated with spinocerebellar ataxia. while expansions of
more than 600 repeats are associated with major psychosis [Vincent J.B. et al., 2000].
Several pathogenic pathways between gene and phenotype have been described in dynamic
mutations [Richards R.I., 2001] In fragile X syndrome (see Chapter 4) and Fnedreich's
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ataxia. the full mutation is associated with loss of gene expression and consequent lack of
protein production. In myotonic dystrophy (see Chapter 5) there is evidence supporting an
effect of the mutation on the functioning of other genes [Tapscott and Thornton, 2001].
Increased messenger RNA production has been suggested as a pathogenic mechanism in the
fragile X premutation [Tassone et al., 2000c).
Once a trinucleotide repeat has reached a critical length and becomes unstable in one
individual, it will remain unstable in the consequent generations, thus creating u "founder"
effect [Laberge, 1989).
5. X-linked mental retardation
At the end of the 19th century, it was suggested thai the prevalence of mental retardation is
higher in males than in females [Johnson G.E., 1897]. The finding was confirmed in a survey
of institutionalised mentally retarded persons in the U.K. [Penrose, 1938]. Lehrke [Lehrke,
1974] noted that this difference might be due to the absence of a second X-chromosomc in
males. Genes on the X-chromosome affecting brain development or functioning could explain
why males were affected, while females could benefit from the homologuc gene on the other
X-chromosome. Years earlier, Martin and Bell had described sex-linked inheritance of mental
retardation in a pedigree [Martin and Bell, 1943]. In this family, several males had moderate
mental retardation, while females were not or only mildly affected. In 1969, Lubs described a
fragile site on the long arm of the X chromosome, the marker X chromosome, to be associated
with sex-linked mental retardation [Lubs, 1969]. Using improved cytogenetic procedures,
Sutherland [Sutherland, 1978] demonstrated that the fragile site on the X-chromosome is
present in only a number of families with X-linked mental retardation (XLMR). This helped
to identify families with fragile-X syndrome (FXS) and to differentiate them from families
with other forms of X-linked mental retardation [Howard-Peebles et al., 1979; Howard-
Peebles, 1982]. At re-examination, Martin and Bell's original pedigree proved to carry the
fragile X chromosome [Richards B.W. et al., 1981].
Differentiating FXS from other forms of XLMR helped to specify the FXS phenotype [Fryns
J. P., 1984; Fryns J. P. et al., 1984a; Hagerman R.J. et al., 1983]. The identification of FXS
was an important step in the acceptance that X-linked genes are responsible for at least a part
of the excess of males in MR. Other X-linked syndromes associated with mental retardation
have been delineated since [Chelly and Mandel, 2001 ].
XLMR can be associated with particular phenotypical characteristics other than the mental
retardation. These are called specific or syndromic XLMR (MRXS). E.g., Rett syndrome is
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associated with a A/£O*2 gene mutation, X-linkcd hydrocephalus/MASA syndrome with ar
£/C/4Ay-gcnc mutation, and Lesch-Nyhan disease with an /WÄr-gene mutation. Other type;
of XLMR are not associated with specific phenotypical signs and are called non-specific 01
non-syndromic XLMR (MRX). Examples of MRX are: the O/igop/iremn-/ gene, and th<
FM/U/F/kLW: gene mutation [Chelly and Mandel, 2001J. A recent count of MRXS and MR>
showed that 209 clinical forms of XLMR have been delineated [Chiurazzi. 2001b; Chiurazz
el al., 2001; Frints et al., 2002. Schwartz and Stevenson, 2002]. A hundred and eighteen o
these have been mapped, and 34 genes have been cloned.
I able 3 Total counts of XLMR, specific (MRXS), and non-specific (MRX).
MRXS
ItaaftMi Midi Kontere
Dominant disorders
Total disorders
MRX
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Syndromes
Neuromuscular
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Total count
81
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12
8
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36
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2
3
61
57
118
Cloned
7
6
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4
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7
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1. Abstract
Quantitative and molecular genetics have made important developments in the last three
decades. There is increasing evidence of the role of heredity in the Held of neuropsychiatric
disorders in children. Sofar, only a few pathways between genes and behaviour have been
unravelled. • ,
Quantitative genetics puts polygenic inheritance models forward. Molecular genetic research
based on these models seems promising, but until now has provided only a limited
explanation for the variance in the studied neuropsychiatric disorders. In these models, the
complexity of the expression of a single gene grows exponentially with the number of genes
involved. Consequently, research on the gene-phenotype relationships and phenotypical
variability in such models is extremely complex.
The candidate gene approach, in which the gene-phenotype pathway of a single gene is
studied, is more manageable, and in our opinion essential in understanding multiple gene
models. We discuss recent findings in the field and their relevance for neuropsychiatric
phenotypes. Single gene defects will only explain a part of the range of neuropsychiatric
disorders in children, but the evidence that this approach can generate may help to clarify
ncuropsychiatric phcnotypes. The discovery of single gene disorders in subgroups of subjects
with a neuropsychiatric phenotype may result in new perspectives for their treatment.
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Our cultural ancestors had clear ideas about the heredity of behaviour and personality
characteristics. Homer attributed to Telemachos the wisdom and godlikcness of his famous
father Odysseus [Homer, 1995]. Telemachos however, had never met his father during the
first twenty years of his life. Nature was stronger than nurture at that time. Much later Sir
Francis Galton [Plomin et al., 2000] approached this phenomenon in a more scientific way by
studying the hereditability of cognitive abilities. This was the basis of quantitative genetics.
Ever since, and in particular in the past three decades, the heredity of behavioural traits and
psychiatric conditions has been widely studied [Gelernter, 1999; Plomin et al., 2000; Rutter et
al., 1999b]. This has not only led to interesting findings on the heredity of personality
characteristics, cognitive abilities and psychiatric conditions, but also to more accurate
descriptions of shared and non-shared environmental effects on development [McGue and
Bouchard, 1998; Rutter et al., 1999b]. In adult psychiatry, the heredity of schizophrenia and
bipolar disorder has been studied extensively [Nürnberger et al., 1994], In developmental
psychiatry, autism has been a particular focus of research [Rutter, 2000]. This has resulted in
valuable information on the heredity and the phenotype of autism, e.g. the concept of a
broader phenotype in some non-autistic family members of autistic probands [Le Couteur el
al., 1996; Murphy M. et al., 2000]. The development of statistical techniques [Rutter ct al.,
1999b] has allowed the study of a range of questions like hypotheses about possible
mechanisms involved in sex differences, or the number of genes that might play a role in the
susceptibility for a child psychiatric disorder. - : - • • . . • <
Several methods can be applied in the search for genes affecting behaviour and/or mental
disorder (see Table 4 for an overview). We refer to other articles on this subject for a more
comprehensive review of how these methods can be applied in neuropsychiatric research
[Rutter et al., 1999b]. Family and genetic epidemiology studies have been accompanied by
molecular genetic studies, in search for genes affecting behaviour and psychiatric disorders.
Initially, linkage analysis has been used to look for single genes that could cause the heredity
of neuropsychiatric disorders. Up to now, successes like the discovery of the gene for
Huntington's disease [Gusella, 1984], in which only one gene (defect) is necessary and
sufficient for a particular disease phenotype, have not been reproduced in psychiatric
conditions. This has different reasons. •
Firstly, research suggests that neuropsychiatric disorders are often caused by several
interacting genetic loci, or quantitative trait loci (QTL's), rather than by a single major locus.
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E.g., this has been demonstrated in schizophrenia [Risch, 1990], and in autism. In autism the
concordance in monozygotic twins is more than twice that in dizygotic twins, suggesting that
more than one gene is involved in the heredity of the disorder in these cases [Rutter et al.,
I999b|. Linkage analysis searching for such QTL's in autism has shown that probably more
than IS loci are involved [Risch et al., 1999], while not a single gene at these loci has been
identified yet. Though there are robust arguments that the phenomenon of QTL's operates in a
substantial number of cases, it is a particularly complex field of research, in part because we
do nol exactly know what to look for. This obstacle can be alleviated by looking in the other
direction: instead ot going backward and look for QTL's starting from the phenotype, one can
focus on the association of candidate genes with a particular neuropsychiatric disorder [Evans
et al., 2001]. This has been performed e.g. in Attention Deficit Hyperactivity Disorder
(ADHD) [Comings el al., 2000]. However, a problem that remains in u forward genetic
approach is that it is not clear how different genes combine to cause a particular
neuropsychiatric phenotype. This is not necessarily through several defective genes, but also
through particular combinations of polymorphic genes. In the population, different alleles of
one gene co-exist. These polymorphisms lead to small differences in the functioning of the
gene product. When several such genes are involved, particular combinations may lead to
dysfunction, as proposed in the study on the additive effects of polymorphisms of three genes
involved in dopamme function in Tourette syndrome [Comings et al., 1996]. Secondly,
different and independent genetic errors can cause the same psychiatric disorder. Different
chromosomal abnormalities are independently associated with autism [O'Brien and Yule,
1995]. This phenomenon demonstrates the genetic heterogeneity of neuropsychiatric
disorders. It is a limitation in linkage analysis based on a QTL model. Such research requires
large groups of subjects or families, and these groups are likely to be genetically
heterogeneous. In different families, completely independent genes or combinations of genes
may cause a similar neuropsychiatric phenotype, blurring linkage analysis. Thirdly, a
psychiatric phenotype and the underlying genetic abnormalities may not always coincide
[Rutter el al.. 1999b]. The same genetic liability seems to underlie conduct disorder and
oppositional defiant disorder, which are generally considered as different diagnostic
categories. A genetically influenced behaviour trait may be a risk factor for a psychiatric
disorder, independently of the genetic liability for the disorder itself. This was demonstrated
for the genetically influenced personality trait neuroticism as a risk factor for depressive
disorder [Kcndler. 1996). A fourth reason is that, ideally, the definition of a particular disease
phenotype should precede the search for causative genes. On the other hand, it often only
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becomes apparent which phenotype is associated with a particular genetic defect or variant
once the latter has been identified Only after it became possible to detect the fragile-X site
Xq27.3. it became clear that not only males, but also carrier females often have clinical
characteristics of the fragile-X syndrome [Fryns J. P., 1984; Hagcrman R.J. et al.. 1986a].
This paradox complicates research on gene-behaviour relationships when starting from the
psychiatric phenotype.
Table 4: Brief overview of main strategies in molecular research for genes affecting
behaviour or mental disorders
Searching for -> Single genes Multiple genes
From behaviour
to genes:
Backward
approach through
linkage analysis
+ Relative routine for linkage
analysis If single locus exists, there
is a good chance of finding it.
-•- Good indication when there is a
clear disease phenotype with
monogenic inheritance in a large
pedigree.
- Long way from finding locus to
finding gene.
- No results if no single major gene
effect, or if penetrance of major
gene is low.
- Finding a single major gene will
often only reflect part of reality in
complex disorders.
+ This is most likely closer to the
reality of the genetics of
neuropsychialnc disorders.
+ QTL models can be taken into
account
- Long way from finding multiple
loci to finding genes
- Even if genes are found, there is a
good chance that their pathogenetic
mechanism is unknown.
- At molecular level, understanding
the simultaneous effect of multiple
genes is extremely complex.
From genes to
phenotvpe:
Forward
approach through
association /
candidate gene
studies
+ Effect of one gene on the phenotype
can be studied in depth.
+ Mechanisms of expression and
variability can be studied for that
gene, as well as function of the gene
product.
+ The procedure may point to other
related candidate genes.
- Inherently, this approach does not
allow describing combined and
quantitative effects of sets of genes.
- Association studies with genes with
an unknown function may lead to
false positive results if there is
another reason for association
between the gene and the phenotype
(e.g. ethnic group...)
+ Not only individual effect, but also
additive effect and interactions of
several (candidate) genes on a
phenotype can be studied.
+ QTL models can be studied.
- What happens at the molecular
level is difficult to study.
- Small or non-significant effect of
candidate genes in a complex model
may erroneously lead to removing
these genes from the model.
- Inherent multiple analysis may lead
to erroneously significant effects,
which do not reflect an effect at the
molecular level.
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Nevertheless, in some neuropsychiatric disorders, it has been possible to define a phenotype
that could be linked to a causative gene. In a single family aggressive behaviour and
borderline intellectual functioning were found to be associated with a mutation in the MAO-A
gene [Brunner et al., 1993]. In the KE-family, a specific language impairment is associated
with the WWW gene [Hurst et al., 1990; Lai et al.. 2001 ]. However, even in a seemingly one-
gene-one-bchaviour situation like Brunner's syndrome, it became clear that the relationship
between the gene defect and the behaviour is not so straightforward. The aggressive
behaviour of (he subjects with a AA4£M gene mutation may be due to distant effects of the
gene on the metabolism of other neurotransmitters (Brunner, 1996].
In conclusion, linkage analysis looking for single causative genes in neuropsychiatric
disorders has only led to very modest results. Linkage analysis looking for multiple genes is
somehow like looking for unknown objects in a haystack. Sometimes this may be a successful
endeavour, but it is generally more rewarding to know more about the kind of object one is
searching. This consideration is in favour of a forward approach based on multiple (candidate)
genes. However, this docs not decrease the complexity of the problem. Considering the given
arguments and questions, we advocate a forward single gene approach as preliminary step
towards more complex models with multiple candidate genes. Understanding the variability
and mechanisms influencing the expression of single genes is in our view elementary in
dealing with multiple gene models, just like a mason should be acquainted with bricks and
mortar before building houses. Moreover, in families where a single gene has a major effect
on the occurrence of a neuropsychiatric disorder, it may help to understand why there such
variability in the phenotype remains.
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3. Aim of this review
Variability in phenotypic expression is rather the rule than the exception in single gene
disorders, e.g. Fragile X syndrome or neurofibromatosis type). A similar variability may be
expected for genes that have an effect in the pathogenesis of a particular neuropsychiatric
disorder. We reviewed a number of the mechanisms that cause variability, to gain a better
understanding of the difficulties occurring in our research with single candidate genes in
neuropsychiatric disorders, in particular mental retardation and autism. These difficulties are
at least multiplied in similar research with multiple candidate genes. We publish this review,
as it may help to understand why for many years to come child psychiatnsts will have to deal
with a discrepancy between general knowledge about the hereditability of neuropsychiatric
disorders and what can actually be demonstrated in an affected individual or family.
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4. Methods
Literature on gene/behaviour research was selected from more than 6000 Medlinc references
on the topic. One group of articles covers the past four decades, and consists mainly of review
articles by influential authors, and articles that have been seminal in the Held of
gene/behaviour research. The second group of selected articles are specific research findings
on molecular mechanisms in single gene disorders. For obvious reasons, we favoured papers
on single gene disorders with an associated behavioural phenotype, though this was not a
strict limitation. Another bias was that we favoured papers on psychiatric and genetic
conditions that are subject of research in our centre, e.g. autism, mental retardation, dynamic
mutations, Vclo-Cardio-Facial Syndrome (VCFS). , . , • .
5. Gene/behaviour relationships in single-gene disorders with a
behavioural phenotype
Behaviour researchers often assume that single gene disorders have a dichotomous effect on
development, with a clear-cut phenotype when the gene defect is present versus normality
when it is not [Plomin et al„ 2000]. While this may be true in Huntingtons chorea, the
dichotomy between normality and impairment is not always so clear in other conditions. In
Neurofibromatosis type I (NF1), even when pathognomonic physical signs are present, the
behaviour of the subject may not be affected, while other subjects manifest marked learning
problems and/or behavioural impairment like poor social abilities and poor impulse control.
In a family, some affected members may only show minor physical signs, while others, with
exactly the same NF/ gene mutation have marked behavioural impairment [KayI and Moore,
2000]. The same phenomenon occurs in females with the fragile X full mutation, of which at
least 25% have no cognitive or behavioural impairment. It is also seen in VCFS caused by a
microdeletion of a small group of genes on chromosome 22ql 1 (22q 11-deletion). Some of
these subjects have marked cognitive impairment, a higher than expected number of them has
psychotic disorders, but others have no marked behavioural impairment. This phenomenon is
independent of cardiac malformations that also occur with great variability in VCFS [Swillen
et al., 1999]. In tuberous sclerosis, some subjects have severe autism and/or epilepsy, while
others are normal [Hunt and Shepherd, 1993].
These examples demonstrate that disorders of single genes that are expressed in the central
nervous system, do not necessarily have a dichotomous effect on behaviour, but rather lead to
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a spectrum of both quantitative and qualitative impairment. In some single gene disorders, the
impairment will be severe and look like a dichotomy. Only a small minority of fragile-X
males have a cognitive level in the normal range [Steyaert ct al., 1996], while the majority
have moderate mental retardation. In other single gene disorders, e.g. NF1. this dichotomy is
not present and the phenotype is a continuum ranging from impairment to normality. These
genes have a reduced penetrance in a number of individuals, and these carriers transmit the
disease through their pedigree while they are clinically unaffected. Thus, in a number of
families with several members with a neuropsychiatric disorder, a single gene anomaly can be
associated with a distinct phenotype, while in other families the same phenotype is caused by
additive effect of multiple genes. For example, in a sample of subjects with schizophrenia, a
small but higher than expected number have 22ql I-deletion [Bassett et al., 1998], while in
other subjects, other genetic or non-genetic factors underlie the disorder. We do not know
how often single gene defects or variants occur in a large population of subjects with a
particular psychiatric phenotype: a large number of single gene disorders is still unknown, and
so is their prevalence. These conditions are not necessarily very rare: 22ql 1-deletion and the
AW-gene mutations are present in I in 4000 individuals. Moreover, single gene disorders are
not always associated with a recognisable physical phenotype: in X-linked mental retardation
(XLMR) at least 33 genes on the X chromosome are associated with moderate or mild mental
retardation in males, without being associated with a particular physical phenotype [Chiurazzi
et al., 2001). It is possible that these so-called non-specific XLMR-genes are actually
associated with specific behavioural phenotypes [Fisch, 2000].
To understand the possible effects of single genes on behaviour, it is important to understand
the mechanisms that can explain the large variability in phenotype. History has shown that
discovering such a mechanism in one gene can help to discover the gene-phenotype pathways
in other genes in which a similar mechanism operates. When intergenerational amplification
of a trinucleotidc repeat was discovered as the underlying molecular mechanism in fragile-X
syndrome, this helped elucidate the phenomenon of anticipation' in several neurological
diseases [Petronis and Kennedy, 1995]. The different impact of a single gene on the
phenotype can be explained by some of the mechanisms discussed below, though this
overview is certainly not exhaustive.
' Anticipation means thai a particular hereditary disease occurs a younger age and has a more severe course in
offspring than in parcnU.
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5.1. Phenorypical differences and genotvpical heterogeneity
One reason why the phenotype of a clinical disorder can differ in severity between subjects is
the fact that the disorder may have different, though often related, genetic causes. In early-
onset Alzheimer's disease (EOAD), at least three different genes coding for enzymes in the
biochemical pathway of amyloid ß peptide lead to a similar neuropsychiatric disorder, though
the average age of onset of EOAD may differ depending on which of the genes is mutated
(Cruts and Van Broeckhoven, 1998].
Another form of genetic heterogeneity is when different mutations of a disease gene coexist in
the population, each of them with a different impact on the phenotype. In the autosomal
recessive metabolic disorder phenylketonuria (PKU), a deficit of the enzyme phenylalanine
hydroxylase results in elevated levels of phenylalanine and a varying degree of mental
retardation when untreated. Different mutations in this gene result in varying degrees of
elevated phenylalanine and mental retardation [Guttler and Guldberg. 2000]. In cystic fibrosis
(CF), an autosomal recessive disorder with severe pulmonary and pancreatic involvement, at
least 300 different mutations in the C'FT/J-gene have been described |Claustres ct al., 2000].
These different mutations have a different impact on the phenotype: the typical severe CF-
phenotype is associated with a "severe" mutation on each of both allcles, while "milder"
mutations on both alleles or a severe mutation on one allele combined with a normal allelc,
are associated with bilateral absence of the vas deferens in males, but not with CF.
5.2. Dynamic repeats, anticipation, variable expression
In the genome many forms of particular sequences of two, three or four base pairs occur.
These di- tri- or tetranucleotide repeats are generally stable. The term "dynamic mutations" is
used for these polynucleotide repeats that may become unstable and expand over generations
[Richards R.I., 2001]. A CGG-trinucleotide repeat was first described in the Fragile X Mental
Retardation gene ( f AYÄ/-gene) [Yu et al., 1991], and later found to be the cause of the fragile-
X phenotype [Verkerk et al., 1991 ]. Healthy subjects have less than 50 CGG repeats, and this
number is stable from parents to offspring. Normal individuals can however also be carrier of
a so-called premutation. with 50 to 200 CGG repeats. This number of CGG repeats becomes
unstable when transmitted by a female. Once the expansion exceeds 200 CGG repeats, the full
mutation is present. Translation of the FA/Ä/-gene is impaired, resulting in absence of the
FMRI-protein [Feng et al., 1995], expressed in the fragile-X phenotype. This mechanism may
take several generations before the syndrome occurs. In fragile-X syndrome, the phenotype
varies in a rather dichotomous way: males with the premutation do not have the fragile-X
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phenotype, while males with the mutation do. Dynamic mutations are the cause of at least
seven disorder phenotypes (see Table 5) (OMIM, 2002; Richards R.I., 2001 ]. In some of these
disorders, e.g. Friedreich's Ataxia and SCA, there is additional genetical and phenotypical
heterogeneity. It is striking that all the dynamic mutations that have been described until now
primarily affect the central nervous system. In trinucleotide repeat disorders, the severity of
the phenotype may depend on the expansion length of the triplet repeat, and there are often
threshold effects. In Huntington's disease the disease occurs above a threshold of 37 CAG
repeats in the gene, and above (hat threshold longer repeats are associated with an earlier age
of onset and a more malignant disease process [Brandt et al , 1996]. It has been suggested that
also in multiplex families with major psychoses an expanding trinucleotide repeat might
explain the finding that the disease process can get worse in consecutive generations
(anticipation) (Petronis and Kennedy, 1995). This hypothesis has not been confirmed sofar.
Table 5 Overview of central nervous system disorders associated with dynamic mutations.
Disorder Mutation
Fragile X syndrome (CCG)n repeat expansion in promoter region of FA/Ä/-
gene; locus Xq27.3
Myotonie Dystrophy (CTG)n repeat expansion in untranslated region of
D J W K gene: locus I9ql3.3
Huntington's chorea (CAG)n repeat expansion in /;Nm;>jg/;>? gene; locus
4pl6.3
Spinocerebellar ataxias type 1-17 (SCAI- At least 17 different genes. In at least 7 of these, the
SCA 17). mutation is a dynamic (CAG)n repeat expansion.
Friedreich's ataxia (FRDA) (GAA)n repeat expansion injra/oxin gene; locus 9ql3.
Other gene (/WMaxm-2) at locus 9p23.
Dentatorubral pallidoluysian atrophy (CAG)n repeat expansion in o/rop/iin-/ gene; locus
12pl3.3l
Spino-bulbar muscular atrophy (Kennedy (CAG)n repeat expansion in androgen receptor gene*;
disease) locus Xql l-q!2
77w oVifa are fräset/ on "On/i'ne A/enaWian /nAeri'rance in A/an "-aVj/aAaie [OMIM. 2002]. 77ii.s
«verWeH' «foes no/ /nc/i«/e aVjordVrj /na/ nai« on/y 6een/ö«nrf m a very jma// numfrer o/ttift/ecte.
•Sma//er /nan average re/Tea/ /engrnj a/ rtu ji/e /xuriMv rryuVf in a njgner m/t/or/war/a/? cancer
[Irvine et al.. 1995]
Another aspect of trinucleotide expansions is that we do not know much about the phenotype
of expansions that exceed the normal range but which are not associated with the classical
phenotype of that disorder. Some findings suggest that in some genes, intermediate repeat
lengths could be associated with different phenotypes. The fragile-X premutation, an
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expansion of 55 to 200 CGG repeats near the FA/Ä/-gcne is not associated with the fragilc-X
phenotype. However, there is strong evidence that female carriers of the premutalion are at
risk for premature ovarian failure |Allingham-Hawkins et al., 1999), and there are suggestions
that a number of them have a different cognitive development (Steyaert et al., 2002; Tassonc
et al., 2000cJ. In the SC.4Ä gene, an expansion between 107 and 127 CTG-repeats is
associated with Spinocerebellar Ataxia. while much longer repeats are associated with major
psychosis in some individuals, and not with Spinocerebellar Alaxia (Vincent J.B. ct al.. 2000).
It is clear that the importance of tnnucleotide repeats in ncuropsychiatnc disorders should be
studied further. ,•• .•_••• - .•.-••,;-.;...... -.- .-,- . • • : ; . i . u ^ . ? • : » , . -
5.3. Sex effect»
An obvious reason for phenotypical variation is sex effect in X-linked disorders. Females can
benefit from the compensatory effect of the homologue gene on their second X-chromosome.
In some conditions, e.g. colour blindness, females will be clinically unaffected carriers of the
gene. In other conditions, e.g. fragile-X, females manifest a broad phenotypical spectrum,
ranging from complete normality to moderate mental retardation. However, more indirect sex
effects also exist in the expression of genes associated with particular phenotypes. Genetic
factors play an important role in the autism phenotype. Autism is strikingly more frequent in
males than in females, but no data have been found in favour of the location of "autism"
genes on the X chromosome. Therefore, it is assumed that pre-natal hormonal effects may
play a role in the expression of the autism phenotype (Manning et al., 2001 ].
5.4. Effects of other genes
Other genes can affect the outcome in a single gene disorder The effect of a defective gene
can depend on the functioning of another gene. In a number of metabolic pathways, poor or
absent expression of two genes may be necessary before any phenotypical effect is present.
This is of course the case in autosomal recessive disorders, where the presence of one normal
copy of the gene is sufficient for normal functioning, while absence of both alleles causes
disease. In addition, more subtle mechanisms exist: in some monogenic mental retardation
disorders, the mutated gene has such an impact on cognitive function that the level of mental
retardation is independent of other factors. In other disorders, though the affected subjects
have a marked cognitive impairment, the intelligence quotient correlates with the cognitive
level of the subject's parents. This was demonstrated in VCFS (22q 11-deletion) (Swillen et
al., 1997], It is assumed that in VCFS "background" genes still influence intelligence, while
they have no effect in Fragile X syndrome.
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It becomes even more complicated when mutations in several different genes are necessary
for the disease to occur, as suggested in the theory of polygenic inheritance of disorders. Few
examples in molecular genetics support this. One example is that of Bardet-Biedl syndrome
(BBS), an autosomal recessive disorder including pigmentary retinal dystrophy, polydactyly,
obesity, developmental delay and renal defects. Two different genes for BBS have been
found. BBS2 and BBS6 and it was expected that subjects with two mutated BBS2 or BBS6
genes would manifest the BBS phenotype [Katsanis et al., 2001]. However, in the studied
pedigrees subjects were found with two mutated BBS2 genes and a normal phenotype, while
an additional mutation in one of the BBS6 genes is necessary to manifest the BBS phenotype.
5.5. Distant effects of gene defects
Gene defects can have molecular consequences that extend far beyond the obvious pathway of
gene, gene product and the metabolic function of the gene product. Firstly, through feedback
mechanisms, poor or absent expression of a gene may increase translation to messenger RNA
(mRNA). Kventually this specific mRNA will accumulate. There is evidence that in Myotonie
Dystrophy, the myopathy is caused by the mutant mRNA, while cardiac conduction defects
and cataracts are caused by a deficiency in the DMPK protein, the gene product of one of the
two known genes responsible for Myotonie Dystrophy [Tapscott and Thornton, 2001]. In
carriers of the fragile-X premutation the mRNA levels of the FA//?/-gene are much higher
than in normal controls [Tassone et al., 2000b], and it is thougth that this may play a role in
the phenotypical anomalies found in some fragile-X premutation carriers (see above).
Secondly, the absence of a particular gene product may have positive or negative feed back
effect on the translation of other genes. In mice without FA/Ä/-gene (knock-out fragile-X
mice), the expression of at least 200 genes has changed quantitatively [Gantois and Kooy,
2002; Gantois et a l , 2002].
Thirdly, in neurotransmitter metabolism changes in a coding gene may alter the efficiency of
an enzyme, resulting in other metabolic equilibriums and consequently different concentration
of the neurotransmilter. In Brunner's syndrome [Brunner et al., 1993] the MAO-A deficiency
has complex effects on the function of several neurotransmitters and it is not clear which of
these changes affect behaviour [Brunner, 1996].
5.6. Chance
Randomness is a fundamental characteristic of probabilistic events and consequently these are
difficult to describe. However, stochastic effects (the cumulative effect of probabilistic
events) play a role in the development of a complex organism. This is one of the reasons why
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monozygotic twins (MZT) arc noi completely similar and may have different anatomical
defects although they share the genetic susceptibility for this defect. Individuals with trisomy
21 or 22q 11 -deletion often have atrioventricular septum defects (AVSD). However, MZT
pairs with these genetic syndromes may be discordant for cardiac defects (Vincent M.C. et al.,
1999]. Even in one individual, a gene defect may affect one side of the body and not the other,
as seen in the Bardet-Biedl syndrome (see above), where the polydactyly may only affect one
hand and not the other. This phenomenon of asymmetry due to probabilistic events can also
be observed in normal development: e.g. selective breeding shows that the average length of
the white leg markings in horses is hereditary, but the differences of these white markings
between left and right legs are probabilistic and not determined by genes [Woolf, 1995].
To demonstrate the stochastic basis of closure of the atrioventricular septum, a computer
model simulating the growth of the septum between the two endocardial cushions during
embryonic development was made [Korenberg and Kurnit, 1995]. The septum closes through
cell division, migration and adhesion. The computer model allowed for skewing of
(genetically determined) parameters for cell division, migration and adhesion between cells,
as seems to be the case in trisomy 21. Consecutive runs of the computer program with an
identical skewing resulted in non-closure of the atrioventricular septum in a number of runs,
but not in others. Thus, changing these genetically determined parameters resulted in an
increased chance to develop an AVSD, but did not predict normal or abnormal development
in a dichotomous way. This is exactly what happens in trisomy 21, where some children with
Down syndrome are born with AVSD and others with a normal heart, even in monozygotic
twins. This shows that stochastic effects can yield significant phenotypic variability among
individuals with identical genotypes and environments.
6. Discussion
Quantitative behaviour genetics investigate to what extent a particular behavioural trait or
disorder can be genetically determined and which mechanisms may be involved in iu
heredity. Molecular behaviour genetics investigate which genes can be involved in behaviour
and psychiatric disorders and by which mechanisms these genes operate. In the past few
decades, quantitative and molecular behaviour genetics have yielded important insights in
developmental psychiatry and valuable new techniques in both fields. Though psychiatric
disorders are often strongly genetically determined, they cannot be seen as one-gene-one-
disorder diseases [Plomin el al., 1994]. Their heredity generally does not follow classic
(40) Oia/?/«?r 3
Mendelian rules, and more complex forms of heredity have been suggested. Quantitative
genetics has provided strong arguments in favour of polygenic causality. According to this
model, a large number of genes, or quantitative trait loci, in interaction with environment
factors, have an additive effect contributing to the psychiatric phenotype. These studies
necessitate large samples of patients and families, which are inevitably genetically
heterogeneous. The examples given in this review compel us to assume that a large sample
with a particular phenotype, e.g. schizophrenia, consists of at least a subgroup in which the
additive effect of a particular set of genes is responsible for the phenotype, and a subgroup in
which a number of isolated genes, or very few genes cause the phenotype. One argument in
favour of the existence of this mono- or paucigenic group is that some single gene disorders
and isolated chromosomal defects are associated with a psychiatric phenotype. A second
argument is that the few molecular studies on polygenic mechanisms have showed so far that
even when the additive effect of a large number of genes is analysed, this only explains a
modest part of the variance, even in disorders with a high hereditability [Comings et a)..
2000). To complicate matters, the polygenic group may in its turn consist of several
subgroups in each of which a different set of genes contributes to the phenotype. However,
there are no simple clinical means to separate the polygenic and the mono- or paucigenic
groups, and we do not know their relative importance and contribution.
Differentiation of the phenotype may be a rewarding technique to obtain different and
genetically more homogeneous subgroups in these samples, which in their turn would
facilitate the search for the involved genes. By differentiating the phenotype "early onset
Alzheimer's Disease", this method led to the discovery of genes that play a role in
Alzheimer's disease. However, we have only dim cues on how to achieve such a redefinition
of phenotypes. Ideally, it should be based on genetic characteristics, and that is exactly what
we are looking for and do not have yet. Eventually, research based on other phenotypic
categories might lead to the conclusion that the relation between genes and phenotype is often
too complex and indirect, or should be studied in a different way.
Considering these methodological difficulties in the study of gene-behaviour pathways using
a backward approach starting from the phenotype side, it is prudent also to study what we can
learn when starting from the side of molecular biology, or forward approach. Disorders
involving only one or very few genes can have a phenotypic expression that is much more
variable than initially expected, as we have illustrated above. In the past 10 years, in-depth
study of the molecular biology of some of these disorders has revealed formerly unknown
mechanisms, which operate in more genes and disorders. Simultaneous effect of other genes.
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distant effect of gene defects, dynamic mutations, probalistic mechanisms, and yet
undiscovered mechanisms explain the broad phenotypic variance of single gene disorders and
their seemingly non-Mendelian patterns of inheritance. They illustrate how complex the gene-
behaviour pathway already is when the genetic causes are comparatively simple, and give us a
faint idea of the complexity of the problem when a large number of genes are involved. The
rule of parsimony in research suggests studying first how single gene may affect
neuropsychiatric phenotypes. We do not know the prevalence of single gene disorders in a
population with a particular psychiatric phenotypc, but can learn a lot from the study of
phenotypes associated with single gene disorders. First, it gives insight in the pathway
between that particular gene and behaviour. Secondly, through showing which behaviour is
influenced by a particular gene, it may help to redefine the phenotype of neuropsychiatric
disorders, and thus open new alleys in gene-behaviour research of these disorders. Thirdly, it
may lead to previously unknown mechanisms in molecular biology. One way to do this is to
study individual patients or families in whom a neuropsychiatric disorder is associated with a
demonstrable gene defect. This is the case in chromosomal rearrangements, microdeletions, or
microduplications. In chromosomal rearrangements, the genes disrupted at the breakpoints
can be identified. In microdeletions, the effect of deleted genes can be analysed, as is the case
in the association of schizophrenia with 22q-deletion. In microduplications. we can study the
effect of redundant genes, as in the recently discovered association between anxiety disorders
and a microduplication on chromosome IS [Gratacos et al., 2001]. Fourthly, better knowledge
of the building blocks may improve our understanding of how multiple genes operate
together. Finally, focussing on single genes in an array of QTL-gcnes underlying a
neuropsychiatric disorder, may open new alleys to treatment, as was illustrated by the finding
that children with ADHD -a polygenic disorder- have different therapeutic responses to
mcthylphenidatc depending on which alleles of the dopamine receptor D2 genes they have
[Winsberg and Comings, 1999].
Clarifying pathways and hopefully phenotypes using this molecular genetic method will
probably lead to new approaches in quantitative genetics. This may allow new insights into
the genetics of polygenic neuropsychiatric phenotypes, and will certainly bring both field» of
research even closer to each other.

Chapter 4 Fragile X syndrome
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1. Introduction
Fragilc-X syndrome (FXS) is the most frequent form of hereditary MR in males. Its
prevalence in (he general population is estimated between 1/1000 and 1/4000 males [Turner et
al., 1996]. More recent prevalence estimations are lower than the earlier ones. The syndrome
has an X-linked semi-dominant heredity pattern. It can affect several subjects in one or more
branches of a family in which MR had not occurred earlier. The syndrome and its particular
pattern of heredity are caused by a dynamic mutation: an unstable expansion of a trinucleotide
(CGG)n repeat sequence in the promoter region of the FA//?/-gene, located at Xq27.3. This
mechanism was discovered in 1991 [Verkerk et al., 1991). Before the mutation could be
detected by molecular techniques, the diagnosis of FXS was made by demonstrating the
fragile site on the X-chromosome in a lymphocyte culture using an adapted medium
(Sutherland. 1977).
There arc (wo levels of CGG-repeat amplification (see this chapter, section 5). In the pre-
mulution, with expansions of less than 200 repeats, the gene is still expressed and the
individual docs not have the classical fragile-X phenotype. These males and females transmit
the fragile X gene to (he next generation. In the full mutation, the expansion exceeds 200
repeats, the /-'AY/?/-gene is not expressed anymore and the classical fragile-X phenotype
occurs. Males with the full mutation are usually significantly affected. In females with the full
mutation, the degree of impairment varies widely.
2. Clinical phenotype
The classical phenotype of FXS is found in affected adult males. The prominent clinical
features are moderate mental retardation, associated with macro-orchidism and typical
craniofacial features: long and narrow face with prominent forehead and lower jaw, and large
ears [Fryns J. P. et al., 1984a]. Other characteristics include relative macrocephaly, joint
hyperlaxity, muscle hypotonia. arched palate, mid-face hypoplasia with sunken eyes, and
seemingly benign mitral valve prolapse [Laxova, 1994]. Several of these signs have been
attributed to a connective tissue disorder [Opitz et al.. 1984; Srceram et al., 1989].
2.1. Mental retardation
The most salient aspect of the behavioural phenotype is MR. Adult males have an average
mental level in the moderately mentally retarded range. Some have a severe MR and
exceptionally a mild MR. Pre-pubertal boys, and in particular pre-schoolers, have a better
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average mental age than adolescents and adults [Borghgraef et al.. 1987]. Longitudinal
analysis demonstrated that individual subjects show a decline in cognitive level and adaptive
behaviour skills | Borghgraef et al.. 1995; Fisch et al., 1996: Hagcrman R.J et al.. 1989]. The
decline occurs in all tested cognitive areas: quantitative skills, verbal reasoning,
visual/abstract abilities and short-term memory (Fisch el al.. 1996). It is not clear whether this
decline is limited to the period of development from childhood to adolescence, or whether it
continues far into adulthood The latter was suggested in a cross-sectional study (Macs et al.,
1994] but not confirmed by longitudinal studies.
2.2. Social contacl
Initial shyness and gaze aversion are often present. In most fragile X males, social skills are in
accordance with the cognitive level. Some subjects with FXS may have autistic features, in
particular when their mental handicap is severe. Once it was thought that FXS could be the
cause of many cases of autism [Brown et al.. 1982; Hagerman R.J ct al.. 1986b). The latter
view was refuted by showing that autism does not occur more frequently in FXS than in other
subjects with the same level of MR (Fisch, 1992].
2.3. Hyperactivity and attention deficits
Attention-deficit and Hyperactivity Disorder (ADHD) symptoms are a part of the behavioural
phenotype in most boys with FXS [Borghgraef et al.. 1987; Fryns J. P. el al.. 1984a;
Hagerman R. et al.. I98S]. These symptoms tend to decline with age, but many adult males
with FXS are still quite active. Treatment with stimulant medication has proven to be
successful [Hagerman R.J. et al., 1988] in a number of cases. Observations of .subjects with
FXS suggest thai the symptoms of ADHD may at least partly be due to sensory
hyperreactivity and lack of stimulus inhibition (Bocaa and Roberts. 2000; Miller et al., 1999].
This was also observed in knockout mouse models of FXS [Chen and Toth, 2001].
2.4. Language
Articulation is poor, and language is repetitive and characterized by short and fast utterances
[Borghgraef et al.. 1987). Cluttering is often present [Hanson et al.. 1986]. Language
acquisition is slow and in adult FXS males it tends to plateau at a level of about 4 years (Fisch
et a) , 1999b). Their vocabulary level is similar or sometimes better than that of subjects of the
same mental level (Maes et al., 1994).
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2.5. Other characteristics:
Hand biting, hand flapping, and fast rocking are often observed [Bardoni et al.. 2000]. These
symptoms occur in particular when subjects are excited or over-stimulated, and are probably a
sign of their hyperreactivily.
A benign form of epilepsy is present in approximately one quarter of young males with FXS
(Musumcci el al., 1991; Sabaratnamet al., 2001]. It disappears after adolescence in half of the
affected subjects.
3. Females with FXS
In females with the full mutation, physical features resemble those observed in males with
FXS ]flull and Hagcrman, 1993; Riddle et al., 1998): long face, prominent forehead and jaw,
joint hypcrlaxity They present a higher variability of the physical phenotype, due to
individual differences in the activation ratio of the X-chromosome carrying the mutated
/•A/Ä/-gcne.
Early studies already found cognitive impairment in a number of heterozygous carriers of the
fragile X chromosome [Fryns J. P. et al., 1984b; Fryns J. P., 1986; Nielsen et al., 1981;
Uchida and Joyce, 1982]. Studies that are more recent show that at least SO to 60% of women
with the full mutation are cognitively impaired. In these subjects, cognitive impairment
correlates with the activation ratio of the fragile X chromosome [Abrams et al., 1994;
Willemscn et al., 2000], rather than with the length of the amplification. A higher activation
ratio of the fragile X chromosome is associated with lower intelligence. Like in males with
FXS, a cognitive decline in full mutation fragile X females has been observed [Fisch et al.,
1999a].
Before the fragile mutation was found and female pre-mutation carriers could be delineated
from full mutation carriers, it was demonstrated that heterozygotes carrying the fragile X
chromosome and with an IQ in the normal range (full scale IQ higher than 85) have more
specific cognitive problems than expected (see also 0) [Brainard et al., 1991; Kemper et al.,
1986; Miezejeski et al., 1986; Steyacrt et al., 1992; Wolff et al., 1988]. A significant increase
of low academic performance was found in these heterozygote carriers with normal
intelligence (Steyaert et al., 1992; Wolff et al.. 1988]. This finding became clearer after 1991,
when DNA analysis of the fragile X mental retardation gene (FA//?/) became possible. The
presence of cognitive deficits in full mutation carriers was confirmed by several studies
[Franke et al., 1998; Thompson ct al., 1994]. The specific neurocognitive problems found
beside mental retardation are: impairment of executive functions [Bennetto et al., 2001;
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Franke et al.. 1999; Thompson ct al.. 1994], attention deficits [Franke et «I.. 1999), and
impairment of visuo-spatia! functions (Bennetto el al., 2001; Cornish ct al.. I999|.
Several studies describe excessive shyness, avoidant disorder, social phobia or selective
mutism in girls and women with the full mutation [Franke et al.. 1998; Freund et al.. 1993;
Hagerman R.J. et al.. 1992; Hagerman R.J el al.. 1999]. Other behavioural characteristics
include schizotypal personality characteristics [Sobcsky et al.. 1994a] and a so-called faking-
good profile on a personality questionnaire ISobesky el al., 1994b; Slcyaert et al., 1994],
Women with the full mutation have a significantly higher lifetime prevalence of major
depressive disorder than mothers of similarly handicapped children without FXS (Thompson
etal.. 1996].
4. Premutation carriers
The case of premutation is more equivocal. Initially, the premutation was thought not to affect
their cognitive functioning (Mazzocco and Holden, 1996; Reiss et al., 1993) Recent research
in children carrying the premutation led to the same conclusion [Myers ct al., 2001]. This
view was challenged gradually as minor anthropomorphic anomalies were described in female
and male premutation carriers [Hull and Hagerman, 1993; Loesch et al., 1994; Riddle et al.,
1998].
Female premutation carriers have a significant increase of premature ovarian failure (POF)
[Allingham-Hawkins et al., 1999], while this is not a characteristic of full mutation camera
[Murray et al., 2000). The neurocognitive findings in female premutalion carriers are
equivocal: while some researchers [Franke et al., 1999; Mazzocco and Holden. 1996] did not
find neurocognitive deficits in female premutation carriers, others found moderate cognitive
deficits in two out of six premutation carriers [Tassone et al., 2000c). Some authors have
found mild emotional impairment in females with a "long premutalion" between 100 and 200
repeats, compared with females with shorter premutations [Johnston et al., 2001 ]. The authora
interpreted the findings as a mild manifestation of the classical phenotype in females with the
full mutation. Others found no cognitive impairment in female premutation carriers [Franke et
al., 1999]. These studies are difficult to compare, as they used different approaches in
assessing the group of subjects. Some delineated different subgroups, while others clustered
all premutation earners. In some studies, only a decline in 1Q was considered as relevant,
while others took specific neurocognitive differences into account. A study by our research
group (see Chapter 7). using the latter approach, suggests that some female carriers of the
premutation have distinct cognitive characteristics, which are qualitatively different from the
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findings in female carriers of the full mutalion [Steyaert et al., 2002]. Like the finding of POF
in premutation carriers and not in full mutation carriers, the latter neurocognitive finding
supports the hypothesis that there are two different phenotypes.
There is less information regarding male premutation carriers, or transmitting males. In some
cases, learning disabilities in males in the upper premutation size range have been observed
[Hagerman R.J. et al., 1996]. It is not clear whether the findings of these case studies are
applicable to the whole group of transmitting males.
5. Fragile X syndrome: molecular biology
S.I. The /W/?/-*ene
The fragile X Mental Retardation gene (f<V/Ä/) is located on Xq27.3. It spans about 40 kb and
is composed of 17 exons, encoding a messenger RNA (mRNA) of 3.9 kb [Bardoni ct al.,
2000]. There is u cylosine guanine-guanine (CGG) repeat of varying length at the 5'
untranslated region of the gene, in the first exon of the FA/Ä/-gcne (Figure 1). It is part of a
CpG island that extends upstream of the transcription initiation site (promoter region) and
plays an important role in FA//?/-expression. Most individuals carry 6 to 54 CGG repeats at
this site [Fu et al., 1991]. Approximately I in 510 X chromosomes carries a fragile X
premutation: a FA/Ä/gene with 55 to 200 repeats [Reiss et al., 1994a; Rousseau et al., 1995].
Transcription of the gene carrying this premutation is normal, though translation may be
impaired in the upper premutation repeat size range [Feng et al., 1995]. There is an overlap or
grey zone between the CGG repeat lengths found in the general population (6-54) and the
repeat lengths found in premutation carriers in FXS families (50-200) [Fisch et al., 1994].
Mcthylation of the CpG island occurs when the CGG repeat expansion exceeds 200 repeats
and results in silencing of the FA/Ä/-gene [Hansen et al., 1992]. Even when hypermethylation
is not present, there is diminished translation of mRNA transcript containing a repeat in the
upper premutation range, close to 200 repeats [Feng et al., 1995]. When the expansion
exceeds 200 repeats. 40S ribosomal subunits stall and translation is strongly diminished.
While allclcs with a normal repeat length are stable in the general population, alleles with a
premutation size repeat are unstable and tend to expand from one generation to the next
through maternal inheritance, but not through paternal inheritance [Smits et al., 1992]. Present
knowledge indicates that the expansion to longer repeat lengths is a prezygotic event, which
probably occurs in oogenesis [Moutou et al., 1997], whereas a selection for cells expressing
FMRP, or for a shorter CGG repeat, occurs in fetal spermatogonia [Malter et al.. 1997].
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The CGG repeat length may vary in somatic cells of one individual. Mosaicism of mutation
and premutation in one tissue occurs in as much as 41% of FXS males (Nolin et al., 1994] and
different mutation lengths in one tissue are frequent. The latter causes a smearing
phenomenon on Southern blot analysis of DNA with the FXS mutation. The phenomenon also
occurs in male premutation carriers, who display both contractions and expansion of the
repeat within the premutation range, in both sperm and somatic tissue (Nolin et al., I999J.
The repeat length may vary within one tissue, but there is only limited variation in the
proportion of different repeat lengths in different tissues [Reyniers et al., 1999; Tassone et al.,
1999a]. Relative homogeneity of the distribution of repeat lengths in different tissues is in
accordance with the theory that expansion of the repeat is a very early phenomenon in
development. Methylation mosaicism may also occur in FXS: in different cells the repeat may
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be methylated, while the same repeat length remains unmethylated in other cells [Gene et al.,
2000: Steyacrt et al.. 1996; Tassone et al., 2000a; Wohrle et al.. 1992]. The phenomenon
occurs in subjects with the full mutation, and has been described in subjects with a
prcmutation [Tassone el al.. 1999b]. These two kinds of mosaicism may cause some
differences in repeat lengths and methylation status between different tissues. Assessing
repeal length and mclhylation status in brain tissue by measuring these parameters in
peripheral lymphocytes, as is mostly done, may thus seem imprecise. With some exceptions
[Dobkin el al.. I996|, most cases reported, and in particular post mortem case studies
including brain tissue, have shown strong similarity of the mutation size and methylation
hiatus between tissues |Rcyniers et al., 1999; Tassone et al., 1999a]. The technique has been
accepted to be reliable. This is supported by clinical research, e.g. the finding of a significant
correlation between methylation status in peripheral lymphocytes and the level of cognitive
impairment |Hagcrman R.J. el al.. 1994; Steyacrt et al., 1996].
5.2. The gene product: FMRP
The FA/Ä/gcne transcript is subjected to alternative splicing. Five or six isofonms are
produced and are collectively termed Fragile X Mental Retardation Protein (FMRP) [Bardoni
et al.. 2000] FMRP is an RNA binding protein that is part of a ribonucleoprotein particle
associated with actively translating polyribosomes, and which can shuttle between nucleus
and cytoplasm. Two highly homologous human proteins, FXRIP and FXR2P, share the same
domain structure as FMRP. and probably have similar functions. The properties of FMRP
suggested that il is involved in nuclear export, cytoplasmic transport, and/or translational
control of target mRNAs. In particular, it may play a role in regulation of protein synthesis at
postsynuptic sites of dendrites. and in maturation of dendritic spines [Bardoni et al., 2001;
Braun and Segal. 2000], Efforts are underway to identify the putative specific mRNA targets
of FMRP, and to study the effect of the absence of FMRP on the corresponding proteins. In
mice without FiWÄ/-gene (knock-out fragile-X mice), the level of expression of at least 200
genes has changed [Gantois et al., 2002]. Other approaches have led to the identification of
proteins that interact with FMRP. Some of them discriminate between FMRP and the
homologous FXRI/2P proteins, and may thus be important for defining unique functions of
FMRP that are deficient in Fragile X patients [Bardoni et al.. 2001]. There is evidence that
FMRP causes dose-dependent translation inhibition of some proteins expressed in the brain
ILietal.. 2001],
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The gene is widely expressed, (hough not everywhere, and in different quantities. FA//?/-
mRNA and FMRP are particularly abundant in neurons, in particular in the hippocampus and
the cerebellum (Abitbol et al.. 1993; Bardoni et al.. 2000). High concentrations of FMRP are
also present in epithelial tissues and in spermatogonia [Bachner et al., 1993). In the mouse
embryo. FAY/?/-expression is high during early development and decreases progressively
afterwards. In human embryos, there is high expression of the FA/Ä/-gcne in proliferating,
migrating and differentiated neurons. This suggests that FMRP plays an important role in
early brain development [Agulhon el al., 1999].
The FXS is associated with lack of expression of the FA/Ä/-gene and absence of FMRP
[Ashley et al., 1993; de Vries et al., 1998]. In individuals carrying the premutation expression
of FMRP is mainly normal. In subjects with 100 to 200 CGG repeats, normal levels of FMRP
are associated with increased levels of FA//J/-mRNA [Tassone et al., 2000b). The increased
levels of FA//?/-mRNA are caused by increased transcription of the FA//?/-gene. This is
probably a mechanism that compensates for diminished translational efficiency of varying
degree throughout the whole or a part of the premutation repeat size range. The increase of
FAY/J/-mRNA in the cell may have an effect on the expression of proteins other than FMRP.
This phenomenon has been observed in Myotonie Dystrophy, where intraccllular
accumulation of mRNA transcripted from the mutated gene causes some symptoms of the
disease [Tapscott and Thornton, 2001 ].
6. Patterns of heredity
Once the full mutation is present in a family, the pattern of heredity is typically that of an X-
linked (semi-)dominant disorder (Figure 2). All males who carry the full mutation are
affected, while females are variably affected. Random but individually different inactivation
of fragile X chromosome in brain tissue is probably the cause of the variation of severity in
female earners of the full mutation.
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It is not clear what events affect transition from the normal size allele to the premutation size
allelc. When the premutation is present in a family, male and female carriers may transmit it
to their children. When male premutation earners, or normal transmitting males, transmit the
premutation to their daughters, as a rule there is no expansion of the mutation. Reduction of
the number of repeats occurs occasionally [Fisch et al., 1995). When female premutation
carriers transmit it to their daughters or sons, expansion of the premutation may occur, and
result in a longer premutation or in a full mutation. Female full mutation carriers have a
normal fertility and offspring who inherit their fragile X chromosome will similarly have a
full mutation. In males with the full mutation, sperm may contain a variety of expansion
lengths, including contractions to shorter alleles |Nolin et al.. 1999). This phenomenon is
probably caused by embryonic selection for cells with • short repeal length amongst the
spermatogonia (see above).
7. Brain imaging
Subjects with FXS have relative macrocephaly from early childhood (Fryns J.P., I989J.
Underlying this, there arc anomalies of total brain volume, and of different brain structures.
Magnetic resonance imaging (MRI) and quantitative morphometry showed that subjects with
an FA//?/-mutation have increased total brain volume, and relatively increased volume of the
caudate nucleus and. in males, the lateral ventricle [Reiss et al.. I99S). Both caudate and
lateral ventricular volumes are correlated with IQ. Caudate volume is also correlated with the
methylation status of the FA/Ä-7 gene. Cerebcllar vermis is decreased in males and females
with FXS and fourth ventricle volume is increased [Reiss et al., 1991a; Rciss et al.. 1991b].
Hippocampal volume is larger [Kates et al., 1997; Reiss et al.. 1994b]
A recent study in female premutation carriers demonstrated anatomical and metabolic changes
in this group [Murphy D.G. et al., 1999). Remarkably, the anatomical changes were not or
only partially similar to those found in full mutation subjects. Some findings where even the
opposite of what was found in subjects with a full mutation. Compared with controls, fragile
X premutation carriers had a significant decrease in volume of whole brain, and caudate and
thalamic nuclei bilaterally, and increase in volume of hippocampus, peripheral CSF
bilaterally, and third ventricle These findings add to the hypothesis of a separate phenotype in
the fragile X premutation.
To our knowledge, functional brain imaging has not been performed in males with FXS. In
females with the full mutation, functional MRI was used to examine visuo-spatial working
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memory (Kwon el al., 20011. This study showed that subjects with fragile X syndrome are
unable to modulate activation in the prcfrontal and parietal cortex in response to an increasing
working memory load, and these deficits are related to a lower level of FMRP expression in
FXS. This finding is in accordance with purely neurocognitive research that shows that
executive functions and visuo-spatial abilities are impaired in females with FXS (see above).
8. Causes of variation in the phenotype
Though there are striking similarities in the behaviour and cognitive level of many individuals
with FXS, there is also a remarkable variation in the phenotype. Obvious differences are
caused by sex difference: as a rule female carriers of the full mutation are less affected than
male carriers, as they can benefit from activation of the normal FAY/?/-gene in a number of
cells It is equivocal whether genetic background plays a role in the seventy of the mental
impairment. One study suggested that in female full mutation carriers, the cognitive
impairment correlates with the activation ratio of the fragile X chromosome, but not with the
cognitive level of their non-carrier sisters [de Vrics et al., 1996]. A more recent study suggests
that background genes do play a modest but significant role in the cognitive development
females with the full mutation, but have no significant effect in full mutation males [Dyer-
Friedman et al., 2002]. <i&
Methylation status of the CpG island in the FA//?/-promoter region has a strong effect on the
level of cognitive impairment. Males with similar repeat lengths, but with a different
methylation status, have strongly dissimilar IQ's, dependent on their methylation status
(Steyacrt et al., 1996].
Environmental factors also influence cognitive outcome to a small extend [Dyer-Friedman et
al.. 2002].
Chapter 5 The behavioural phenotype in Myotonie
Dystrophy
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1. Introduction
Myotonie dystrophy (Dyslrophia Myotonica, DM) is a heritable, slowly progressive muscle
disorder with involvement of multiple organ systems. Not only the muscles are affected, but
also the eye. heart, gastrointestinal tract, skin, immune system, endocrine system, skull,
kidneys [Thornton. 1999] and brain [Ashizawa. 1998]. Moreover, these systems may be
affected differentially; the age of onset is variable, as well as the course of the disease. The
severity of the disease tends to increase from one generation to the next, while the age of
onset decreases. This phenomenon is called anticipation. The underlying genetic mechanism
of myotonic dystrophy is that of dynamic mutations, which it shares with tragile-X syndrome,
Huntington'*» disea.se and almost 20 other di.sea.ses affecting the central nervous system. The
molecular mechanisms of myotonic dystrophy have been partly elucidated in the last 10 years.
All these characteristics make myotonic dystrophy "perhaps the most variable of human
disorders" |Harper, 2001].
Myotonic dystrophy affects the brain, and patients with the disorder have a wide range of
behavioural symptoms. Perhaps the most common symptom is daytime sleepiness. Children
with myotonic dystrophy have mild to moderate developmental delays, or may have more
specific behaviour problems. In this chapter, after a review of the clinical and genetic features
of the disease, 1 will focus on the effects of myotonic dystrophy in brain and what is known
about the consequent cognitive and behavioural problems.
2. History
Myotonic disorders are characterized by myotonia, the stiffness of a muscle after contraction.
The first description of this rare clinical sign was made in 1876 by Dr. Julius Thomsen, a
German neurologist who was affected himself. He described a benign hereditary myotonia
beginning in early childhood in his family: Thomsen's disease or myotonia congenita. In the
following years, it became clear that a variant of this clinical entity existed. The new variant
started later in life, and was accompanied by progressive muscle weakness and muscle
wasting. In 1909, Steinen, another German neurologist, delineated this new hereditary
myotonia as a separate entity, which was later named after him. Steinen was the first to
describe clinical signs in systems other than the muscles. Later, the disease was called
dystrophia myotonica, referring to the combination of muscle wasting and myotonia.
Since then, considerable progress has been made on the clinical and genetic aspects of this
disease. Research in myotonic dystrophy can be arbitrarily divided in three phases: an early
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phase, approximately from 1909 to the 1970s, during which most of the symptoms were
described by experienced clinicians who reported case studies or small groups of patients. The
second phase of research in myotonic dystrophy is from the 1970s to 1992, when the
discovery of the gene and the mechanism of the mutation were published (Aslanidis et al.,
1992; Buxton et al.. 1992; Harley et al., 1992a). This phase is characterized by systematic
clinical studies on one hand and a hunt for the myotonic dystrophy gene on the other. In this
"middle phase", it became clear how variable the phenotype of myotonic dystrophy could be.
Unfortunately, knowledge of the different subtypes was not universally shared. Consequently,
many high quality studies contain heterogeneous groups of subjects and are difficult to
compare with each other. The present phase of research on myotonic dystrophy began with
ihe discovery of the mutation, after which the diagnosis could easily be made through a DNA
test. This phase is characterized by fundamental research on the pathway between the
mutation and phenolypc, clinical studies on different aspects of the disease, and in specific
forms of myotonic dystrophy. Several clinical studies have looked for correlations between
clinical characteristics and length of the mutation (see section 4.2, this chapter). One of the
consequences of the easy and definite diagnosis through DNA testing is that subjects with a
mild form of the disease, or at a very early stage of the disease, can be included. For instance,
this has led to the finding that in a particular form of the disease, namely the juvenile onset
myotonic dystrophy, behavioural symptoms can precede neuromuscular symptoms [de Dic-
Smulders C , 2000; Steyaert et al., 2000].
3. Clinical aspects
3.1. Prevalence
Myotonic dystrophy is the most common of myotonic diseases. Its prevalence is estimated at
around one in 8000 persons [Wieringa, 1994]. However, this may be an underestimation as it
is based on the prevalence of the congenital and classical or adult type of the disease, and
probably does not include patients who were not diagnosed because they had not yet
manifested significant symptoms.
3.2. The classical type of myotonic dystrophy
The classical form of myotonic dystrophy begins in late adolescence or adulthood, generally
in the third or fourth decade of life (see Table 6 for overview of symptoms). Retrospectively,
it is often difficult to pinpoint the time when symptoms first occur. Patients may have had
vague cognitive or gastro-intestinal complaints well before any neuromuscular sign appeared.
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Clinicians who are not very familiar with the disease may not interpret this as possible early
symptoms of myotonic dystrophy. Before the first complaints of muscle weakness, the disease
often begins with myotonia: muscles that relax only gradually after an effort. This
phenomenon can impair smooth and precise manual activities. It becomes more severe in cold
weather, and is most pronounced after forceful movements have been made, hand movements
in particular. Most patients experience this only as a minor discomfort and rarely seek medical
attention for the problem. Tongue fasciculations, fine and rapid uncontrolled movements of
the tongue muscles, are another sign of myotonia.
Muscle weakness generally begins in the face, jaw, neck and forearms. Patients typically
exhibit little facial expression, and have progressive ptosis of the eyelids, wasting of the
temporal and |uw muscles, articulation and swallowing problems. Gradually, the muscle
wasting and weakness worsens and patients may eventually become wheel chair bound with
severe respiratory problems, partly due to weakness of the diaphragm and other respiratory
muscles.
One of the most common complaints in adult myotonic dystrophy patients is somnolence
during the day. Patients can fall asleep anywhere and at any time. Besides these prominent
and progressive muscle problems and typical daytime sleepiness, other organ systems are
involved to a varying degree.
A frequent non-muscular symptom of myotonic dystrophy is progressive cataract: the eye lens
becomes gradually more opaque and sight is impaired. In some patients with myotonic
dystrophy, cataract may be the only symptom. These will often occur in members of the older
generations in families with myotonic dystrophy, while members of younger generations are
more severely affected, evincing symptoms in several organ systems. This phenomenon
puzzled early researchers on myotonic dystrophy (Fleisher, (1918) cited by Harper [2001])
and could be explained once the molecular mechanism of a dynamic mutation (see this
chapter, section 4.1) was found to cause myotonic dystrophy.
Myotonic dystrophy not only affects skeletal muscles, but smooth muscle tissue also. Smooth
muscles are responsible for the motility of the gastrointestinal tract from the pharynx and the
oesophagus to the anal sphincter. Smooth muscles control the functions of the urinary
bladder, as well as the working of the iris and the lens in the eye. In myotonic dystrophy, the
smooth muscles of the gastro-intestinal tract are generally the most affected and this leads to a
wide range of complaints and symptoms. Involvement of the pharynx and oesophagus can
lead to swallowing problems and frequent trachea! aspiration. Problems of the colon range
from vague complaints due to motility problems, to more impairing dysfunctions. Some
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patients have chronic diarrhoea, while others have constipation, spastic colon, laxity of the
anal sphincter and faecal soiling. Among patients who have only minimal impairment of
skeletal muscle function, gastro-intestinal problems can be the first real impairment and
reason to seek medical attention.
Cardiac rhythm problems are another complication of myotonic dystrophy. Due to an
abnormality in the conduction fibres of the heart, its electrical activity can be disrupted,
leading to slow and/or irregular heart rhythm. Abnormalities of the electrocardiogram are
frequent in myolonic dystrophy patients, but only a limited number of them have clinically
significant cardiac problems. In the worst case, sudden death occurs. It is unclear how many
premature deaths in myotonic dystrophy are due to cardiac arrhythmias.
Another frequent symptom of myotonic dystrophy is early balding, which is more pronounced
in males than females. The combination of muscle wasting of the jaw and temporal muscles,
lack of facial expression and ptosis of the eyelids, and early balding, give the typical facial
appearance of the adult patient with myotonic dystrophy. Patients with myotonic dystrophy
frequently have an otherwise seldom benign epithelioma of the hair follicles.
These clinical symptoms are the most prominent and well known. Other problems of
myotonic dystrophy include endocrine dysfunctions, disorders of the immune system, of the
liver, gallbladder and kidney and of the peripheral nerves. The endocrine dysfunctions consist
of insulin resistance that may influence brain metabolism (Annane ct al., 1998], abnormal
secretion of growth hormone, testicular atrophy and others. Infertility is frequent in patients
with myotonic dystrophy, particularly in males. • . # * • • * • • . • - . • • ; . « ~ - ^ f S s • * • ,• ,<.• • , • « * * :
Behavioural changes in adult patients, due to involvement of the central nervous system, have
been known since early research in myotonic dystrophy. In addition to daytime sleepiness,
other cognitive and personality changes have been described [Harper, 2001]. These will be
reviewed in section 5, this chapter. Myotonic dystrophy is a progressive degenerative disorder
and, as such, problems become worse with age. Though the variability in symptoms and
degree of impairment varies widely in myotonic dystrophy, the disease can be a cause of early
death The mean age at death in patients with the classic form of myotonic dystrophy is
around 54 years [de Die-Smulders C.E. et al., 1998], the main causes of which are due to
respiratory and cardiac problems.
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Table 6 Principal clinical manifestations in myotonic dystrophy.
System affected Symptoms*
Skeletal muscles - Myotonia. in particular in adult and mild forms, absent in congenital
form
- Progressive wasting & weakness, beginning in face, head and neck,
distal limb muscles, respiratory muscles
- Speech problems.
- In adull and mild form: myotonia
- In congenital form: severe muscle hypotonia. clubfool
Gastrointestinal
Heart
Respiratory system
Endocrine
Eye
Skin
Immune system
Peripheral nerve
- Swallowing problems, oesophageal dysfunction, constipation,
megacolon, laxity of anal sphincter, diarrhoea, vague complaints due to
motility problems
- Conduction problems leading to arrhythmia, cardiomyopathy
- Weakness of respiratory muscles and poor regulation of respiratory
rhythm due lo central nervous system problems; ensuing poor
vcnti\alton and \ung infections
- Testicular atrophy and infertility; insulin resistance with diabetes
mellilus
- Ptosis of the eyelids, cataract, slow reactions of the pupil muscles, slow
eye movements
- Early balding, hair follicle tumors
- Reduced levels of immunoglobulins
- Polyneuropathy
Central nervous system - Excessive daytime sleepiness, excessive nighttime sleep, apathy,
specific memory problems, possible personality changes
- Mental retardation in congenital myotonic dystrophy.
- Learning problems in childhood onset myotonic dystrophy.
- Other behaviour problems in children: social functioning, ADHD.
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3.3. The congenital type of myotonic dystrophy
In I960, Vanier gave the first description of myotonic dystrophy in infants [Vanier, I960].
This was much later than the descriptions of the classical type of myotonic dystrophy in
adults. Frequent neonatal deaths in families with myotonic dystrophy had previously probably
not been recognized as children with a severe form of the disease. Alternatively, they may
have been attributed to maternal problems due to myotonic dystrophy. Indeed, children with
congenital myotonic dystrophy generally inherit the disorder from their mother (see section
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5.1. this chapter), while patients with the classical adult form may inherit it from either parent.
Only when children with congenital myotonic dystrophy could be kept alive by means of
improved neonatal resuscitation techniques did it become clear that a congenital form of
myotonic dystrophy existed. Symptoms are already present before birth, as these children
show reduced foetal movements. Neonates have severe muscle weakness, with potentially
fatal feeding and respiratory problems. If they survive this initial phase of extreme hypotonia,
muscle strength improves and the child will develop slowly. Muscle weakness is pronounced,
but improves with age. Unlike patients with adult onset myotonic dystrophy, these children
have no marked muscle wasting. Muscle weakness is particularly evident in the face, with an
open mouth and tented upper lip as clinical hallmarks of congenital myotonic dystrophy.
Motor development of these children is delayed, and many will need physiotherapy to Icurn to
walk. A number of infants are born with clubfeet (talipes). Myotonia is markedly absent in the
congenital form.
Cognitive development in children with congen'ita'i myoioriic dystrophy is öriaycö. TYicy YIKVC
an average mental age in the mildly retarded range (sec section 5.1, this chapter). Due to
peripheral muscle hypotonia and to developmental problems in the central nervous system,
speech and language development are delayed [Harper, 2001].
As in the classic form of myotonic dystrophy, gastro-intestinal symptoms occur in early life.
Other systemic features of the classical type of myotonic dystrophy may be present in patients
with the congenital form. Longitudinal research looking at the various systemic problems in
this form of myotonic dystrophy is scarce, and it is still unclear whether these symptoms arc
already present in early life, or whether they appear gradually in the course of development.
Most children with congenital myotonic dystrophy generally live into adulthood. In
adolescence and early adulthood, they have increasing muscle weakness and other
characteristics of the classical adult type. Only half of them survive into their thirties and
forties [Mathieu et al., 1999].
Though it is now evident that the classical adult form and the congenital form of myotonic
dystrophy have the same genetic cause, they seem to belong to two different categories of
disorders [Harper. 2001]. Adult myotonic dystrophy is a typical progressive degenerative
disorder, where a formerly healthy individual becomes gradually more impaired. Congenital
myotonic dystrophy however, has more characteristics of a developmental disorder, in which
an individual with severe problems in early childhood improves progressively though he or
she maintains a number of features of the disorder. Only in later life do individuals with
congenital myotonic dystrophy show signs of degeneration. Despite the same genetic cause, it
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is still unclear whether different pathophysiological mechanisms account for the different
characteristics in these two forms of myotonic dystrophy.
3.4. Other phenotypes in myotonic dystrophy
Although the classical adult type and the congenital type of myotonic dystrophy arc best
known and generally well recognized by physicians, two other forms exist: the mild form and
the childhood or juvenile form (see Table 7). In the mild or minimal form of myotonic
dystrophy, subjects have no or only minimal muscle weakness and myotonia. Symptoms
begin after the age of SO and are not easy to differentiate from normal senescence [Thornton,
1999). Cataract of the eye lens at an earlier age may be considerable and sometimes this is the
only reason why affected individuals seek medical attention. In these patients, the diagnosis of
myotonic dystrophy is often made only after the diagnosis has been made in more affected
relatives.
_,j HS ..,.•!• i ...,,...... , Table 7 The four subtypes of myotonic dystrophy
Subtype Age at onset Initial symptoms Range of number
of CTG repeats
Congenital Pre-natal/ Reduced foetal movements, swallowing 1000-5000
birth and respiratory problems at birth,
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Childhood yy *? 1-12 years Learning and/or behaviour difficulties; 500-2000
(juvenile) speech problems
Adult (classical) 12-50 years Myotonia, muscle weakness 100-1000
Mild > 50 years Cataract 40-80
<Wqprec//rr>m <fr Dic-SmuMers [de Die-Smulders C, 2000p
In the childhood or juvenile type of myotonic dystrophy, children are unaffected at birth and
show symptoms before the age of 12. Mild muscle signs develop in late childhood or
adolescence, and arc seldom impairing [de Die-Smulders C. 2000]. These children may have
significant cognitive and/or behavioural problems that precede the muscle symptoms
[Steyaert et al., 1997; Steyaert et al., 2000]. Medical attention is sought first for behaviour or
learning difficulties, rather than for physical complaints. If the clinician is not aware that
myotonic dystrophy occurs in the family, he or she may miss the fact that the presenting
behaviour problems may be early symptoms of this disease. In adulthood, children with the
juvenile form have progressive muscle weakness and the other system manifestations of
myotonic dystrophy. Though these individuals have earlier signs of the disease and manifest
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earlier impairment, current research does not clarify whether these patients have an average
shorter life expectancy than patients with the classical adult type |Mathieu el al., 1999],
3.5. Other myotonies ' ****••»«»«* -^ t*' -''
When the gene and the mutation for myotonic dystrophy were discovered on chromosome 19,
the mutation could not be demonstrated in all affected families. Based on clinical differences,
the phenotype in these families was called proximal myotonic myopathy (PROMM)|Moxley
•nd Ricker. 1995; Rickcr. 1999] More recently, the ZA'FP gene with a related type of
mutation was discovered on chromosome 3 in individuals with PROMM/DM2 [Liquori et al..
2001]. Based muinly on the different causal genes, a differentiation is made between
myotonic dystrophy type I - with a mutation on chromosome 19, and the most frequent
mutation (95%of cases)-, and myotonic dystrophy type 2 (about 5% of cases), which is caused
by a CCTG tetranucleotide repeat mutation in the ZW9 gene on chromosome 3. It is unclear
whether all cases of PROMM have in fact myotonic dystrophy type 2, or whether there is still
another genetic cause. We will not consider PROMM and DM type 2 further, as little is
known about central nervous system involvement in this disorder. ' ' , •
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Myotonic dystrophy is an autosomal dominant inherited disorder: a carrier of the mutation has
a 50% risk of transmitting the mutant gene. A striking characteristic of families with
myotonic dystrophy, is that older generations are only mildly affected and exhibit symptoms
at an older age, while individuals in younger generations are more severely affected and
present symptoms at an earlier age [Höweler et al., 1989]. As in some other inherited
neuropsychiatric disorders, such as Huntington's chorea, the symptoms of myotonic
dystrophy may worsen and manifest themselves at an earlier age in each consecutive
generation. This phenomenon is called anticipation. The underlying mechanism is that of
expanding polynucleotide repeats, or dynamic mutation [Richards R.I., 2001]. To understand
this mechanism we have to look at the molecular genetics of myotonic dystrophy. " /,"" :
4.1. Molecular genetics
The mutation causing the disease was discovered in 1991 [Aslanidis et al., 1992; Buxton et
al., 1992; Harley et al., 1992a]. The mutation is within a gene on chromosome 19 (19ql3.3)
that codes for an enzyme, the myotonic dystrophy protein kinase (DMPK). The precise
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function of this protein is not yet clear. An untranslated2 region of the gene contains an
unstable repeat sequence of three base pairs: CTG. This locus is called the DM I-locus. In the
general population the number of (CTG)n repeats varies between five and 37 repeats, and the
same number of CTG repeats is inherited from generation to generation. In some families
however, the number of CTG-repeats increases from one generation to the next. When a
threshold of 50 repeats is reached, subjects may be mildly affected. The longer the expansion,
the more unstable it becomes and may expand from one generation to the next. The increase
in repeat number from one generation to the next and the moderate correlation between repeat
number and the seventy of the phenotype demonstrates the phenomenon of anticipation
IHarpcr et al., 1992] There is evidence that the repeat length increases more during maternal
rather than paternal transmission [de Die-Smulders C , 2000; Lavedan et al., 1993]. Men with
moderately long expansions are generally infertile, while women are often still fertile.
Consequently, an increase from a moderate to a long expansion will almost exclusively occur
after maternal inheritance. As longer expansions are often associated with the congenital
phenotype, this phenotype will usually occur after maternal inheritance [Hageman et al.,
1993).
Another characteristic of the mutation is that it is not only unstable from one generation to the
next, but also within one individual. There is marked somatic mosaicism of the expansion
length [Lavedan et al., 1993] and, at least in peripheral blood cells, the expansion length
progresses with age [Martorell et al., 1998]. Consequently, the expansion length found in
peripheral lymphocytes of an individual of a certain age, is not the same and most likely
longer than that in brain cells.
More complicated than the genetics of myotonic dystrophy is the fact that the mutation occurs
in an untranslated region of the gene, and that cells containing the mutation in the DA/PA"-
gene produce the intact protein, although probably in lower quantities. Several theories have
been proposed, and are described elsewhere [Tapscott and Thornton, 2001]. What is important
to know from the present findings is that different mechanisms may underlie different groups
of symptoms. Some symptoms, like the cardiac rhythm problems, are likely caused by a
limited availability of the gene product of the myotonic dystrophy gene, the DMPK-protein.
There is evidence that other symptoms may be caused by the messenger RNA (mRNA)
' Transcription is 'he process occurring in (he cell nucleus in which the DNA is copied into messenger RNA
(mRNA). mRNA carries (he genetic information from the cell nucleus to (he cytoplasm of the cell. In the
translation process, the mRNA is used as information in the building of proteins, (he final product of genes. In
(he translation process, only pans of the mRNA are actually used Some parts have no direct coding function,
and though transcnpied from DNA to mRNA. they will not be translated.
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transcribed from the mutant gene This mRNA also contains a long expansion and cannot be
processed as effectively as normal mRNA. It accumulates in the cell nucleus and may disrupt
normal cell functions by perturbing the processing of other mRNAs such as those for ion
channels [Kimura et al., 2000), insulin receptor [Savkur el a).. 20011 and cardiac isoform of
tropomn T [Philips et al.. 1998). This is thought to cause the muscle weakness and wasting.
Still other mechanisms may be responsible for the cataract of the eye, mediated through
haploinsufficiency for the SLVi-gene [Klescrt et al., 2000; Sarkar el al., 2000, Winchester et
al., 1999]. It is currently not known which mechanism causes the dysfunctions of the central
nervous system in myotonic dystrophy.
4.2. Correlation between expansion length and clinical form of myotonic dystrophy
Four clinical forms of myotonic dystrophy can be differentiated from each other (Table 7). In
forms with an older age of onset, subjects have in average a shorter expansion length. This is
a group effect, and there is significant overlap between the groups. At both ends of the range,
there seems to be a threshold effects: subjects with congenital myotonic dystrophy always
have more than 1000 CTG-repeats at the mutation site, while patients with the mild form have
fewer than 80 CTG-repeats [Thornton, 1999). For CTG repeats between 80 and 1000, the
correlation between phenotype severity and number of repeats is lower. Severity, defined in
terms of cognitive and neuromuscular impairment, correlates more with the age of onset than
with the expansion length of the CTG-repeat. The same is true for life expectancy. Subjects
with the congenital form have, on average, a shorter life expectancy than those with childhood
or adult onset [Mathieu et al., 1999]. Here too, there is significant overlap between the groups.
Subjects with the mild form probably have a normal life expectancy.
5. Behavioural and cognitive aspects of myotonic dystrophy
Early studies described behavioural anomalies in adult myotonic dystrophy patients [Harper,
2001]. Early researchers noted apathy and neglect as signs of myotonic dystrophy and stated
that the myotonic patient's home could be identified through its neglected aspect (Caughey
and Myrianthopoulos, 1963, cited in [Harper, 2001]). Lower intelligence, lack of initiative,
and apathy, were considered as part of the disease, in studies matching myotonic dystrophy
with other muscular dystrophies with comparable muscle impairment. Excessive daytime
sleepiness has been frequently described in adult type myotonic dystrophy, and some studies
suggest a higher incidence of depression and/or personality disorders in adult patients with
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myotonic dystrophy. Children with congenital myotonic dystrophy often present with a
developmental delay.
These findings raise several questions. (I) Which behaviour characteristics are typical for the
myotonic dystrophy phcnolype. and which are rather anecdotal or coincidental? (2) Are the
different subtypes of myotonic dystrophy associated with different behaviour problems? (3)
Arc the behavioural findings a consequence of brain involvement in myotonic dystrophy, or
arc they secondary to the muscle weakness and chronic disability that patients with myotonic
dystrophy experience?
S.I. Cognitive characteristics
Early research on myotonic dystrophy suggested that the disease might be a cause of mental
retardation (Calderon, 1966). Larger studies in the 1980s and early 1990s confirmed the fact
that, as a group, patients with myotonic dystrophy are cognitively impaired [Woodward et al.,
1982). The degree of cognitive delay varied from study to study. Bird and colleagues found
that six out of 29 patients had IQ's below 70 [Bird et al., 1983]. Portwood [ 1986] studied 43
patients and found significant intellectual impairment in the subgroup of patients with
maternal inheritance, but-not in the patients with paternal inheritance. Sinforiani [1991]
confirmed this later. Bird [1983] and Franzcsc [1991] found females to be intellectually more
impaired than males, though others did not confirm this. Degree of intellectual impairment
was found to correlate with age of onset [Huber et al., 1989]. All these studies were
performed before the genetic mechanism of myotonic dystrophy had been revealed, which
made the findings that intellectual impairment correlated with age of onset and with maternal
inheritance difficult to understand.
After the discovery of the dynamic mutation in myotonic dystrophy, studies on intellectual
impairment could be correlated with the length of the CTG expansion. Turnpenny [1994] and
later Perini [1999] found that longer expansion lengths at the myotonic dystrophy mutation
locus correlate moderately with the degree of intellectual impairment. This is different from
what is seen in Fragile X syndrome. In Fragile X syndrome there is a sharp threshold
phenomenon between the premutation and the full mutation. In myotonic dystrophy, the
variance is large, and the expansion length does not predict individual functioning accurately.
In Turnpenny's study, younger age of onset correlated more strongly with lower intelligence
than expansion length. However, as mentioned in the section on molecular genetics, there are
important problems in correlating the expansion length in peripheral blood cells and in brain
cells in a group of individuals with a wide age range: there is a continuous growth of the
A/yofom'c
repeat with increasing age, and there is a significant somatic mosaicism (Martorell ct al.,
1998].
The level of cognitive impairment seems to be directly related to age of onset and repeat
length, but not to muscular impairment. There is broad consensus that children with
congenital myotonic dystrophy have the lowest IQs [Aicardi et al., 1975; Harper, 1975; Huber
et al.. 1989; Johnson ER. et al.. 1995; Roig ct al., 1994; Steyaert el al., 1997; Tuikka et al.,
I993J. At least 75% of them have IQs below 70. Most are in the mildly retarded range, but
some children have a moderate to severe mental retardation. Theoretically, their cognitive
impairment might be caused by a direct effect of the mutation on the brain, or the effect of
muscular impairment in infancy on psychomotor development. Subjects with juvenile-onset
myotonic dystrophy already have cognitive impairment before they have significant muscular
complaints [Goossens et al., 2000; Steyaert et al., 1997]. On the other hand, cognitive
impairment in adult-onset myotonic dystrophy is generally very mild [Franzese et al., 1991J
or even absent [Tuikka et al., 1993].
Data on possible cognitive deterioration during the course of the disease are limited and
equivocal. Tuikka [1993] found no cognitive decline in sixteen myotonic dystrophy patients
after an average follow-up time of 12 years. In a study of 16 children and adolescents with
congenital or juvenile onset myotonic dystrophy, reliable two year follow-up data were
available for two subjects and both showed a significant decline on the same IQ-test, the
Wechsler Intelligence Scale for Children Revised [Steyaert et al., 1997]. Possible cognitive
deterioration in myotonic dystrophy is certainly a subject of further research, particularly in
children with the congenital and juvenile form of the disease.
Another area where further research is necessary is whether there is only a global cognitive
impairment in some forms of myotonic dystrophy, or whether more specific cognitive
problems can be observed. Most studies have not found significant differences between verbal
and performance intelligence. Palmer et al. [1994] noted lower intelligence, visual-
constructive and executive function problems in patients with maternal inheritance but not in
those with paternal inheritance. Memory and visual-perception skills were normal in both
groups. It should be noted that individuals with maternal inheritance will more often present
with congenital myotonic dystrophy, and thus be more affected as a group. A more recent
study with a homogeneous group of non-congenital onset patients, all with normal
intelligence, showed that these persons do have specific memory impairment [Rubinsztcin et
al.. 1997]. In this group, there was a trend towards impairment of executive function as
measured by the Wisconsin Card Sorting Test. Earlier, Woodward and colleagues found more
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severe impairment of executive function in a group of 17 myotonic dystrophy patients
(Woodward et al., 1982). In their study, subjects with myotonic dystrophy scored worse than
controls on almost every neuropsychological measure, and the finding of executive function
impairment was not specific. A study by the Maastricht-Leuven research group demonstrated
Attention Deficit Hyperactivity Disorder (ADHD) in 4 of 16 children with congenital and
juvenile myotonic dystrophy (Chapter 9) [Steyaert et al., 1997], which is significantly higher
than the frequency of 3-5% ADHD occurring in the school-age children's population
[American Psychiatric Association, 1994). These data were confirmed in a second study
limited to children with juvenile onset myotonic dystrophy, where 8 in 24 children were given
this diagnosis [Goosscns ct al., 2000). As the pattern of neuropsychological findings in
children with ADHD implicates deficits in executive function [Faraone and Biederman. 1998;
Sergeunl. 2000J. the finding of ADHD in children with myotonic dystrophy probably reflects
deficits in executive function in these children.
5.2. Somnolence, hypersomnia and sleep apnoea.
In early observations, the somnolence or excessive daytime sleepiness of individuals with
myotonic dystrophy may have been seen as a form of fatigue or as a consequence of
respiratory depression due to muscle weakness [Harper, 2001). The symptom is perhaps one
of the most common features of myotonic dystrophy, and occurs typically when attention is
not focused. Somnolence in myotonic dystrophy is independent of irregular breathing during
night sleep and sleep apnoea. which may also occur in myotonic dystrophy [Gilmartin et al.,
1991; van der Meche ct al., 1994; Ververs et al., 1996). The symptom is significantly more
frequent in subjects with myotonic dystrophy than in controls with other neuromuscular
disorders (Phillips ct al., 1999; Rubinsztein et al., 1998). Rubinsztein et al. [1998) showed that
somnolence is independent of apathy and of depression in patients with myotonic dystrophy.
They conclude that it likely reflects central nervous system involvement and is not secondary
to other symptoms. Phillips et al. [1999] showed that daytime somnolence in myotonic
dystrophy is partially correlated with the degree of muscular disability.
Several authors report that adult patients with myotonic dystrophy also have excessive
nighttime sleep (Ono ct al., 1995; Ono et al., 1998; Rubinsztein et al., 1998). The same
observation was made in children with juvenile myotonic dystrophy (de Die-Smulders C,
2000; Steyaert et al.. 1997).
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5J. Apathy
Apathy, lack of initiative, sitting idly, and indifference have been reported since the early
observations on myotonic dystrophy [Harper, 2001). Systematic observations on apathy in
myotonic dystrophy have been performed by Ambrosini and Nürnberg (1979) and more
recently by Rubinsztein et al. [1998]. The latter study could elegantly demonstrate that apathy
is a common and independent feature of myotonic dystrophy, and cannot be accounted for by
depression or muscle weakness. It is, therefore, likely to reflect central nervous system
involvement. One possible consequence of apathy in myotonic dystrophy may be the high
level of unemployment found among patients with mild physical disability [Fowler et a).,
1997].
5.4. Personality changes
A more controversial subject is whether individuals with myotonic dystrophy have a
particular personality profile, or a higher frequency of personality disorders. Based on
personal impressions of their patients, several early researchers on myotonic dystrophy found
unusual personality characteristics [Harper, 2001]. However, their impressions were not all
the same. Some authors found myotonic dystrophy patients to be cheerful and careless, others
saw them as hostile and unreliable. Research on personality problems has become more
objective, but even then, the subject remains unclear in myotonic dystrophy. Using the
Minnesota Multiphasic Personality Inventory, Bird [1983] found significant personality
changes in eight of 25 (32%) subjects with myotonic dystrophy. On the other hand, Franzese
[1991] did not find significant personality traits in a group of 28 patients with juvenile or
adult-onset myotonic dystrophy. Palmer et al. [1994] found a high incidence of "dependent
tendencies" in the personality of myotonic dystrophy subjects, and attributed this to their
adjustment to a disabling disorder. In another study, Delaporte el al. [1998] found a
homogeneous personality profile in the group of myotonic dystrophy subjects they studied.
They used the International Personality Disorder Examination in adults with minimal muscle
weakness, a group of healthy controls and a group of controls with facioscapulohumeral
dystrophy. Most of the IS subjects with myotonic dystrophy displayed traits of avoidant
personality, four of whom exhibited avoidant personality disorder. They concluded that a
profile consisting of avoidant, obsessive-compulsive, passive-aggressive and schizotypic traits
could not be attributed to adjustment to the disease, but reflected central nervous system
involvement in myotonic dystrophy.
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In these different studies age of onset, degree of physical disability, research instruments and
definition of personality changes vary widely. It is thus impossible to compare them
accurately. However, most researchers and clinicians agree that many persons with myotonic
dystrophy have "something" in the area of emotional functioning and interpersonal
relationships, which is not observed in patients with comparable degree of muscle weakness
due to other progressive neuromuscular diseases. It remains a challenge to identify this
something, perhaps because classical personality inventories that were used in these studies
are not suitable to detect personality traits that mainly occur in organic personality changes.
5.5. Depression
Several studies have suggesied that signs of depression are found more frequently in DM
patients. Duveneck |I986] described significantly more depressive tendencies in patients with
myolonic dystrophy than in patients with other non-progressive or progressive neuromuscular
disorders. However, the degree of depressive traits was mild and the authors could not
conclude that depressive disorder occurs more frequently in myotonic dystrophy. Another
study found depressive disorder in 17% of myotonic dystrophy patients with severe muscle
impairment [Colombo et al., 1992], Less severely affected individuals were not found to be
more severely or more frequently depressed than normal controls (Bungener et al., 1998;
Rubinsztein et al., 1998]. To the contrary. Bungener [1998], found flat affect among persons
with myotonic dystrophy. It is possible that some symptoms like flat affect, apathy,
somnolence (see section 5, this chapter) and other characteristics of myotonic dystrophy may
give the wrong impression that mildly affected myotonic dystrophy patients appear to be
depressed. On the other hand, one can imagine that the threat of further physical decline or
even sudden death due to cardiac arrhythmia can cause depressive disorder in already severely
affected patients. The risk of transmitting the disease to their children is another severe
Stressor for parents with myotonic dystrophy [Faulkner and Kingston, 1998], and this might
also affect these individuals' mood. The question as to whether patients with myotonic
dystrophy have a higher incidence of depressive disorder; and, if so. whether this reflects
central nervous system involvement or adjustment problems in having or transmitting the
disorder, remains to be answered.
5.6. Child psychiatric findings in myotonic dystrophy
The congenital and juvenile forms of myotonic dystrophy have been described more recently
than the classical adult-onset form. To our knowledge, research on the behaviour phenotype in
these forms of myotonic dystrophy is limited, apart from the consistent finding that children
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with congenital myotonic dystrophy have cognitive developmental delays, with an average in
the mildly retarded range (see section S.I, this chapter). Although children with congenital
myotonic dystrophy initially present with neuromuscular problems and developmental delay,
we observed that the first complaints in children with juvenile onset myotonic dystrophy -
symptoms occur before age 12, but are absent at birth - were often learning and attention
problems, even in children with IQs in the low-normal range [Goossens et al., 2000; Steyaert
et al.. 1997] (Chapters 9 & 10. this thesis). Using the Child Behavior Checklist, we found a
marked increase of attention deficits and social problems in children with juvenile myotonic
dystrophy, all of which had no or minimal muscle weakness. A standardized child psychiatric
interview showed u higher than expected frequency of Attention Deficit Hyperactivity
Disorder: 4 in 16 in (he first study [Steyaert et al., 1997], 8 in 24 in the second study
[Goossens et al., 2000]. Symptoms of lack of impulse inhibition and of attention deficit were
more pronounced in these children than symptoms of hyperactivity. Both studies also showed
an increase of anxiety disorders in children with juvenile myotonic dystrophy.
These studies do not demonstrate convincingly whether the behaviour problems and child
psychiatric disorders were a direct consequence of central nervous system involvement, or of
adjustment problems to the disease. The latter hypothesis seems unlikely for several reasons.
In most subjects, the behaviour problems existed before any neuromuscular sign of the
disease, and the very significant increase of one particular child psychiatric disorder.
Attention Deficit Hyperactivity Disorder, rather suggests a brain involvement. Indeed,
adjustment problems would most likely be transient, more diverse, and in line with the
personality development of the individual subjects.
6. Brain involvement in myotonic dystrophy
Individuals with neuromuscular disorders with a genetic origin may show behavioural
problems. These problems however, should not automatically be attributed to a direct effect of
the mutant gene on the brain. Having a chronic disability may cause emotional and mood
problems in affected individuals, e.g. individuals with diabetes mellitus have higher levels of
anxiety and mood problems than controls [Konen et al., 1998]. The idea of having transmitted
the mutated gene to one's children may add to the stress, as observed in otherwise healthy
mothers of children with fragile-X syndrome [Franke et al., 1996; McConkie-Rosell et al.,
1999]. In children with congenital myotonic dystrophy, the severe breathing problems at birth
might lead to brain damage and the muscle weakness in early childhood might impede the
child's normal development. These would be indirect mechanisms influencing the behaviour
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phenotype. In myoiomc dyslrophy research, many resources have been used to demonstrate
direct effects of the mutated gene on the brain. However, questions remain open concerning
the importance of indirect effects of this disabling disorder on development and behaviour.
Insulin resistance is prominent in myotonic dystrophy patients, and impairs cerebral glucose
metabolism [Annanc et al., 1998].
Various approaches have been used to demonstrate direct effects. One has been to take
subjects with other forms of ncuromuscular impairment as control subjects in behaviour
studies with myolonic dystrophy patients. Facioscapulohumeral dystrophy and Charcot-
Manc-Tooth disease arc other hereditary neuromuscular disorders that begin in late childhood
or adulthood, with slowly progressive disability. The degree of disability is very similar to
that in myotonic dystrophy. This approach demonstrates that personality problems [Delaporte,
1998), relative underemployment |Fowler et al., I997|, apathy and hypersomnia [Rubinsztein
ct al., 1998] arc specifically associated with myotonic dystrophy, and not with having a
ncuromuscular disorder. These findings support the idea that myotonic dystrophy is not only a
neuromuscular disorder, but that the brain is also directly involved.
A second and more fundamental approach has been to examine the brains of patients with
myotonic dystrophy. This approach has provided convincing evidence that myotonic
dystrophy is a brain disorder, as much as a neuromuscular disorder [Ashizawa, 1998].
Ncuropathological studies in adult onset myotonic dystrophy have shown several
neurodegenerative changes in the brain: cell loss, neuronal inclusion bodies, neurofibrillary
tangles, and others IHarper, 2001). These changes are somewhat different from those found in
Alzheimer's disease, and thus can be directly related to myotonic dystrophy.
Neuropathological findings in congenital myotonic dystrophy are less conclusive, though
neuronal migration problems have been found in a few cases.
Many brain-imaging studies have been performed in myotonic dystrophy. The earliest ones,
using air encephalogram, showed enlarged cerebral ventricles [Refsum et al., 1967]. This
finding was reproduced in later studies with magnetic resonance imaging (MRI) [Glantz et al.,
1988; Huber et al., 1989]. In some patients, cortical atrophy was also demonstrated [Censori
ct al.. 1994], Although some studies showed that cognitive impairment correlated with degree
of cerebral atrophy (Huber et al., 1989], others did not confirm this finding (Censori et al.,
1994). An important problem in these equivocal results is that the different forms of myotonic
dystrophy had not been clearly delineated in these studies. Hashimoto et al. compared MRI
findings in congenital versus adult onset myotonic dystrophy and demonstrated that the
cerebral atrophy is more marked in the congenital form [Hashimoto et al., 1995]. Giubilci et
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al. found that atrophy of the anterior part of the corpus callosum correlates with sleep
breathing irregularities (Giubilei et al., 1999].
Another common MRI finding in myotonic dystrophy is the presence of white matter
hypenntense lesions [Damian et al., 1994b; Di Costanzoet al., 2001: Hashimoto et al., 199S;
Sinforiani et al., 1991]. Damian el al. found that these white matter lesions correlate with
cognitive impairment when they lie in the white matter immediately adjacent to cortex, but
had no clear clinical significance when they have a perivenincular localization [Damian et al..
1994b]. Neurocognitive dysfunctions correlate more strongly with white matter anomalies
than with ventricular enlargement [Abe et al., 1994]. Chang et al. [1993] found evidence of
diminished cerebral blood flow, most severe in the frontal and lemporoparietal association
cortex. Functional Magnetic Resonance Imaging (FMRI) is a non-invasive imaging technique
that makes it possible to study the concentration of specific chemical compounds in the brain
of living patients. Using FMRI, Chang et al. [1998] demonstrated changed concentrations of
several chemical compounds in the brain of patients with myotonic dystrophy. The degree of
changes correlated well with the length of the CTG-expansion in the myotonic dystrophy
gene.
Brain imaging studies are subject to the same limitation as psychological investigations,
which is that different researchers have included different subgroups of the broad spectrum of
myotonic dystrophy phenotypes, thus making comparisons across investigations difficult.
Nonetheless, the neuropathological studies, and the more recent brain imaging studies, give
convincing evidence that the brain is involved in myotonic dystrophy and support the view
that at least a substantial part of the behaviour phenotype is the direct consequence of a brain
disorder. However, elucidating the pathophysiological mechanisms between the molecular
changes in myotonic dystrophy, the anatomical and functional signs of brain involvement, and
the behavioural phenotype, still requires a lot of work.
7. Diagnosis of myotonic dystrophy
Until the discovery of the gene and the molecular causes of myotonic dystrophy, the diagnosis
was based on clinical observations and family history, and demonstrating electromyographical
and pathological changes in the muscles [Harper, 2001]. Now that direct detection of the
mutated gene through a DNA-test has become possible, making the diagnosis has become
easier. This will probably lead to making the diagnosis in unaffected, or only minimally
affected, family members of patients with myotonic dystrophy. This raises ethical questions,
in particular if parents request asymptomatic children to be tested. The ethical consideration
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about paediatric genetic testing is that if children who are potential carriers of a disease of
which they have no signs (yet), and if uncertainty about their carriership has no effect on later
prognosis, these children should not be tested for the disease until they are mature enough to
decide themselves whether they want to be tested. On the other hand, one should consider that
in children, myotonic dystrophy may begin with behavioural rather than neuromuscular
symptoms, and that lack of the latter symptoms should not impede making an early diagnosis.
Another possible side effect of the easy and very reliable DNA-test is the fact that parts of the
clinical assessment may be neglected in these patients with a complex multi-system disease.
8. Conclusions
Myotonie dystrophy is a multi-system disease with a wide spectrum of clinical
manifestations. Depending on the widely varying age of onset and degree of impairment, four
forms of myotonic dystrophy can be distinguished. The congenital form may present
(initially) an a developmental disorder, with severe symptoms in infancy and consequent
improvement The other three forms present as a slowly progressive degenerative disorder,
which i.s also the fate in adulthood of patients with congenital myotonic dystrophy. There is
convincing evidence that the brain is directly affected, contrarily to many other
neuromuscular disorders. The path from mutant gene to brain pathology, neurophysiological
changes, and finally to behaviour is still unclear.
The behavioural phenotype is quite characteristic, but its degree of expression is variable. As
a rule, an early age of onset of the disorder correlates with a more severe behavioural
phenotype. There is a weaker correlation between age of onset and length of the CTG-
expansion at the mutation site in the gene.
Mild mental retardation is common in congenital myotonic dystrophy, and milder learning
problems are frequent in juvenile myotonic dystrophy. Often, they even precede
neuromuscular symptoms in these children, and should thus warrant the possibility of
myotonic dystrophy in children with learning problems in myotonic dystrophy families. It is
equivocal whether adult-onset patients as a group have a lower intelligence, and there is a
marked lack of follow-up data on the evolution of intelligence in all forms of myotonic
dystrophy.
Besides these global impairments in cognitive ability, impairment of executive functions is
present in all forms of myotonic dystrophy, but not in all individuals with the disease. In
children with juvenile onset, deficits of attention and impulse control may be signs of poor
executive functioning. Apathy is a very common symptom in myotonic dystrophy and is
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independenl of sleep anomalies and depression [Rubinsztein et al, 1998]. In
neuropsychological literature, apathy is mentioned as a sign of frontal lobe dysfunction and as
such may correlate with poor executive function [Kolb and Whishaw, 1996]. Specific
memory dysfunctions have been found in adult-onset myotonic dystrophy. Somnolence
(excessive daytime sleepiness) and hypersomnia are frequent symptoms in myotonic
dystrophy, and reflect brain involvement rather than fatigue due to muscle weakness.
It is equivocal whether myotonic dystrophy patients have a higher incidence of depressive
disorders, and if so, what the pathological mechanism is. Some researchers have found a
higher prevalence of particular personality traits, and/or personality disorders in myotonic
dystrophy, while others have not. It is not clear whether these possible personality problems
are independent of the apathy, poor executive functions and other neurocognitive signs that
we discussed above.
Finally, to our knowledge, nothing is known about the behavioural phenotype in patients with
the mild, late-onset form of myotonic dystrophy. Considering the reflections on age of onset
and degree of behavioural impairment, it is most likely that these patients have no or only
minimal behavioural characteristics.
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1. Abstract
Here we present the results of the study of the cognitive profile of 11 adult, normally
intelligent female fragile X carriers. In all individuals, three types of testing were performed:
full scale Wechsler Adult Intelligence Scale, a set of neuropsychological tests and an
arithmetic achievement test.
All II subjects showed an average to above-average intelligence but 10 of 11 performed better
on the performance than on the verbal subscale. Neuropsychological tests suggest a
dysfunction of the reticulo-thalamic axis with deficiency on tests requiring visual memory and
a pronounced deficiency of attention skills combined with an impulsive way of completing
tests
i'iw /wo///e myemä/e/ragiYe A' carriers. (81)
2. Introduction
During the past few years an increasing number of studies have dealt with the psychological
and behavioural profile of fragile X males [Borghgraef, 1991), (Curfs ct al., 1989]. However,
few studies have been reported on the intellectual and cognitive functioning of fra(X) carrier
females.
3. Materials and methods
We tested 11 women, all obligate carriers of the fragile X syndrome through the female line,
age between 24 and 36 years. All had a normal phenotype. Fragile X screening was low (less
than 4 % fra(X) cells in 4, and negative in the 7 others). Full-scale Wechsler Adult
Intelligence Scale (WA1S) testing was done and the same sequence of subtests was applied in
all subjects.
The second part of the lest setting was a set of neuropsychological tests covering a wide range
of cognitive functions, all tested with the same sequence. The Bourdon-Wiersma test consists
of a widely used cancellation task, evaluating continuous and focussed attention. Verbal
memory and verbal learning were evaluated with Rey's 15- words test; auditory memory
performance for digits with the digit subtest of Elizur's Test for Psycho-organicity; ability to
structure and reproduce visual material with Rey's Complex Figure-test. The Trail-Making
test was taken to evaluate the ability of the subjects to alternate different "mental tracks".
Stroop's Colour Word test was taken to evaluate the ability to suppress interfering stimuli.
Specific arithmetic disabilities were tested with an arithmetic achievement lest evaluating the
four basic arithmetic operations separately. This test is a Dutch school achievement test
designed lo evaluate fourth and fifth grade performance of Belgian school children, i.e. the
level of arithmetics (hat school children should attain to succeed in vocational secondary
schools and corresponding to the level which might have been expected from the tested
subjects, taking inio account their general educational level (7 vocational school, 2 technical
school, and 2 non-university high-school).
4. Results
4-1. Intelligence
The mean intelligence quotient (1Q) of the 11 women was verbal IQ (V1Q) 111.6 (sd= 9.3).
mean performance 1Q (PIQ) 120.0 (sd= 9.9). and mean full scale IQ (FSIQ) 116.5 (sd=9.1).
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Ten of the II subjects had a higher PIQ than VIQ. The mean group difference VIQ-PIQ was
significant: -8.4 (p=O.OI6).
In the subtesl analysis we tried to circumvent the problem of averaging a subtest when the
subjects have different IQ's, as this would automatically lead to between-subject differences.
Hence, before averaging, we compared within-subject deviation of separate subtests. First, the
average standard score was calculated in each subject, for the verbal and performance scale
separately. Then, the difference between a particular subtest and the individual subscale
average was calculated. Finally, these differences for each subtest separately were averaged
for the group (Table «). t-Values were calculated for the mean deviation, which should be
zero for a group, considering the construction of the Wechsler-scales and their standard
scores.
In the verbal subscalc, the subtest "comprehension" was significantly higher than expected for
the VIQ, while "arithmetic" was significantly lower then expected. In the performance
subscalc, we found that the subjects scored lower than expected on the subtest "object
assembly".
Table 8 Mean deviation of mean Standard Scores for WAIS subtests.
Subtest
Vcrbul Subscalc
Information
Comprehension
Arithmetic
Similarities
Digit Span
Vocabulary
Performance subscale
Coding
Picture Completion
Block design
Picture arrangement
Object assembly
For / / .vu/>/>c/.v f<#.W<i
Mean score for the
group
6.45
7.27
5.64
6.82
6.18
6.45
7.54
7.36
7.45
7.73
5.82
(), /><0.05 wAen/-va/ue >
Mean deviation from individual
mean standard score
-0.09
1.18
-0.91
0.27
-0.36
-0.09
0.37
0 18
0.27
0.55
-1.36
•Z28 or f-vo/ue <.?..?£ fmariked wi/A • /
T-score
0.854
4.64*
-2.86*
0.6S
-1.22
-0.38
1.08
0.46
0.98
1.20
-2.56»
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4.2. Neuropsychological
Since performances on many neuropsychological tesis do not follow a normal distribution, we
decided not to use the standard deviation normally applied in the statistical analysis of these
tests. We rather used distribution-free methods i.e. the signed test around the median, or tests
for proportions. In the latter, we compared the probability that the results might be distributed
as they are in the test group, regarding the distribution in the normative population. The
compared distributions are proportions (U-values at statistical analysis) around the raw score
of a particular centile rank (centile 25) or cut-off score in the normative population.
Subjects had problems performing Rey's Complex Figure Test. In this test the score
"structuration type" applies to the strategy the subject follows to copy the figure, while score
"details " is an evaluation of the number and the position of particular details in the subject's
drawing. The norms applied for the copy are more difficult than the norms applied for the
memory reproductions. This group of subjects performed poorly on both "structuration type"
and "details" when copying the figure. This effect was less pronounced at the memory
reproduction. This pattern of performances at Rey's Complex Figure Test is frequently
observed in older children with attention deficits and poor cognitive strategies.
That attention skills were poorer in these 11 adult fragile X carrier females than in the average
population was confirmed in the results of Bourdon's Cancellation Task: 4 subjects went
through the test with more important variation of speed than allowed, 8 subjects had more
omissions than the cut-off score. Subjects performed well on tests that required only visual
skills and orientation. We did not interpret the fact that 9 out of 11 subjects had one indicative
error on Bender's Visual Gestalt Test as a problem of visual skills, as almost all subjects
made the same error: in the Bender Test drawings that have dots, they drew little circles
instead. The subjects did this as well drawing with a soft pencil as with an ink marker. The
testing psychologist thought this phenomenon was rather due to the subjects' impulsive way
of drawing than to a lack of visual skills.
The subjects performed well on auditory memory tasks, as well with digits as with unrelated
words (Rey's 15 Words Test). However, they performed poorly on a visual memory task with
non-complex nonsense drawings (Rey's 15 Figure Test).
As there was no well-standardized Dutch test that could evaluate verbal skills at the limits of
normality, and as there is no overt aphasia in the subjects, we did not evaluate the verbal skills
of the subjects through separate tests. However, clinical observations suggest a discrepancy
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between the quite high verbal fluency of most of the subjects, and the rather poor speech
content in several of them. Taking into account the above- average intelligence of the
subjects, this observation needs further investigation.
4.3. Arithmetic test
All subjects performed well above median percentiles on the four subtests of the arithmetic
achievement test that was used: addition, subtraction, multiplication and division. However, it
is appropriate to use this test rather for adults with average, or slightly below average
intelligence and vocational school education. Although these criteria probably would apply
for most female fragile X carriers, they do not apply for the present group of above average
subjects. Thus, we consider the results of this test as rather inconclusive.
5. Discussion
The aim of the present study was to obtain data on the cognitive profile in fragile X carrier
females As the data and results of neuropsychological tests are only reliable in normally
intelligent individuals, we therefore selected a group of 11 women with normal intelligence,
belonging to eight different fragile X families diagnosed at the Centre for Human Genetics in
Leuven All were obligate fragile X carriers through their mothers and had at least one
affected son and one affected male relative in the maternal line. Females who inherited the
fragile X from their normal transmitting father were not included and will be the subject of a
later study. It is well known that daughters from normal transmitting males constitute a
separate subgroup of fragile X carriers without apparent effect of the carrier state on their
phenotype and their intellectual functioning and, therefore, possibly also on their cognitive
profile [FrynsJ P. 19891.
The results of the Wechsler Adult Intelligence Scale tests showed an average to above-
average performance in all subjects; all but one subject performed better on the performal
than on the verbal subscale. The subjects performed better than normal on the subtest
"comprehension" which indicates that their intelligence was not overrated. They performed
significantly below average on the suhlest "arithmetics" and on the "object assembly" subtest.
However, is it premature to conclude that arithmetic skills arc necessarily abnormally poor in
fragile X carriers: the subtest "arithmetic" not only requires arithmetic skills, but also good
attention skills is the task is given orally and in several items the data and required operation
are embedded as a story, and. as is shown in the neuropsychological tests, precisely the
attention skill of these women was well below expected values
/>ro/f/e in/ema/eyragi'/e A' carriers. (85)
The neuropsychological tests show a deficiency on tests that require visual memory.
Furthermore, there was a pronounced deficiency on tests requiring attention skills: Bourdon's
Cancellation. Task and Rey's Complex Figure Test. In addition, we noted the impulsive way
the subjects worked at most tasks, which is, for instance, reflected in the very poor
"structuration type" at copying Rey's Complex Figure Test and the rude, although
geometrically correct drawings in most tests e.g. the plain circles instead of dots in Bender's
Gestalt Test
This combination of poor attention skills and an impulsive way of completing tests is similar
to that found in fragile X boys, who are in addition hyperactive. We may conclude that the
present group of normally intelligent female fragile X carriers have similar cognitive profiles
as affected fragile X boys, although they show it rather as a "trait" than as gross abnormality.
It should be underscored that we do not know objectively whether this trait affects the general
functioning of these women. Nevertheless, we have the strong impression that most of the
tested subjects function below what might be expected for their intelligence level, and
moreover, we noted that more than half of them show rather chaotic thinking. These
observations suggest deficient executive functions.
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1. Abstract
Several mechanisms can explain the occurrence of full-mutation fragile X males with an IQ
level above -2 SD below mean, also called "high-functioning fragile X males." Incomplete
mcthylation of the CpG island at the 5' end of the FA/A/ gene is one of these mechanisms.
The present study describes the physical and behaviour phenotypes in seven fragile X boys
with CGG repeal insertions in the FA/Ä/ gene between 600-2,400 base pairs. The degree of
methylation at the FA/Ä/-associaled CpG island ranges in peripheral blood lymphocytes from
0-95%. Subjects with a low degree of methylation at this site have mild or absent physical
characteristics of the fragile X syndrome, while subjects with a high degree of methylation at
this site have more severe physical characteristics. In this range of CGG repeat insertion (600-
2.400 base pairs), the degree of mcthylation at the FA/Ä/-associaied CpG island is a good
predictor of intelligence, while CGG repeat insertion length is not
A/0//ecii/ar-//i/?//igence corre/a/ion in ma/« wi/A a fAorr /\A/ÄV mura/ion. (89)
2. Introduction *•
In the first descriptions of fragile X syndrome, mental retardation was considered an absolute
characteristic of fragile X hemizygotes. Later, transmitting males were found in whom mental
retardation and other characteristics of fragile X phenotype were absent, i.e., the so- called
normal transmitting males |Daker, 1983). [Sherman et al., 1985). After the molecular basis of
the fragile X mutation was described [Verkerk et al., I99I], (he normal transmitting males
were found to have a shorter CGG-rcpeat amplification at the FM/f/-gene, and the
differentiation was made between a premutation, with an insertion of <600 base pairs, and a
full mutation, with a longer insertion. Most males with a full mutation in the FA//?/-genc have
fragile X syndrome. Besides physical characteristics and often characteristic behaviour traits,
the fragile X phenotypc includes mild, moderate, or even severe mental retardation
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Only recently, fragile X males with a full mutation have been described with an intelligence
level in the so- called borderline or even normal range [Hagcrman R.J. et al., I994J,
[Rousseau et al., 1994b]. These IQ ranges are defined as between -2 and -1 SD below mean
for borderline range, and IQ higher than -1 SD below mean for normal range. Hagcrman
[Hagerman R.J. et al., 1994) found mild physical signs of fragile X syndrome in most of these
males. Several mechanisms may explain this phenomenon. First, intelligence is a
characteristic influenced by many genes. Thus, as in any population, in a population of fragile
X males the distribution of intelligence level follows a bell-shaped curve. However, in this
particular population, the mean is displaced to the left and is around an IQ of 40, instead of IQ
100, as in the total population. A sporadic individual with a complete FA//?/-mutation could
be at the far right end of the fragile X curve and have an IQ in the normal range. However, in
studies on large groups of fragile X males, Rousseau [Rousseau et al., 1994a] found no males
with a full mutation and normal intelligence, and Hagerman [Hagerman R.J. et al., 1994]
(subjects 17 and 24) reported only 2/29 "high-functioning" fragile X males with a full FA/Ä/-
mutation and complete methylation at the FA/ÄZ-associated CpG island.
Another mechanism to explain the occurrence of "high- functioning" fragile X males is
somatic mosaicism of the mutation. In one tissue, e.g., peripheral lymphocytes, full mutation
and premutation, or different lengths of full mutation or premutation, may occur
simultaneously. This instability can give either two distinct types of cells in a particular tissue
(full mutation / premutation mosaicism), or a whole spectrum of insertion lengths, showing a
smear on Southern blot analysis. Fragile X males with a mosaic pattern of CGG insertion
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length in peripheral lymphocytes seem to have a better average IQ than subjects with only full
mutation [Hagerman R.J. et al.. 1994].
A third proposed possibility is that mosaicism for the length of insertion may not only occur
within one tissue, but also between different tissues. Consequently, while in peripheral
lymphocytes or another tissue a full mutation is found in a subject, it is possible that the brain
cells of this subject carry only the premutation and hence produce FMRI- protein and allow
the subject to have a normal IQ. However, at present little is known about the importance of
mutation differences between different tissues and hence, whether this mechanism contributes
significantly to the occurrence of "high-functioning" fragile X males. For obvious reasons, it
is not possible to evaluate the insertion length in brain cells of subjects.
A fourth mechanism has been described recently: in some "high-functioning" fragile X males
mclhylation of the CpG island al the 5' end of the FA//?/ gene is found in only a fraction of
the cells with a full mutation [Hagerman R.J. et al.. 1994], [Rousseau et al.. 1994b]. The other
cells with the full mutation show no mcthylation at this locus. As methylation represses
>'A/A/-gcne transcription [Sulcliffc el al.. 1992], one could expect some FMRl-protcin to be
produced in subjects with a full mutation but partial melhylation. Hagerman (Hagerman R.J.
et al., 19941 demonstrated FMRI-protein production in two of their "high-functioning"
subjects. In these subjects, the amount of FMRI-protein produced was limited, probably
because the FA/Ä/ mRNA was available only in a limited number of cells. And even in these
cells with full mutation and no methylation, a slowdown of FA/Ä/ mRNA translation can play
a role in limited protein production [Feng et al., 1995].
Combinations of these different mechanisms operating in one subject are also possible,
making the molecular-phenotypical relations only more complex. The present study analyses
the effect of partial methylation of the CpG-island at the fragile X site in a group of boys with
a full CGG repeat expansion in the A'A//?/- gene. . • ' • • - .
3. Materials and Methods
3.1. Subjects
In our patient population, we found seven boys, between 7-15 years old, with a full mutation
at the fragile X site and an incomplete degree of methylation of the FA/Ä/-gene associated
CpG island. The subjects come from five unrelated families: five of them are index patients
who presented at the outpatient clinic (subjects 2,4, 5, and 7) or were seen in an institution for
A/o//ecu/ar-j/t/e///ge/tce corn/a/Zon in mates H>i/A a jAorf FA/Ä7 mu/afioa. (91)
the mentally retarded (subject 6). The two others (subjects 1 and 3) are sibs in two different
families. One of the sibs (subject 3) was known to have learning difficulties, and attention and
behaviour problems, years before fragile X was detected in his younger brother (subject 7). In
the other pair of sibs, the sib who was not an index subject (subject I) had not been reported
as having problems before detection of fragile X in his brother (subject 5).
Six of the seven subjects underwent physical examination in our centre. The seventh subject
(subject 6) underwent physical examination elsewhere, and his physical phenotype will not be
included in the data. Any degree of fragile X phenotype will be reported as "phenotype
present". Intelligence was tested in all subjects with the revised Wechsler Intelligence Scale
for Children (WISC-R), Dutch or French version.
Next, we took a behaviour and psychiatric history of all subjects. In five children, the
Achenbach's Child Behavior Checklist. Dutch version [Verhulst F. C. ct al., 1990], was also
taken. We scored as characteristic for fragile X behaviour phenotype only the combination of
attention deficits/ hyperactivity and some form of shyness or social am- bivalence. We also
scored "behaviour phenotype present" in two adolescent subjects (subjects 2 and 3) in whom
these problems hud occurred in earlier phases of development, but were not clinically
significant anymore.
3.2. Molecular Data
FA//?/ status was determined on DNA analysis of peripheral lymphocytes. Southern blot
analysis using probe St 12.3 was performed after double digestion with EcoRI and Eagl. When
multiple bands of insertion length, or a smear, were found, statistical analysis was performed
separately with the minimum and the maximum insertion length. Degree of methylation was
determined by densitometry on the Southern blot radiograph. When only a thin streak of
methylated DNA and a dense zone of unmethylated DNA were found, limits of precision of
densitometry forced us to consider this arbitrarily as methylation in approximately 5% of
cells.
4. Results
4.1. Phenotypic Characteristics (Table I)
All but one boy of the six who were clinically examined had physical characteristics of fragile
X syndrome. In subjects 2 and 3 this involved only macroorchidism. Subject 4 had
craniofacial characteristics and long ears. Subjects 5 and 7 had the full fragile X phenotype.
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Full scale WISC-R (Table I) intelligence quotient (FSIQ) in subjects ranged from 53-119,
with an average of 78. Subjects 5-7 go to special education schools. In the sib pairs we found
large differences in intelligence level: in the pair subject I/subject S the difference was 63 IQ
points or 4 SD (in the WISC-R, IS IQ points is I SD). and in the pair subject 3/subject 7, 30
IQ points or 2 SD.
Table 9 Summary of Molecular and Phenotypical Data in seven Boys with Fragile X mutation.
Subject
number
1
2
3
4
5
6
7
A«*
10
13
16
7
12
19
9
Full-scale
WISC-R IQ
119
87
83
77
36
70
33
Methylation
(%)
0
13
5
46
88
83
93
Repeat length
(kb)
060
0.90 (smear)
0.55
0.90
1.10
0.2-2.40
(smear)
0.70
Phenotypical
features
present
No
Yes
Yes
Yet
Yes
Missing data
Yes
Behavioural
features
present
No
Yes
Yes
Yes
Yes
Missing data
Yes
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o/ me/Av/af/o/f o/7Ae FA//?/-ajrioc/a/ea' CpG is/ana' Aurer/ion re/err to /ewg/A «/"
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Five of the six boys who underwent psychiatric examination have or have had behaviour
characteristics associated with fragile X syndrome. Subjects 2 and 3 were known as
hyperactive preschoolers and primary school children, though this has disappeared at puberty
in both. Subject 3 had been treated for Attention Deficit Hyperactivity Disorder before fragile
X was known in the family. The mutation was found in this family only later, through subject
3's younger brother, subject 7. Subjects 2 and 3 have had problems in socializing with peers,
with a tendency to withdraw in both. Subject 3 still has these problems. Subject 4 is a
hyperactive child and has problems with social ambivalence. Subject 5 is a hyperactive boy.
Subject 7 is a shy, hyperactive boy and reacts with tantrums to many external stimuli,
especially to acoustic stimuli. Subject 1 also has mild behaviour problems: he has a phobia,
not categorized as typical for fragile X syndrome.
4.2. Molecular Data
Four subjects have a homogenous CGG insertion length in the FA/Ä/ gene, ranging from 600-
1,100 base pairs (Figure 3). In these subjects, percentage of methylation of the
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associated CpG island ranges from 0% (subject I) to 95% (subject 7). Subject 6 has a mosaic
mutation with a small CGG repeat insertion around 200 base pairs (* on gel in Figure 3). and
a longer smear, with mean insertion length at 2,400 base pairs. In this subject, only the CpG
island associated with the longer insertion is methylated. The longer insertion is found in 85%
of lymphocytes. Subject 2 shows a smear centred around 900 base pairs, with 8%
methylation. Subject 3 shows an unmethylated insertion of 550 base pairs and a light streak of
methylated DNA, of a corresponding insertion length. This light streak is interpreted as 5%
methylation.
Figure 3 Southern blot assays with probe Stl2.3 of DNA samples of the seven fragile X boys
were <//#»/«</ wiVA £coÄ//£aj?/ 77ie me/Ziy/a/ea" 6a/«/ of <ipproxjmare/y
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4.3. Statistical Analysis
Pearson correlations between CGG insertion length at (he /•'M/?/-gene and degree of
methylation of the A"A//?/-associated CpG island were calculated. There was no significant
correlation between insertion length and degree of mcthylalion (Pearson correlation 0.519, F
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= 0.223). In a stepwise regression analysis with IQ as dependent variable, the first step with
repeat length as independent variable, could only explain a very small part of variance (r2 =
0.089). When adding degree of methylation to the model, the explained variance significantly
increased (r2 * 0.770). This is also reflected in partial regression correlations with IQ (FSIQ)
of -0.298 for repeat length and -0.860 for degree of methylation. The multivariate regression
analysis is near significance (F = 0.053) in this small sample. Simple regression with degree
of methylation as independent variable is significant (F = 0.013), but not significant for repeal
length as independent variable (F = 0.SI6).
5. Discussion
Since (he finding of an abnormally high and unstable number of CGG repeats at the 5' side of
(he /•A/Ä/gcnc [Verkerk et al.. 1991) as the molecular basis for fragile X syndrome, a
dichotomy has been made between a so- called fragile X prcmuiation, with an unstable CGG
insertion of <600 base pairs, and a full fragile X mutation with a longer CGG insertion and
concomitant methylation of the FA//?/-associated CpG island. The basis for the dichotomy
between premutalion and mutation is the fact that an insertion of <600 base pairs is not
associated with fragile X phenotype, while a longer insertion is associated with fragile X
phenotype in most males, and with a milder phenotype in approximately I in 2 females. The
mcchunism that operates is probably that an insertion of >600 base pairs is generally
associated with methylation of the CpG island at the 5' end of the FM/?/-gene. This
methylation docs not allow transcription of the FA/Ä/-gene, and consequently there is no
production of FMRI -protein in these cells. Sutherland et al. [Sutherland et al., 1991] found
that this process of methylation probably occurs in early embryonic life. However, for some
unknown reason, in some subjects with a mild CGG repeat insertion, methylation does not
occur in all cells. This leads to a phenomenon of partial methylation, in which a fraction of the
cells in a particular tissue is methylated at this site and a fraction is not. Previous studies
showed that fragile X males in whom this occurs are less severely affected than males with
methylation at- this site in all cells. Hagerman [Hagerman R.J. et al., 1994] demonstrated that
this incomplete methylation correlates with some production of FMR 1-protein in these males.
Thus, absence of methylation in a fraction of cells is one of the mechanisms explaining
relatively high functioning in some fragile X males.
In the present study, incomplete methylation occurred mainly in subjects with a CGG
insertion length between SSO and 1,100 base pairs in all lymphocytes. One subject (subject 6)
showed mosaicism of 200/2,400 base pairs. We have not yet found subjects with a long
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insertion in all cells and incomplete methylation. One subject (subject 3) shows mild physical
and behaviour characteristics of fragile X, while insertion length in peripheral lymphocytes is
only 550 base pairs. In this subject, methylation of CpG is present in a small pro- portion of
cells.
The other finding is that in this range of insertion lengths, insertion length per se has no
predictive value for intelligence level or penetrance of other phenotypical characteristics. By
far the most important predictor of intelligence level is the degree of methylation at the
FA/Ä/-associated CpG island. Indeed, linear regression analysis shows that intelligence level
correlates negatively with degree of methylation at this site.
Considering physical phenotype, the present data suggest that with the same insertion length,
[he degree of methylation influences the number of physical signs. Males with a lower degree
of methylation are less severely affected. The data also suggest that in these mildly affected
subjects, macroorchidism is the most frequent physical characteristic of fragile X syndrome.
In this small sample, we did not analyse this finding statistically.
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Chapter 8 A distinct neurocognitive phenotype in
*-* *^ female fragile X premutation carriers
assessed with visual attention tasks.
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1. Abstract
Premature ovarian failure (POF) and underlying hormonal changes are recognised as a
distinct phenotype in female fragile-X premutation carriers. Neurocognitive deficits, in
particular mental retardation, are associated with the full mutation in males and females. In
female full mutation carriers this neurocognitive phenotype is expressed more mildly than in
males. Research on whether the fragile-X premutation is associated with a particular
neurocognitive phenotype or not, has been equivocal. By means of the SVAT computer based
battery of neurocognitive tasks we assessed reaction time on different tasks in three groups of
.subjects: female premutation carriers, female full mutation carriers, and female control
subjects. The results show that a fraction of the female premutation carriers perform poorly on
several selective attention tasks, but not on other tasks. Their neurocognitive profile is
different from that of control subjects and of the majority of female premutation carriers. It
may also be different from the phenotype of female full mutation carriers, though in that
respect this study remains inconclusive. These findings support earlier findings that the
fragilc-X premutution may affect neurocognitive functioning, in particular aspects of
attention.
j»*«ioope in./ema/e.s wi/A a/ragj/e A'/vrmu/af/o/t. (99)
2. Introduction
Fragile-X syndrome is (he most frequent inherited cause of mental retardation in males
[Rousseau et al., 1994a; Rousseau et al., 1995]. The molecular defect consists of an unstable
expansion of a CGG trinucleotide repeat within the 5" untranslated region of the FA//?/-gene
situated at the Xq27.3 fragile-X site of the X chromosome, or FRAXA-site [Verkerk et al.,
1991 ]. Depending on the size of the expansion, the mutation is categorised in two types [Fu et
al., 1991; Hcitz et al., 1992): the full mutation, with an expansion of more than 200 repeats
(>0.6 kbase), and the premutation. with an expansion between SS and 200 CGG repeats (0.15-
0.6 kbase). The full mutation is associated with the fragile-X syndrome in males, and less
frequently in females [Bardoni et al., 2000; Riddle et al.. 1998). In patients with fragile X
syndrome, the expanded CGG triplet repeats in the FA//?/ promoter region of the full
mutation are hyperrnethylated and the expression of the FMÄ/-gene is repressed, which leads
to the absence of FMRI -protein (FMRP) and subsequent mental retardation (Jin and Warren,
2000]. The prcmutution is not associated with hypcrmethylation, and the gene is transcribed
to messenger RNA. Recently, it has been demonstrated that premutation carriers have
increased levels of /•'Ay/f/gene translation [Tassone et al., 2000b] and reduced level of FMRP
[Kenneson et al., 2001].
Initially, the premutation was thought not to affect the phenotype of male and female
premutation carriers [Cianchetti et al., 1992; Mazzocco and Holden, 1996; Reiss et al., 1993].
However, this view was challenged gradually, as minor anthropomorphic anomalies were
described in female permutation carriers [Hull and Hagerman, 1993] and neurocognitive signs
in male premutation carriers [Hagerman R.J. et al., 1996] and recently also in a subgroup of
premutation carriers [Bennetto et al., 2001]. The most striking and robust finding in female
premutation carriers, however, was the occurrence of menopause before the age of 40 due to
premature ovarian failure (POF) in approximately one in six female premutation carriers
[Allingham-Hawkins et al., 1999; Murray et al., 2000]. Moreover, the prevalence of
premutation carriers is significantly increased amongst women with idiopathic POF [Marozzi
et al., 2000; Murray et al., 1998; Uzielli et al., 1999]. Remarkably, the prevalence of POF in
female full mutation carriers is not increased [Allingham-Hawkins et al., 1999; Murray et al.,
2000]. Other reproductive and hormonal anomalies include possible increased twinning in
female obligate fragile-X carriers [Fryns J. P., 1986], and specifically in premutation carriers
[Vianna-Morgante, 1999], and raised serum FSH in female premutation carriers [Murray et
al., 2000]. More recently, anomalies in brain anatomy and metabolism were found in eight
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female premutation carriers [Murphy D.G. et al., 1999], but intelligence does not seem to be
affected (Franke c ta l . 1999). *•
There is not only growing evidence that female and perhaps male premutation carriers may be
different from control subjects. There is also evidence that the pattern of problems is different
in premutation carriers compared to full mutation carriers [Murray et al., 2000], and that the
premutation carriers do not have a mild expression of the classical fragile X phenotype, as is
the case in subjects with a short full mutation with incomplete methylation [Merenstein et al.,
1994; Steyaert et al., 1996). Female full mutation carriers are characterised by behavioural,
neurocognitive and physical features, but not by reproductive anomalies, while reproductive
and associated hormonal anomalies are the most robust finding in a fraction of the female
premutation carriers. The few ncurobiological findings that have been described in female
premutation carriers are also different from those in full mutation carriers. While
neuroimaging shows increased brain volume of the nucleus caudatus in female and male full
mutation carriers [Reiss et al., I99S|, the opposite has been described in female premutation
carriers (Murphy D.G. et al.. I999|. The neurocognitive findings in female premutation
carriers arc equivocal: while some researchers [Franke et al.. 1999; Mazzocco and Holden,
1996] did not find neurocognitive deficits in female premutation carriers, others [Tassone et
al., 2000c] found moderate cognitive deficits in two out of six female premutation carriers. A
recent study on neurocognitive functioning in both full mutation and premutation carriers
showed problems in executive functions in some premutation carriers [Bennetto et al., 2001].
The available data are insufficient to indicate whether the possible neurocognitive deficits in
female premutation carriers are similar to or different from those found in full mutation
carriers. Earlier research showed deficits in executive functions in obligate female carriers
[Mazzocco et al., 1992] and specifically in female full mutation carriers [Abrams et al., 1994;
Sobesky et al.. 1994b]. Executive functions include temporal organisation of activities,
response selection and control of behaviour. These are controlled processes, which require
selective (focused) attention [Franke et al., 1999; Kolb and Whishaw, 1996] also described
deficits in sustained attention in female full mutation carriers. The finding of an increased lie-
scale [Sobesky et al., 1994b] or "faking-good profile" [Steyaert et al., 1994] on the Minnesot»
Multiphasic Personality Inventory in female full mutation carriers might also reflect defective
executive functions.
In conclusion, there are arguments supporting the existence of two different phenotypes in
female fragile X carriers. One phenotype is associated with expansions of less than 200
repeats and no hypermethylation at the fragile X site, and one is associated with more than
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200 repeats and methylation at the fragile X site. The premuiation phenotype is associated
with hormonal and reproductive anomalies in females, and possibly with neurobiological and
neurocognitive changes, while the full mutation is associated with the classical fragile X
phenotype, or Martin-Bell syndrome. In addition, the different findings raise the question why
in the group of female premutation carriers only a minority of subjects are affected. Does this
represent the left end of a left-shifted distribution, or a separate group of subjects in the
population of premutation carriers?
In order to test (his hypothesis further and differentiate possible neurocognitive deficits in
female premutation carriers, we assessed a group of female FRAXA carriers with a sensitive
computerised test battery that measures different aspects of attention. Objectives are to look
whether female premutation carriers, or some of them, have attention deficits, and if so,
whether these are different from neurocognitive deficits in full mutation carriers.
3. Methods
3.1. Subjects ' • . . - • „ • •
We contacted 40 mothers of fragile-X children and their sisters, known at the Centres for
Human Genetics in Leuven and Maastricht. No selection criterion was used. The sisters could
be included either as subjects or as controls, depending on what their FRAXA status would
prove to be in the study. Thirty-seven of them accepted to participate in the study. Their
FA//?/ repeat status was estimated by Southern blot analysis. Six subjects had an FA/Ä/-
expansion in the full mutation range (expansion > 200 repeats), 27 subjects had an expansion
between 55 and 200 repeats, and were classified as premutation subjects. Four sisters had no
expansion in the FAY/?/-region and were classified as normal subjects and put in the control
group. Twenty women of non fragile-X families, consisting of students and administrative
and technical personnel at the department of genetics, were asked to participate as control
subjects. Eighteen of them agreed. FA//?/ status was not checked in these subjects.
Consequently, the subjects were put in either the case group of female FA//?/ full mutation
carriers (6 subjects), the case group of FA//?/ premutation carriers (27 subjects), or the control
group (22 subjects). The age distribution (see Figure 4) is significantly different (two sample
t-test: p<0.001) between control subjects and premutation subjects. There is no significant
difference (p=0.478) between the control subjects and the full mutation subjects. The
difference in age between full mutation and premutation subjects is at the limit of significance
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(p=O.O52). All subjects attended normal school in Belgium or the Netherlands, at least to the
age of 16 years. We did not collect additional information on specific learning disabilities at
school.
The Raven Progressive Matrices [Raven et al„ 1984] was obtained from 16 control subjects
and 30 of the 33 subjects with a full or a premutation. This non-verbal intelligence test was
taken in order to rule out subjects with a low non-verbal intelligence, as this might influence
test performance. All tested subjects scored above the 10th percentile on this preliminary test
and none of them were excluded. The three cases and six controls that were not tested had
completed at least secondary school and we had no reasons to suspect that they might have an
abnormally low intelligence level.
3.2. Assessment of FKAXA status
Gcnomic DNA was collected for Southern blot analysis in the obligate carriers and the control
subjects who were family members of fragile X children, but not in the other control subjects.
In 17 premutation cases, the mcthylation status of the two X chromosomes was analysed by
means of densitometric analysis of the Southern blot electrophoresis gels in order to calculate
the activation ratio of the normal X-chromosomc (Sobesky et al.. 1996].
3.3. Neurocognitive testing
The Sonneville Visual Attentions Tasks battery (SVAT) [de Sonneville and Njiokiktjien,
I988| was used to assess aspects of visual information processing in female premutation and
full mutation carriers. The computer-based battery is designed to address aspects of visual
attention: quality of sustained attention, selective and divided attention. It consists of six
different tasks in which reaction times are measured. Each task addresses one or more aspects
of visual attention Conclusions are drawn from the pattern of reaction times in different tasks
or subtasks. A particular pattern represents strengths or weaknesses in specific aspects of
visual attention. Five essential tasks of the battery were taken from all subjects. Different
tasks have more than one measured variable, e.g. reaction time for correct responses and
reaction time for incorrect responses. In this study, the reaction times for correct responses
were used. The error rates are also reported.
The first task, the Finger Motor Speed Exercise (FMSE), is a baseline test of reaction speed
under the lowest cognitive demands possible. It is used to assess whether pure motor slowness
may have a significant influence on performance on the other tasks.
The Letter Pattern Exercise (LPE) addresses aspects of focussed as well as of divided
attention Subjects have to remember one or more target letters, and press a "correct" button
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when the letter(s) appeals) in consecutive square frames containing four letters. When the
target letter is not present, the subjects actively respond by pressing a "false" button. In each
frame, the subjects are confronted with a new set of four letters, that may or may not contain
the target letter. As each frame can be different from all the previous ones, automatic
processing of the task is not possible. The subjects have to focus intensely on each new set of
four letters.
The Focussed Attention Exercise (FAE) also requires selective attention and response
selection. It resembles the LPE. with the additional difficulty that the subjects may only give a
"correct" response when the target letter is presented on a particular diagonal.
The Dot Pattern Exercise (DPE) is a rather dull task with low cognitive load that addresses
sustained attention. Demands on selective attention are much lower in this task. The subjects
are presented 600 consecutive frames with three, four or five dots. They give a "correct"
response (hit) when four dots appear, and a "false" response (correct rejection) when three or
five dots appear. Subjects seem to automatise this task easily, as there are only three
possibilities, and after less then ten of the 600 frames, the subjects have seen the three
possibilities. To limit the total of variables to analyse, we selected only the reaction time for
ihe hits (four dots).
In the Compatible/Incompatible Response Exercise (CIRE) the subjects are shown 60
consecutive frames with the words "right" or "left", printed either in white letters on a black
screen, or in black letters in a white background frame. When the letters are in white, the left
or right-hand button should be pressed, compatibly with the word left or right. When the
letters are in black, the reverse response should be given. In the SVAT, this is called an
incompatible response. As there are only four possible responses, a subject has seen them all
soon, and processing is at least partly automatic. Even if the level of attention has to remain
high. In the statistical analysis, reaction times for left and right compatible responses were
clustered (TCOMP), as well as the reaction times for left and right incompatible response
(TINCOMP).
3.4. Data analysis
All statistical tests were performed using the Systat 7.0 package [SYSTAT®, 1997]. Two
control subjects, one premutation subject and one full mutation subject were left-handed. The
effect of handedness on task performance is assessed by t-tests comparing the reaction times
of left-handers with the group mean for right-handers of each category of subjects.
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Stepwisc discriminant analysis was performed to analyse which of the SVAT variables is the
strongest discriminator between the three groups of subjects, with the rationale that if there is
a latent fourth group (unusual premuiation subjects), analysing the distribution of the most
differentiating variable would be the best approach to separate this fourth group.
As some groups contained less than 20 subjects, we used non-parametric two-sample
Kolmogorov-Smirnov test to assess between group differences. Non-parametric tests are more
rigorous while parametric tests may yield falsely positive significance in small groups. This
does not allow analysis of covariance however. Classical parametric analysis of covariance
(ANCOVA) was used to analyse the effects of intelligence and age as co-variates.
4. Results
4.1. Effect of handedness
T-tesls comparing left-handed subjects with right-handed subjects were performed for all the
reported SVAT-variables. but did not show influence of handedness. The results of these t-
tcsts are not reported further here.
4.2. Discriminant analysis
Slepwise discriminant analysis aimed at detecting which of the SVAT tasks could
differentiate best between the three groups of subjects, yielded a satisfactory prediction model
(p=O.OSl) including the variables. In this model the reaction time for correct responses on the
LPE has the highest F-value, F=2.63, and was therefore selected as discriminating variable.
The task LPE correlates moderately to highly with other SVAT tasks, and has low
correlations with the independent variables age (Pearson correlation 0.2IS) and non-verbal
intelligence as assessed with the Raven Progressive Matrices intelligence test (Pearson
correlation -0.342). The good differentiating power and the low correlation with age and
intelligence make LPE a suitable variable to analyse further whether subgroups can be found
in within the group of female premutation carriers.
4.3. Premutation carriers versus controls
As two-sample Kolmogorov-Smimov (KS) analysis showed significant group differences
between premutation carriers and controls for the variables age (KS: p=0.001) and Raven IQ
(KS: p=0.007) (see Table I), we performed analysis of covariance (ANCOVA) on LPE with
the covariates age and Raven IQ. ANCOVA for LPE with age as covariate did not yield
significant differences between the premutation carriers and controls: p=0.147. ANCOVA for
LPE with Raven IQ as covariate yielded similar results: p=0.278.
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4.4. Selection of "slow" premutation subjects:
In the next step we evaluated the distribution of this variable in the group of premutation
carriers, which proved to be markedly broader then for the normal controls (see Figure 4):
standard deviation of correct reaction time on the LPE task in normal controls is 67 msec
(mean 588 msec), while it is 139 msec in premutation carriers (mean 650 msec). Subsequently
we selected as "slow" premutations the premutation carriers with scores on LPE exceeding
two standard deviations above the mean of the normal controls. This yielded a group of five
premutation carriers, with markedly slower reaction times on LPE, with a range between 741
and 1122 msec. (Fig. 1.) The remaining premutation carriers are defined as "regular"
premutalions.
4.5. Characteristics of the "slow premutation" subjects
Two-sample KS analysis between controls and the group of regular and slow premutations
respectively, yielded no significant group differences for Reaction Time (T) without cognitive
load. There were however significant differences between controls and slow premutation
subjects on the LPE task while performances of the regular premutation subjects where not
different from that of the controls on these tasks. Error rate on the LPE was not significantly
different between the three groups. Performance of the three groups on the FAE task showed
a similar pattern as the LPE: significant differences on all tasks between the control subjects
and the slow premutation subjects, as well as between the regular and slow premutation
subjects, but no differences between the control and regular premutation subjects. Error rates
on the FAE tasks are not different for the three groups. There were no significant differences
between controls and slow premutations on the DPE task for sustained attention. On the task
Compatible Incompatible Response Exercise (CERE) there were different performances
between the controls and slow premutation subjects, which were significant for the
compatible (TCOMP) but not for the incompatible (TINCOMP) responses. The difference
between regular and slow premutation subjects was more pronounced and reached
significance for both variables. Error rates on all the tasks are not significantly different
between the three groups
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Two-sample KS-analysis on the variable age showed significant differences between controls
and regular premutations. as well as between controls and slow premutations. There was no
significant difference between the slow and the regular premutation subjects. Pearson
correlations between age and the different SVAT tasks were not significant (not shown). As
KS analysis had shown a significant group difference between slow premutations and controls
for the variable age. we performed ANCOVA for LPE with age as covariate. The group effect
controls versus slow premutation remained significant: p < 0.001.
Figure 4 Distribution of reaction time in milliseconds for LPE for the four groups of subjects.
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4.6. Molecular data
Two-sample KS-analysis for premutation length did not show significant differences (p=
0.548) between regular premutation (mean expansion length 0.30 kb; sd=0.12), and slow
premutation subjects (mean expansion length 0.26 kb; sd=0.09). We obtained X-activation
ratio for the normal FA//f/-gene for 13 of the 22 regular premutation subjects and for 4 of the
5 slow premutation subjects. Mean X-activation ratio in the whole group of 27 premutation
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carriers was 62.4% (sd=28.2, CI= 47.9% to 76.9%). which is a non-significant difference
(p=0.09) from the expected 50%. Between groups KS-analysis for differences in X-activation
ratio showed a significant difference (p=O.O48) between the regular premutation group (mean
X-activation ratio 72.7%, sd=2l.7) and the slow premutation group (mean X-activation ratio:
28.7%.sd=l9.6).
5. Discussion
We assessed different aspects of attention in 27 female FRAXA premutation carriers, 6
female FRAXA full mutation carriers, and 22 control subjects with the de Sonneville Visual
Attention Tasks battery, in order to see whether these specific ncurocognitive tasks could shed
evidence on the existence of a separate phenotype in female FRAXA premutation carriers.
The mean X-aclivation ratio of the group of 27 premutation carriers was non-significantly
skewed (62.4%). We have no other explanation than that this is a chance effect in a relatively
small group. Though the group of premutation carriers where significantly older than the
control subjects and had a lower Raven IQ, analysis of covariance did not show any
significant effects of these variables on the measured reaction times. Obviously, the
differences in age and intelligence where not that large that they could account for differences
in task performance. There were no significant differences on any SVAT task between the
control subjects and the total group of premutation carriers.
By means of statistical analysis, within the total group of 27 female premutation carriers we
differentiated a group of five who performed significantly different from control subjects and
from other premutation carriers. These 5 (18.5%) premutation carriers are characterised by
slower information processing speed on tasks with a high demand on controlled processing
(selective attention and complex response selection), but not on tasks that require mainly
automatic processing and/or sustained attention. The 22 other premutation carriers do not
differ from normal controls on any of the attention tasks. In our sample, these "slow"
premutation carriers are not different from the other premutation carriers in terms of
intelligence, age, nor repeat length. However, both groups differ significantly in X-activation
ratio in peripheral lymphocytes: the X-activation ratio is 72.7% in the "regular" premutation
carriers, and 27.8% in the "slow" premutation carriers. Lower expression of FMR protein and
higher expression of FA//J/-messenger RNA (mRNA) have been observed in some
premutation carriers [Kenneson et al., 2001; Tassone et al.. 2000c]. It is not clear how this
may affect neurological development and neurocognitive functioning. Lower X-activation
ratios might be associated with lower FMRP expression and/or higher FMff/-mRNA levels.
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]n the present research, we did not have the opportunity to test the premutation carriers for
FMRP expression and fMÄ/-mRNA levels. This has to be investigated further.
The fact that tasks requiring a more difficult response selection and attentive processing are
impaired in the "slow" premutation carriers, while sustained attention is not, suggests that
frontal lobe functions may be more impaired in these subjects. Indeed, response selection is
highly mediated by frontal lobes [Nüitänen and Sokolov, 1992], as are other executive
functions like temporal organisation [Kolb and Whishaw, 1996). Some researchers who also
assessed executive functions in female premutation carriers |Franke el at., 1999; Mazzocco
and Holden, 1996; Thompson et al., 1994] found no differences with normal controls. Our
Findings rather confirm the recent finding of problems in executive functioning in a subgroup
of premutation carriers [Bennetto et al., 2001]. The different Findings may be caused by the
fact that in earlier studies the premutation carriers were analysed as a homogeneous group.
We purposefully tried to detect a different subgroup, in following of the findings with POF in
premutation carriers, where POF also seems to affect only a subgroup of female premutation
carriers. Another reason for these different findings may be the fact that in (his study we used
a sensitive test to measure aspects of attention, of which focused attention is one. Earlier
studies focused more on executive functions related to temporal organisation and flexibility
[Franke et al., 1999; Mazzocco and Holden, 1996; Thompson et al., 1994].
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Comparison of the "slow" premutation carriers with full mutation carriers shows that the
"slow" premutation carriers are more impaired than the full mutation carriers on most tasks,
and that the difference is the largest in the tasks requiring selective attention. However, not all
the differences between the two groups are significant, possibly because both groups are too
small in this study. The comparison of these two groups is more equivocal: the impairment of
executive functions appears to be more important in "slow" premutation carriers than in full
mutation carriers, but the profile of impairment (selective attention more impaired than
sustained attention) is rather similar. Consequently, though it is clear that a subgroup of
female premutation carriers have a different neurocognitive phenotype than the majority of
premutation carriers, who are similar to control subjects, it is inconclusive whether these
"slow" premutation carriers have another neurocognitive phenotype than the full mutation
carriers. However, it is unlikely that these 18.5% "slow" premutation carriers are all women
with a tissue mosaicism for the FRAXA full mutation, with full mutation in a substantial part
of brain cells, and premutation in the peripheral lymphocytes: the unstable expansion seems to
acquire mitotic stability in very early foetal life [Wohrle et al., 2001], and while expansion
mosaicism is common within tissues [Wohrle et al., 2001], large expansion differences
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between different tissues are not a frequent phenomenon in fragile X [Allingham-Hawkins et
al., 1996. Reyniersetal.. 1999;Tassoneetal., 1999a; Wohriectal., 2001J. .
This sludy cannot show whether the premutation carriers with this different neurocognitive
phenotype are the same as the ones with premature ovarian failure (POF), as most subjects are
younger than the age at which POF occurs. Assessment of their hormonal status may give
additional evidence on this issue. A final limitation is that we have insufficient data on the
school career of the subjects to discriminate whether the "slow" premutations had more
learning problems reflecting weakness in executive functions -e.g. ADHD-like symptoms-
than the other prcmuutions or control subjects. , • •'•'. - .?»*•
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1. Abstract
We report data on intelligence and on possibly associated psychopathology in 16 children and
adolescents, between 7 and 18 years of age with congenital or juvenile myotonic dystrophy
(DM). We found that all the subjects have an intelligence level below the population mean,
four of them in the mentally retarded range. An unexpected number of subjects are in the
clinical range on the Child Behaviour Checklist. In nine of the sixteen subjects, a child
psychiatric diagnosis was found using a standardised psychiatric interview. The most frequent
child psychiatric diagnosis was Attention Deficit Hyperactivity Disorder.
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2. Introduction
Myotonie Dystrophy (DM) is a progressive neuromuscular disease characterized by a wide
variation in neuromuscular symptoms and multisystem involvement. Besides myotonia and
progressive muscular weakness other symptoms can be present, depending on the affected
organ system: cataract, smooth muscle disturbances (esophageal spasms, spastic colon,
diarrhoea), gonadal dysfunction (subfertility), mental retardation, depression, somnolence,
diabetes, and cardiac conduction defects (bradycardia. arrythmias) [Harper, 2001 ].
D.M. is an autosomal dominant inherited disorder, caused by an expanded and unstable CTG
repeat sequence in the 3' untranslated region of a gene on chromosome 19. The sequence of
this gene predicts its protein product to be a member of the protein kinasc family [Aslanidis et
al.. 1992: Brook et al., 1992; Buxton et al., 1992; Harley et al., 1992a; Harley et al., 1992b;
Shaw et al., 1993].
The prevalence of the DM-mutation in the general population is estimated to be I in 8000
[Hunter et al., 1992].
Harley proposed a classification of four different categories of myotonic dystrophy in relation
to age of onset and of clinical symptoms [Harley et al., 1993].
1. The w/W/orm of DM with cataract and minimal or no neuromuscular symptoms in
middle or older age.
2. The c7ö5.s/ca/ or aaWf/orm with typical neuromuscular symptoms in adolescence
or early adult life.
3. TheyMvem'/e or c/w'W/zooa'yörm: symptoms are present in childhood before the age
of 12 years. Learning disabilities are often prominent, while neuromuscular
symptoms are rather mild or sometimes even absent.
4. The coM^ew;7a/ybrm with clinical symptoms present from birth on or in utero:
hypotonic cerebral palsy, respiratory and/or feeding problems, and mild to
moderate developmental delay in survivors.
The psychiatric and cognitive evolution of individuals with the adult form of DM has been
well documented in the past, with controversial findings. Studies rather suggest an increased
incidence of depression in the group of patients with DM [Cuthill et al., 1988; Harper, 2001].
It is equivocal whether the presence of a carefree temperament is typical for patients with DM
[Harper, 2001]. Some studies in adults suggest intellectual impairment and lower IQ as age of
onset of signs and symptoms is lower, but this is not confirmed in other studies [Broughton et
al., 1990; Censori et al., 1990; Perini et al., 1989; Ragazzoni et al., 1991; Ragazzoni et al.,
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1993; Tuikka et al.. 1993; Turnpenny el al.. 1994; Van Spaendonck ct al., 1995]. Apart from
the fact that neuromuscular symptoms are frequently associated with developmental
problems, not much is known about the cognitive and behavioural aspects of the infantile and
juvenile form of DM.
We studied intelligence and possibly associated psychopathology in 16 children and
adolescents, between 7 and 18 years of age, with either the congenital (2 patients), or the
juvenile form (14 patients) of DM. The study is also the first phase of a longitudinal study on
possible cognitive and developmental changes in subjects with infantile or juvenile DM.
3. Subjects and methods
3.1. Subjects
We studied a group of 16 children and adolescents, between the age of 7 and 18 years, 9 girls
und 7 boys. Eleven were index-patients in their respective families and all were referred to the
centre for clinical genetics because of a great variety of neuromuscular problems (hypotonia,
somnolence. ...etc.). other somatic problems (gastrointestinal problems), or developmental
problems und learning difficulties. The other five subjects are affected brothers and sisters of
the index patients. The clinical diagnosis of DM was confirmed by molecular studies and
further family studies were performed. Table 1 gives a summary of the age of onset of clinical
symptoms, the present age and the molecular data in the 16 children and adolescents and of
the molecular data in the affected parents. All affected parents presented a classic, adult onset
DM.
History and clinical findings allowed classifying the 16 subjects in two groups, following the
classification we propose:
Severe hypotonia was noted at birth in the two children. A foetal hypokinesia sequence with
reduced foetal movements and polyhydramnios was seen in one child. One child presented at
birth a talipes equinovarus deformity of both feet, one other a respiratory distress syndrome,
and both children had serious feeding- and swallowing difficulties from the beginning. They
had facial weakness with typical tented upper lip, myotonia, dysarthric speech and extreme
slow movements. One is mildly mentally retarded (FSIQ between SO and 70) and one has a
borderline intelligence (FSIQ between 70 and 85).
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No major problems were noted in these children at birth. Five of them had feeding problems
(slow suckers: bottle-feeding was started after birth because breast feeding was not possible),
while pre- and perinatal history was normal in seven patients. The five patients with early
feeding problems were diagnosed as having DM before the age of eight, based on the
following symptoms: muscular hypotonia (I child), tiredness after physical exercise (I child),
gastrointestinal symptoms (I girl with feeding difficulties with constipation and diarrhoea),
learning difficulties (all five). The others were diagnosed before the age of 15 years based on
ihe following: learning difficulties (4 patients), muscular hypotonia (2 patients), and
somnolence (1 patient).
Data on intelligence were as follows: mild mental retardation (3 subjects), borderline
intelligence (5 subjects), learning difficulties with IQ's between 85 - 100 (5 subjects). Nine of
the 12 children are in a special education program. The fourteen children with JDM were
hypoionic and presented facial weakness, and myotonia in the face and the hands. Delayed
fine motor development was noted in five of them and somnolence in four others.
Most children in both groups needed a rather long night rest: 12 of the 16 children needed 10
or more hours of sleep a day.
3.2. Cognitive testing
Intelligence was tested with the Wechsler scales: WISC-R scale in the children (Van Haasen
et al. 1974) and WAIS scale (Stinissen et al. 1970) in the adolescents older than 16 years.
These scales are subdivided in a performal and verbal subscale. Each subscale contains
different subtests (verbal subscale: information, similarities, arithmetic, vocabulary,
comprehension and digit span; performal subscale: picture completion, picture arrangement,
block design, object assembly, substitution and mazes). The resulting data give us a total
intelligence quotient (FSIQ), a verbal intelligence quotient (VIQ), a performal intelligence
quotient (PIQ) and an intelligence profile. Differences over time in FSIQ in a single patient
are present when the 95%-reliabiIity intervals of the first and the last IQ result do not overlap
[Van Haasen et al., 1974]. Thus, a decline in IQ can be demonstrated with a probability below
0.05. • ; -^.
3.3. Behavioural measures ,. _.
The Dutch version of the Children Behavior Checklist (CBCL) [Verhulst F. C. et al., 1990], a
well-validated checklist standardized in children with normal and borderline intelligence (IQ
> 70), was completed by the parents. The results from this checklist are transformed in a total
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problem score, in two subscores for respectively the internalising (withdrawn, somatic
complaints and anxious/depressed) and externalising problem behaviour (delinquent and
aggressive) and in a profile of clusters with specific problem behaviour (withdrawn, somatic
complaints, anxious/depressed, social problems, thought problems, attention problems,
delinquent behaviour and aggressive behaviour). The responses are transformed into T-scores
(X=50, s.d.= 10). In the total problem score, and the internalising and externalising subscores,
a T-score of 63 or higher (coinciding with 90th centile or higher) are considered to be of
concern and are called by the authors as being "in the clinical range". T-scores in the range of
70 or higher (> 98th centile) are found in populations with severe behaviour or emotional
problems For the specific problem clusters T-score of 66 or higher (> 93rd centile) arc
considered to be of concern (Vcrhulst F. C. el al.. 1990).
Dcprcssivity was assessed by two questionnaires, adapted for a Dutch population: the Child
Depression Scale ILuteijn. 1981] in 9 children younger than IS years, and the Beck
Depression Inventory [Beck et al., 1961; Bouman et al., 1985] in S adolescents older than IS
years. > • * ; - . « ; i v , ^ ' • - . • • • . . . . • ; •; • - , . . • ; - . . . . . * . . • , . . • . . • . • • . • . . • ,
Finally, the possible presence of clinical child psychiatric syndromes was assessed by means
of a structured parent-interview: the Dutch version of the Diagnostic Interview for Children
and Adolescents (ADIKA) (Kortenbout et al. 1993). This instrument, based on the criteria of
the DSM-1II-R classification, has been adapted in Dutch, but the norm values for a Dutch
population arc not available yet. Therefore, we applied the DSM-III-R criteria [American
Psychiatric Association, 1987] and the U.S.-norms of the Diagnostic Interview for Children
and Adolescents [Reich et al., 1982; Wclneret al., 1987].
The length of the insertion at the DM-site was assessed on peripheral lymphocytes. Genomic
DNA was extracted and two Southern blots were performed: one to assess longer insertions,
after digestion with EcoRI, and one to assess shorter insertions, after digestion with Bgll.
Standard techniques were used, with p25B1.4 as a probe. Repeat lengths were measured and
expressed as difference in repeat size with a normal control.
^ 4. Resu l t s (Table 11)
4.1. Molecular data ,
The mean repeat size was 3.5S kb in the two subjects with congenital DM. 1.88 kb in the
group of juvenile DM. All affected parents presented a classical adult form of DM. The mean
repeat size in the transmitting mothers was 0.66 kb and 2.3 kb in their affected children. The
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mean repeat size was 1.2 kb in the transmitting fathers and 1.5 kb in their affected children.
ANOVA of repeat size between the two categories shows significant differences between the
categories (p=0.001. multiple r2=0.61). • ^ : -' 4
4.2. Intelligence ' " " ' ' ^ *' ' "•"*
The full scale IQ (FSIQ) was below 100 in all 16 subjects; individual lQ's varied between 62
and 95, and the mean FSIQ was 79. Average FSIQ (Table 2) in the category Congenital DM
(CDM) was 68. and 80 in the category juvenile DM (JDM).
ANCOVA of FSIQ between the two categories of DM, with age as co-van ate, shows
significant differences (p=O.O39) between these categories. Regression analysis of FSIQ in
function of in the whole group of subjects shows an inverse correlation (p=O.O25).
Table 11 Type of DM, sex, age, insertion length, transmitting parent data, full scale Wechsler IQ
and psychiatric diagnosis in 16 DM subjects.
Congenital
Myotonie
Dystrophy
Sex
female
female
Present
«Re
16
18
Age«t
diagnosis
3
7
CTG
repeal
size (kB)
3.6
3.5
Full
scale IQ
73
62
Child psychiatric
diagnosis
earlier ADHD
separation anxiety
disorder
Affected
parent
mother
mother
CTG
repeat
size la
parent
1
0.5
Juvenile
Myotonie
Dystropy
female
male
female
male
female
female
female
male
female
male
male
male
male
7
9
10
11
17
11
12
12
14
14
16
16
IS
7
7
8
8
3
9
3
4
4
11
IS
12
14
1.6
2.2
2.1
1.2
1.5
2.6
1.9
1.0
2.0
1.5
1.8
1.9
2.1
78
71
65
83
90
87
74
89
63
95
76
92
94
adjustment
disorder
ADHD
generalized anxiety
disorder
ADHD
none
none
separation anxiety
disorder
none
none
none
ADHD
ADHD
Autism
mother
mother
mother
father
mother
mother
father
father
mother
mother
mother
father
mother
unknown
0.35
0.35
0.7
1.4
0.3
2.4
0.5
0.5
0.3
0.4
2.4
0.6
female 10 2.9 63 mother 0.6
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Analysis of the Wechsler subscales in all patients showed no significant difference between
the average performal IQ (PIQ: 82) and the average verbal IQ (VIQ: 79). Kaufman's three-
factor analysis of the Wechsler scales [Van Haasen et al., 1974] showed an average factorl-
IQ (verbal reasoning) of 79, factor2-IQ (visuo-spatial reasoning) of 82 and factor3-lQ
(attention) of 81. The differences between these three factors are not significant.
Longitudinal IQ data were available in two subjects. Results on the W1SC-R in two children
with juvenile DM showed a significant (p<0.05) decline of FSIQ over a period of 2 years
(FSIQ's from 94 to 71 and from 75 to 65). . , ^ s - - '> . :; '
4.3. Behavioural and emotional functioning ' • ' " - • , . •
Results on the CBCL, parent form, (Figure 5) showed problem behaviour in the clinical range,
in 5 of the 16 subjects: I of the 2 subjects with congenital DM and 4 of the 14 subjects with
juvenile DM. Problems lay mainly in the internalising subscale of the CBCL: six subjects
score in the clinical range on the internalising subscale, while only one subject scores in the
clinical range on the externalising subscale. On the separate symptom clusters, the clusters
"withdrawal" (three subjects), "social problems" (four subjects) and "attention problems"
(two subjects) are in the clinical range (T-scorc > 70, or above 98th centile).
Two children scored in the clinical range of depression on the depression questionnaires: 1
girl with juvenile DM on the Children's Depression Scale, and 1 girl with congenital DM on
the Beck Depression Inventory. . • •
Figure S Scorn on the different dimensiom of the Child Behaviour Checklist (Parent's Questionnaire):
San r«pr*i«*r M* number o/»6/«cts jcoriKg aftowr +2 rtWorrf rfrviancm o/>A
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4.4. Child psychiatric syndromes ,-« ^A<.' . «fa ,,-;, s. •.;
On (he siruciurcd psychiatnc interview. (ADIKA) nine subjects showed a clinical syndrome
(Table 11). Four subjects fulfilled the criteria for Attention Deficit and Hyperactivily Disorder
(ADHD): all four have juvenile DM and normal or borderline intelligence. The diagnosis
ADHD was clinically diagnosed by the child psychiatrist in three of these four subjects. One
of the females, with congenital DM, fulfilled the criteria for the diagnosis ADHD in
childhood, but did not fulfil them anymore at the time of the study. - • -••£.: .„.•«*<
One mildly mentally retarded female with congenital DM and one borderline intelligent
female with juvenile DM manifested a separation anxiety disorder before the age of 15 years.
Finally, one mildly mentally retarded female DM had a generalized anxiety disorder and one
borderline intelligent female had an adjustment disorder with depressive mood These two
subjects have juvenile DM. • .
One boy with normal intelligence and juvenile DM fulfils the criteria for autism on the
Childhood Autism Rating Scale.
. 5. Discussion
We assessed sixteen children and adolescents with congenital or juvenile DM, and with
intelligence levels in the normal, borderline or mildly retarded range. • .:--...-•.-
In the two children with congenital DM, severe muscular hypotonia was present from birth
on. In one subject, a foetal hypokinesia sequence with polyhydramnios was already noted in
the third trimester of pregnancy. Despite these obvious symptoms, the diagnosis DM was only
made at their respective age of 3 and 7 years. This long interval period between the age at
onset of the first symptoms and the age at diagnosis may be explained by the fact that the two
subjects were index-patients in their respective families. Further family studies showed that
both inherited the DM mutation from their mother who presents a classical adult form of DM.
In the 14 subjects with juvenile DM the mean age at diagnosis was 8.1. Although in these
children other symptoms were present at the time of diagnosis, the first problem that alarmed
the parents were learning difficulties. The fact that learning difficulties were the reason to
seek help in these patients where DM was not known in the family may be the reason why the
age at which the diagnosis was made coincides with the beginning of primary school. «.;(;«
In the patients we describe, within each category of DM, there is an important variation in
severity of symptoms and affected organ systems within each diagnostic group. Repeat length
does not permit to predict the variation within one diagnostic group, but there is a significant
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correlation between repeat length and FSIQ. In this study, we found a significant difference in
repeat length between the diagnostic groups juvenile DM and congenital DM.
Moreover, further family studies showed that all affected parents (3 fathers and 8 mothers)
presented a classical adult form of DM. As expected, the mean repeat size in the transmitting
mothers was much smaller than in their affected children. Transmitting fathers had about the
.same repeat size as their affected children, although the differences in clinical severity
between fathers and their children arc important. Possible factors that may influence the
phenotypic expression arc somatic mosaicism, ongoing instability of the repeat expansion
after birth, and the intrinsic characteristics of the protein kinase (DMPK) itself [Johnson K.
and Siciliano. 1995).
On intelligence tests, all subjects in this study show a full scale IQ (FSIQ) below the
population mean. The mean FSIQ of the group is 79. This result may not be representative for
the whole population of DM patients, as in this group there was an ascertainment bias due to
the fact that for several subjects the reason for consultation had been learning difficulties
rather than somatic complaints. Previous studies performed in adult-onset DM showed higher
mean FSIQ, runging between 84 and 96. These data are not very representative, as the subject
group in these .studies is always biased |Turnpenny et al., 1994]. In the present study, the
subjects with congenital DM have a significantly lower FSIQ than the subjects with juvenile
DM. As the subjects in the study are a group of referred patients, we cannot demonstrate
whether the lower mean intelligence that was found, is due to ascertainment bias or reflects a
truly lower intelligence in the population of children and adolescents with DM.
Several studies of cognitive functioning in adult DM have already demonstrated attention and
concentration problems, and deficits in visuospatial and visuoconstructive abilities in affected
individuals [Turnpenny et al., 1994J. However, some other studies showed hardly any
evidence of cognitive dysfunction [Van Spaendonck et al., 1995). In the present study of 16
affected children and adolescents, the profile of the intelligence test did not suggest specific
cognitive deficits in the verbal or visuospatial area. However, more specific
neuropsychological testing should be performed to assess this issue.
Longitudinal data on IQ evolution with age were available in two children and they showed a
significant decline with age. Results of IQ evolution with age of several studies in adult-onset
DM are controversiallBird et al., 1983; Portwood et al., 1984; Portwood et al., 1986; Tuikka
elal.. 1993).
With regard to behaviour (results of the Child Behaviour Checklist, parents form) we found
that an unexpectedly high number of children scored in the clinical range (five of sixteen
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children for total problem score). All these children are children with FSIQ > 70 and. who are
well in the range of intelligence for which the CBCL was designed. The pathological scores
arc mainly on the dimensions "withdrawal", "social problems" and "attention problems".
Two subjects scored in the clinical range on the Depression Scale we used. This incidence
may not be very different from the incidence of depression in a normal population (2 to 5%)
and a mentally retarded population (8 to 15%). according to the numbers of Lovcll (Lovell
and Reiss. 1993). Both these children reported being teased at school.
A structured child psychiatric interview (ADIKA) showed Attention Deficit and
Hyperactivity Disorder (ADHD) in four subjects at present, and in one more subject in the
past. The diagnosis was made in three of these subjects at clinical assessment by a child
psychiatrist. The discrepancy between the higher number of subjects, who fulfilled the
diagnostic criteria of the DSM-IIIR (ADIKA) and the somewhat lower number diagnosed by
the child psychiatrist, can be due to the fact that the subjects mainly present symptoms
relating to attention deficit and impulsivity, and fewer relating to hyperactivity. This may lead
IO the child psychiatrist not concluding to the presence of the diagnosis, although the criteria
are fulfilled. The prevalence of ADHD in a population with intelligence higher than 70 is
estimated to be between 1 and 3% [American Psychiatric Association, 1994]. In our sample,
the prevalence was 25% (4/16). Besides the subjects in whom the full diagnosis of ADHD
was made, attention problems were one of the most frequent complaints of the parents in the
other subjects. Thus, attention problems, with or without hyperactivity and impulsivity seem
to be frequent problems in the population of children with DM. It is not clear how much
somnolence or problems of circadian rhythm in DM contribute to the attention problems in
DM.
Another frequent diagnosis was that of anxiety disorders (three in sixteen subjects).
In two adolescents (> 16 years, 2 juvenile DM) reduced initiative was reported and they
presented more pronounced muscle weakness. In the other fourteen subjects, there were no
complaints that could refer to the presence of apathy. Apparently, the clinical diagnosis of
"apathy" which is made in many DM children may be a false impression caused by their
expressionless face.
In conclusion, the observation made in the present group of 16 DM children and adolescents
are interesting and reveal an unexpected incidence of different child psychiatric syndromes
(ADHD, anxiety disorders).
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1. Abstract
Emotional and behavioural profile and child psychiatric diagnosis in the childhood type of
myoionic dystrophy: We report data on behaviour and possibly associated psychopathology in
24 children and adolescents between 9 and 22 years of age, with the childhood type of
myotonic dystrophy. The patients were recruited through a patients association, as family
members from patients with myotonic dystrophy (DM). In 4 1 % of the subjects, a score in the
clinical abnormal range was found on the Child Behavior Checklist (completed by parents and
by teachers). In 62% of the subjects, a child psychiatric diagnosis was found using a
standardised psychiatric interview. The most frequent child psychiatric diagnoses were
Attention Deficit with Hypcractivity Disorder and Anxiety Disorder.
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2. Introduction
Myotonie dystrophy (DM) is an autosomal dominant, neuromuscular disease, characterised by
myotonia and progressive muscular weakness. Other symptoms can be present depending on
the affected organ system: smooth muscle disturbances (swallowing problems, spastic colon,
diarrhoea), cataract, gonadal dysfunction in males (subfertility), cardiac conduction defects. In
adults hypersomnia. loss of initiative and apathy are among the most common systemic
complications. When the disease starts at young age. mental retardation, usually mild to
moderate in degree, is the rule. DM is caused by an expanded and unstable CTG repeat
sequence in the 3' untranslated region of the D.WA' gene on the long arm of chromosome 19
(Harper, 1998]. Four disease types can be distinguished based on the age of onset and
predominant symptoms [Harper. 2001]: (I). The m»M ryj* with cataract and minimal or no
neuromuscular symptoms in middle or older age. (2). The c/ass/ca/ or a<A<// rypc with
neuromuscular symptoms in adolescence or early adult life (age at onset 12-50 years).
(3). The cAi7<#too</ or yuvem/e (vpe with symptoms before the age of 12 years and an
uneventful pre- and neonatal history and normal development within the first year of life.
Learning disabilities are often prominent, while neuromuscular symptoms are rather mild or
sometimes even absent [de Die-Smulders C, 2000]. (4). The congem'fa/ fype with clinical
symptoms present in utero (reduced foetal movements and history of polyhydramnios) or
from birth (hypotonia, facial diplegia, often skeletal deformities, respiratory and/ or feeding
problems). Mild to moderate developmental delay is seen in survivors.
Psychopathology in patients with myotonic dystrophy has been documented in several
studies. In adults a variety of problems was described, such as a high incidence of avoiding
personality, and a medication-responsive major depressive disorder [Brumback and Carlson,
1983; Colombo et al., 1992; Delaporte, 1998]. However, others did not find anxio-depressive
symptomatology or other significant psychiatric morbidity [Bungener et al., 1998; Cuthill et
al., 1988]. Disturbances of mood and affect, a depressive attitude with a somatic concern,
difficulties in social life or an emotional deficit and changes in character are also described
[Bungener et al., 1998; Cuthill et al., 1988; Franzese et al., 1991]. Ambrosini and Nürnberg
[Ambrosini and Nürnberg, 1979] mentioned clinical evidence for an altered mental
functioning as a basic feature of DM, rather than a reactive or secondary phenomenon, due to
a possible difficult adaptation to the threatening implications of the disease. Their hypothesis
was that thalamic dysfunction causes the (neuro)psychopathologic changes (e.g. changes in
diurnal rhythm, narcolepsy, hypersomnia, disorientation, confabulation, somnolence and
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akinetic mutism). Primary cerebral involvement in DM patients was confirmed by the
presence of abnormalities in neuro-imaging studies, such as cerebral atrophy and focal white
matter lesions (Ashizawa. 1998; Censori et al., 1994; Damian et al., 1994a; Damian et al,
1994b]. Some cerebral lesions seem to be characteristic of the disease, while others are
similar to the age related alterations [Censori et al., 1994]. Damian et al. [Damian et al.,
1994b] concluded that the cognitive impact of brain lesions depends on (he distribution as
well as the total extent of white matter lesions, e.g. subcortical lesions have more impact on
cognitive functioning than periventricular lesions and arc responsible for attention problems,
not for deficit in intelligence. Furthermore cerebral hypoperfusion on single photon emission
computed tomography (SPECT) and an altered cerebral metabolism have been documented
[Chang et al.. 1993; Chang et al.. 1998; Fiorelli et al.. 1992). Neuropathological examination
of bruins of adult DM patients found intracytoplasmatic inclusions, neurofibrillary tangles
containing pathological lau protein and neuronal loss [Ashizawa, 1998). In affected children
the central nervous manifestations may be much more conspicuous than those seen in adults,
as mental retardation is a major feature in the congenital as well as in the childhood type
[Ashizawa, 1998; de Die-Smulders C . 2000]. Although serious anatomical brain defects are
not a constant finding, ventricular dilatation and hypoplasia of (he corpus callosum were
found in an MRI study on congenital DM [Hashimoto et al., 1995] and malformations of the
cerebral cortex were reported in a neuropathological study of two patients with presumed
childhood onset DM [Rosman and Rebeiz, 1967]. However, psychopathology in DM affected
children and adolescents is scarcely documented. Blondis et al. [Blondis et al., 1996]
described a 10 years old DM affected girl with Asperger syndrome. In a pilot study, Steyaen
et al. [Steyaen et al., 1997] showed that more than half of the children with childhood onset
DM shows signs of psychopathology and that most subjects have some form of cognitive
impairment. The present study is an extension of the latter study. It is part of a research
project where we assess the clinical features, cognitive functioning, neuropsychological
impairments and psychopathology in children with childhood DM [de Die-Smulders C,
2000].
3. Subjects and methods
3.1. Subjects
We studied a group of 24 children and adolescents, between the age of 9 and 22 years, 14
boys and 10 girls. They were children of members of the Dutch patient organisation for
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Myotonie Dystrophy patients and were recruited by way of a call for patients. They were
included in the study on the following basis: clinical diagnosis of DM with onset between I
and 12 years, and learning difficulties, severe enough to cause failure at primary school level,
as well as absence of congenital features. All subjects had been diagnosed with DM prior to
the study The diagnosis of DM was confirmed by molecular studies. In most participants the
parents worried about possibly neurological and or learning problems in their child. The
patients came from 23 families (one sibpair). Twenty one of the subjects attended school: 4
subjects were in a normal school programme, 17 subjects were in a special education
programme (II for the mildly mentally retarded, 3 for children with specific learning
disabilities. 2 for motor disabled persons and I for moderate menial retarded children). One
subject works in a sheltered workshop.
The subjects were tested with the Wechsler Intelligence Scale for Children, revised version
(WISC-R) (Vander Steene ct al.. 1986) or the Wechsler Adult Intelligence Scale (WAIS)
[Stinissen et al.. 1970] in the adolescents older than 16 years. Full scale IQ (FS1Q) varied
beiween 50 and 97 The mean FSIQ is 72.25 with a SD of 14. There is no significant
difference between verbal and performance IQ.
Data on the transmitting parent's clinical type of DM could be obtained for all our subjects.
Twenty-two DM parents had the adult type of DM, one had the mild type and one was free of
symptoms. In thirteen subjects the mother was the transmitting parent and in 11 subjects it
was the father. Molecular data on the transmitting parent were available for 13 families.
3.2. Methods
The Dutch versions of Achenbach's Child Behavior Checklist (CBCL) and the coupled
Teacher Report Form (TRF) [Verhulst FC. et al., 1996] are well-validated checklists to assess
behaviour and emotional problems in children. These checklists have been standardised for
children between 4 and 18 years old. The parents complete the CBCL; the teacher completes
the TRF. In this study the CBCL was completed by the parents in all subjects. A TRF was
completed by the teacher in 13 of the 24 subjects.
The results of these checklists are transformed into a total problem score and into two
subscores for, respectively, the internalising and externalising problem behaviour. This total
problem score and the two subscores are transformed into T-scores. A T-score higher than 63
(> 90th centile) is found to discriminate between normal children and children with emotional
and/or behaviour problems who would benefit from care. A T-score of 70 or higher (> 97th
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centile) is found in children with severe emotional and/or behavioural problems (30). The
results are also transformed into eight clusters of specific problem behaviour: withdrawn,
somatic complaints, anxious/depressed, social problems, thought problems, attention
problems, delinquent behaviour and aggressive behaviour. Each of these are transformed into
a T-score (mean = SO, S.D. = 10). A T-score higher than 67 (> 95th centile) is considered to
be of concern. A T-score of 70 or higher (> 97th centile) is considered to be in the clinical
abnormal range.
A structured child psychiatric interview with the parents has been used to find out a possible
child psychiatric syndrome. We used the Dutch version (AD1KA [Kortenbout van der Sluijs
et al., I993J) of the Diagnostic Interview for Children and Adolescents (DICA [Reich et al.,
19911). This interview is based on the criteria of the DSM-UI-R classification |American
Psychiatric Association, 1987]. As the DSM-III R criteria for the diagnosis Attention Deficit
Disorder with Hypcractivity (A.D.H.D.) are quite different from the DSM-IV criteria for
A.D.H.D (American Psychiatric Association, 1994], we used an adaptation of the ADIKA
|C<lis(in-Wcslrcich and Ponjacrt. 1998] that includes the new DSM-IV criteria. For the
diagnosis of autism, which is not included in the structured interview, we adapted the
ADIKA. based on the DSM-IV criteria.
Differences between intelligence scales were assessed using Student's t-test. The probability
of finding a particular number of child psychiatric diagnoses or abnormal findings on the
scales of the CBCL was estimated using a test for probability of binomial distributions. For
each measured variable, the number of abnormal findings was compared to the expected
proportion of abnormal findings in the general population, e.g. when we used the cut-off for
abnormality at the 95th centile in the CBCL, the findings in the studied subjects were
compared to a frequency of abnormality of 5%. Pearson's correlations were used to compare
the continuous variables "repeat length in child", "Full Scale IQ" (FSIQ), and "CBCL Total
Problem Score".
Two procedures were used to assess the possible effect of the transmitting parent's sex on the
presence of behaviour problems. (1) For the categorical data in the child psychiatric interview
(ADIKA): as the number of subjects is small, the effect of the transmitting parent's sex on the
type of psychiatric problems cannot be statistically assessed, and thus for analysis we
dichotomised the results of the ADIKA in "psychiatric problems present" and "psychiatric
problems absent". Using the Pearsons Chi-square test this dichotomous variable was
correlated with the dichotomous variable "transmitting mother" versus "transmitting father".
(2) The effect of the transmitting parent's sex on the continuous variables "Full scale IQ" and
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Total problem score on the Child Behaviour Checklist" were assessed by means of ANOVA
and ANCOVA analysis. In both assessment techniques, the effect of the clinical type of DM
in the transmitting parent could not be assessed, as the number of "mild type" parents was
only two.
4. Results
4.1. Behavioural and emotional problems: CBCL (Table 12)
Using the CBCL. we found a total problem score in the clinical range in 10/24 subjects
(42%). This is significantly (p< 0.001) above the expected number of subjects considering
that we set the threshold at the 90th centile. as recommended by Verhulst et al. [Verhulst F. C.
el al.. 1990]. Nine subjects (37.5 %) score in the clinical range for internalising problems (p<
0.001) and 2 subjects (8 %) score in the clinical range for externalising problems (p=0.564).
Table 12 Results of the CBCL and TRF.
Main scales
Total problem
Internalising
Externalising
Problem domains
Withdrawn
Somatic Complaints
Anxious Depressed
Social problems
Thought problems
Attention problems
Delinquent
behaviour
Aggressive
behaviour
hiab'ra
Number in
clinical range
(n=24)
10
9
2
7
9
3
13
6
9
1
2
•art (CBCL)
Probability lo
find this
prevalence
< 0.001
0.003
0.564
< 0.001
< 0.001
0.116
< 0.001
< 0.001
< 0.001
0.661
0.339
Taachcr'i
Number in clinical
range (n=13)
3
5
0
3
4
3
5
2
1
0
0
rcnort (TRF)
Probability lo find
this prevalence
0.134
0.006
0.2S4
0.024
0.003
0.024
< 0.001
0.133
0.487
0.513
0.513
AWiAer o/juA/cc/5 w/fn o «ore in /ne c/m/'ca/ range/or f/ie severa/ JCÖ/M anrf/7roA/em domains o /
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On the Teacher's Report Form (TRF) of the behaviour checklist. 3 of 11 subjects (27%) had a
total score in the clinical range (p< 0.09), S others (4S.4 %) had an internalising score in the
clinical range (p=0.003) and none of the subjects had a score for externalising problems in the
clinical range. The specific problem scales show that the subjects have most problems in the
areas "withdrawn", "social interaction" and "inattention" (Table 12). Nine children also
scored in the clinical range in the problem domain "somatic complaints".
No correlation between FSIQ and total problem score on the CBCL could be demonstrated:
Pearson's correlation between the two continuous variables was 0.111 (p=0.607). Nor was
there a significant correlation between total problem score on CBCL and CTG repeat length
of the children: Pearson's correlation 0.158 (p=0.484).
Table 13 Child psychiatric diagnoses (ADIKA).
Diagnosis on ADIKA
No diagnosis
Anxiety disorder* combined
Separation anxiety disorder
Generalised anxiety disorder
Simple phobia
Attention Deficit Hyperactivity Disorder
Dysthymic disorder
Encoprcsis
hnuresis
Adjustment disorder
Number of subjects with
this diagnosis (n=24)
9
6
4
1
1
8
2
1
1
4
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4.2. Child psychiatric syndromes
Using the ADIKA we found out that 15 of the 24 subjects (63 %) had a child psychiatric
diagnosis (Table 13), and 11 subjects had no psychiatric diagnosis. Eleven subjects (45.8 %)
had one diagnosis, three subjects had 2 diagnoses and I subject had 4 diagnoses. Looking at
the whole group, we found Attention Deficit Hyperactivity Disorder (ADHD) in eight
subjects (33 %): 6 have the combined type. 2 have the predominantly inattentive type. Two
subjects (8%) had symptoms of ADHD but did not fulfil the diagnostic DSM-IV criteria for
duration or for age of onset. In six subjects (25 %) we found an anxiety disorder as first or as
second diagnosis: separation anxiety disorder in 4. generalised anxiety disorder in I and
specific phobia in 1. In two subjects (8.3 %) a mood disorder was found as first or as second
diagnosis. In one subject (4 %) we found encopresis as the fourth diagnosis and in one subject
(4 %) we found cnurcsis as the fourth diagnosis. Four subjects (16%) have signs of an
adjustment disorder.
4.3. Effect of transmitting parent
The thirteen (54^) children where mother was the transmitting parent had an mean CTG
repeat length of 752 triplets (sd=l4l). and a mean FS1Q of 67 (sd = 12.1) The eleven (46%)
where father was the transmitter had a mean CTG repeat length of 517 triplets (sd=!43). and a
mean FSIQ of 79 (sd =13.3). ANOVA analysis showed a significant effect of the transmitting
parent's sex on the Full Scale IQ of the affected child (p=0.034). However, the effect of the
transmitting parent's sex disappeared as separate predictor of the children's FSIQ when the
childrens' repeat length at the DM site was taken into account as a co-variable in ANCOVA
analysis. This ANCOVA model yielded an F = 0.052 (p=0.822) for transmitting parent's sex
and F = 6.065 (p=O.O24) for the co-variate "child's repeat length" There is a high correlation
between the transmitting parent's sex and the child's repeat length (separate ANOVA:
F= 14.640, p=0.00l).
The same analysis was performed for transmitting parent's sex and the Total Problem Score
on the Child Behavior Checklist. This yielded no association between both variables:
ANCOVA effect of transmitting parent F=0.181 (p=0.675) and effect of the co-variatc
"child's repeat length" F=0.065 (p=0.802).
Pearson's chi-square to test the effect of the transmitting parent's sex on the presence of child
psychiatric pathology on the ADIKA yielded no significant correlation: chi-value 0.906 (1
d.f.:p=0.34l).
5. Discussion
We studied a group of 24 children and adolescents with the childhood type of DM. As this
category of DM patients is not known to have important neurological symptoms or motor
impairment, the subjects in this study were not clinical patients. We looked at their
intelligence, their level of behaviour and/or emotional problems, and finally at the absence or
presence of diagnosabie child psychiatric syndromes.
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Though most subjects had only minimal neurological signs, their mean full-scale intelligence
quotient (FSIQ) was well below normal. Lower FSIQ was correlated with longer repeat
lengths, which in turn correlated with the transmitting parent's sex: inheritance from mother
gives longer repeat lengths. However, the data suggest that there is no independent effect
from the transmitting parent's sex on the FSIQ of the affected child, and that lower FSIQ is
mediated through longer repeal lengths when the child inherits the D M expansion from his
mother
The Child Behaviour Checklist showed that an unusual number of children have behaviour
and/or emotional problems in the clinical range. This means that the psychological
development of many of these children is of concern. A correlation between D M repeat length
and problem scores could not be demonstrated. Neither could we Find a correlation between
the transmitting parent's sex and the problem scores.
We found an important number of subjects with a child psychiatric diagnosis, mostly ADHD
and Anxiety Disorder. ADHD has a significantly high prevalence in this group, considering
that in DSM-IV |American Psychiatric Association, 1994] the prevalence of ADHD in the
general population is estimated between 2 and 5% (rxO.OOl for a population prevalence of
5%). The statistical significance of the number of children with anxiety disorders in the DM
group is not clear, as the prevalence of anxiety disorders in children is not well documented.
However, (he prevalence of 25% in this childhood type D M group is likely to be unusually
high. The presence or absence of a child psychiatric syndrome was not associated to the
transmitting parent's sex.
With this larger group we confirm the findings of Steyaert et al. [Steyaert et al., 1997], who
documented an unexpected prevalence of psychiatric disorders in children with DM. Van
Spaendonck et al. [Van Spaendonck et al., 1995] concluded that there is evidence for poor
cognitive control of behaviour in adult patients with D M , and attention deficits and vigilance
problems are frequent problems in subjects with an early onset type of D M [Harper, 2001].
Therefore, it is not unexpected to find ADHD in children and adolescents with DM, as
attention problems and poor cognitive control are key features of ADHD. We did not observe
a significantly higher prevalence of mood disorders in children and adolescents with
childhood type D M , in contrast with the finding of Cuthill et al. [Cuthill et al., 1988] that
adults with D M having more depressions.
Not much is known about the causal mechanisms of psychopathology in children with DM,
and this study falls short of clarifying these. Three hypotheses can be suggested: (1) D M is a
brain disorder that affects brain functioning directly - e . g . at the molecular or structural level -
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and leads to psychological development problems; (2) children have a reactive maladjustment
to the fact that they have a chronic an progressively impairing condition; this leads to
behaviour and/or emotional problems; (3) a transmitting and affected parent has poor
parenting skills and this affects the child's development.
Three arguments are in favour of the hypothesis of a brain disorder leading to developmental
problems. The first is that brain-imaging studies demonstrated functional bruin anomalies in
congemtally affected children and adults with DM [Ashizawa. 1998; Hashimoto ct ul.. 1995).
One may assume that these brain anomalies are also present in childhood onset DM. The
second argument is that as a group, children with childhood onset DM have a significantly
lower intelligence level. As they do not present significant motor impairment in childhood, it
is likely that the lower IQ has a primarily central origin. A third argument is the high
prevalence of ADHD in these children. ADHD is generally considered as a form of
psychopathology arising from a dysfunction in brain development rather than us a reactive
pattern of psychopathology.
The "reactive maladjustment" hypothesis is less probable, as the cognitive and behavioural
symptoms often occur well before the diagnosis has been made, at a time (hut the physical
signs are mild or absent and the children have no muscle impairment. Thus, it is unlikely that
their neurological condition would be a Stressor at this stage. And though their lower
intelligence level and learning disability can be a cause of stress, the number of child
psychiatric conditions is unlikely high even for a group of children with borderline IQ or a
mild learning disability.
In the present study there are no strong arguments in favour of the "poor parenting"
hypothesis. If poor parenting by an affected parent would have a major effect on the child's
psychological functioning, one might see that the degree of psychological dysfunction would
be dependent on whether mother or father is affected. In the present study we found that full
scale IQ is correlated to the transmitting parent's sex, but that this effect can almost
completely be attributed to the effect of the transmitting parent's sex on the DM repeat length
in the child. Total problem score on the Child Behaviour Checklist, and presence of child
psychiatric syndromes did not correlate with the DM repeat length, nor did these correlate
with the transmitting parent's sex. This suggests that other factors, combined with the
expanded DM repeat, are necessary for children with childhood type DM to develop clinically
significant behaviour and/ or emotional problems, while having a low intelligence is directly
associated with a longer repeat length.
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In order to clarify further the mechanisms of psychopathology in children with D M , it will be
necessary to analyse (he psychopathology in these subjects more thoroughly, including using
unaffected siblings as controls. In this perspective an important question is which central
neurological differences exist between D M subjects with different psychopathology, or
without problems. A first hypothesis is that in D M , there is a progressive dysfunction of at
least the frontal lobes. This could explain both the apathy in advanced D M subjects and the
problems of impulse inhibition and attention seen in the young patients with childhood DM
and ADHD
In conclusion, the results of this sample of 24 children and adolescents with childhood onset
D M reveal an unexpected high incidence of different child psychiatric syndromes (mainly
ADHD and anxiety disorders). Although we do not know how representative this sample is
for the whole population of children with D M , it seems likely that children with childhood
type D M arc a group with important risks for emotional and behavioural problems. This study
also underlines the importance of accurate neurological and/or genetic investigation of
children, admitted to child and adolescent psychiatry units with learning disabilities, ADHD,
or other behavioural and/or emotional problems. Finding the underlying somatic diagnosis
may have major implicaiions for their treatment and long-term prognosis.
Part III. GENERAL DISCUSSION
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Chapter 11 Single gene disorders and behavioural
phenotype
1. The problem of complexity
In the vast amount of ongoing research and discussion on the relationships between genes and
behaviour, single gene disorders arc a challenging opportunity to understand at least some of
the mechanisms involved in the genetic aspects of neuropsychiatnc conditions. These
conditions arc likely to be influenced by many genetic and non-genetic factors. Ideally, the
gene-behaviour relationships in these conditions should be analysed with models that take
into account multiple genes and both genetic and non-genetic factors. Using such models,
behaviour sciences and quantitative genetics have generated interesting findings regarding the
hereditary and environmental influences in neuropsychiatric conditions [Plomin et al., 2000;
Ruder et al., 1999a, b|. However, the study of the molecular biology of these conditions is
accompanied by major difficulties. The first problem is the phenotype itself (0). There is no
good evidence that the way neuropsychiatric disorders are conventionally delineated is an
effective entry into the molecular research of these disorders. E.g. all individuals with autism
fulfil the current diagnostic criteria for the disorder. However, they show a wide variation in
cognitive and behavioural characteristics and family history. The clinical differences are so
large, that it is unlikely that they reflect between-subject variation of one disease. It is more
probable that in autism we are confronted with different phenotypes, with different underlying
ncuro-psychopathological pathways, each with quite different (genetic and other) causes.
Teasing apart these phenotypes may be necessary to refine molecular research. A second
problem is that the molecular biology of a multifactorial polygenic model is extremely
complex. We do not (yet) have the methods to analyse them, and often the knowledge of the
molecular pathways to which the candidate genes belong is insufficient. This is like sorting
out a huge jigsaw puzzle without the example, while knowing that many pieces are missing.
A third problem is that knowledge on the developmental trajectories of brain and mind and
how genes affect it is still very limited. Consequently, integrating this essential factor of
development in multifactorial polygenic models would lead to even more terra incognita.
Omitting it on the other hand, undermines the credibility of the proposed models. In fact, this
is a circular problem of the chicken-or-cgg-first type which can only gradually been solved by
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combining the fields of genetic and developmental research: genetic research helps to
understand development: knowledge on development helps to find the role of genes
2. The manageable study of single genes
These different obstacles urge us to be humble and study the manageable rather than the
impossible. In this thesis, I advocated that (he collaboration between clinical genetics and
molecular biology in research on chromosomal defects and single gene disorders shows
behavioural geneticists a path to follow. Through accurate clinical observations, phenolypes
of disorders like Fragile X Syndrome could be described and delineated (0). which helped
molecular geneticists to find the causal genes. Once a gene has been found, the mechanisms
and pathways between defect and phenotype can be analysed for that particular gene. In its
turn, this has led to completely new insights, like the discovery of dynamic mutations (0) and
the variable effect that they have on the phenotype (0 Fragile X Syndrome; 0 Myotonie
Dystrophy). Other mutations have a variable penetrance, that can depend on stochastic
factors, and/or the effect of other genes (0). In some mutations the effect of other genes is
gradual and either small (e.g. Fragile X syndrome) or large (e.g. Velo-cardio facial
syndrome). In other mutations, the effect of other genes is discontinuous and a necessary
condition for the expression of a mutation (e.g. in Bardet-Biedl syndrome) (0). Research on
the Fragile X and Myotonie Dystrophy mutations have demonstrated that not only deficiency
of gene product, but also overproduction of mRNA can have pathological effects and explain
some aspects of the phenotype.
All these mechanisms that cause variation in the molecular pathway between gene and
phenotype are no exceptions. Recent history of the discovery of single genes shows that after
initial detection, subsequent research often reveals the complexity of the expression of the
gene. Consequently, this complexity in the expression of individual genes should be taken
into account when one tries to reconstruct biological pathways in which sets of genes and
their gene products participate, as one does when putting a number of candidate genes in a
molecular model to explain a particular neuropsychiatric condition, e.g. in presenile
Alzheimer Dementia [Theuns and Van Broeckhoven, 2000] or Tourette Syndrome [Comings
etal., 1999].
The fact that research on single genes is of manageable complexity has made it possible to get
bener insights not only in molecular biology, but also in some aspects of brain development.
Research on brain development in some forms of nonspecific X-linked menial retardation due
to single gene mutations, has led to the finding of defects in signal- transduction pathways
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that are believed to function during neuronal maturation. These findings provided insights
into molecular and cellular defects that underlie mental retardation. [Chelly and Mandel,
2001 ;Frinus et al. 2002].
Similarly, single gene disorders can form a starting point to study the interaction between
environmental factors and gene expression. To our knowledge, research in this Held is still
very limited.
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Chapter 12 Dynamic mutation disorders
1. Dynamic mutations
The typical phcnotypc of Fragile X Syndrome had been known since more than a decade
when the mutation in the promoter region of the FMÄ/-gene was found (0). The discovery of
a new type of mutation, a trinucleolide repeal expansion [Verkeri et al, 1991] was a
milestone. Since then, at least a dozen mutations of this type, now called dynamic mutations,
have been discovered. All of them are in genes that are mainly expressed in the central
nervous system. The significance of this is unclear.
The core characteristic of dynamic mutations is the variable length of the mutation (0). In (his
thesis we reviewed the research on genotypc-phenotype relations in dynamic mutations.
Different mutation lengths can be associated with different clinical characteristics In some
disorders, e.g. Huntingtons chorea and Myotonie Dystrophy, longer expansions arc
associated with an earlier age of onset of the disease. In other dynamic mutation disorders,
e.g. Fragile X syndrome and Spinocerebellar Ataxia (SC4£-gene). there is evidence that very
different expansion lengths are associated with a qualitatively different phenotype.
2. Fragile X Syndrome
One of the consequences of the discovery of the "marker X chromosome" in Fragile X
syndrome (FXS) [Lubs, 1969; Sutherland, 1977], was that carriership (of what was later
found to be the full mutation) could be demonstrated in family members who did not show the
typical Fragile X phenotype, or who were clinically unaffected. Detection of the "marker X
chromosome" in males with FXS made it possible to determine which mothers were obligate
carriers, even if the "marker X chromosome" could not be found in these female subjects. We
examined 11 female obligate carriers who did not show the typical Fragile X phenotype (0).
Subjects of at least normal intelligence were chosen for this study, and we demonstrated that
even under that condition a higher than expected number of subjects shows academic
problems and/or specific cognitive weaknesses. At the time of this study, we did not have the
opportunity to study further the molecular characteristics of the FA//?/-gene in these subjects.
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The discovery of the irinucleotide repeat expansion and the development of the DNA-test to
detect it, made the problem of the variance in phenotype even more complex. Beside mentally
retarded carriers of the full mutation, carriers of the full mutation who did not display the
typical Fragile X phenotype, and carriers of the premutation could be detected from then on.
We studied two different aspects of the genoiype-phenotype correlation in subjects who do
not display the typical Fragile X phenotype.
The first of these two studies (Chapter 7) focused on males with FXS. Beside the majority of
males with the typical FXS, there is a minority of subjects who function markedly better. One
possible cause is mosaicism: subjects in whom a fraction of the cells carries the full mutation,
and a fraction the premutation. Another cause is incomplete hypermethylation of the CpG-
island in the promoter region of the FA//?/-gene. In the full mutation this CpG-island is
normally hypermcthylated. We described seven boys with a full mutation, but incomplete
mcthylation of the CpG-island and demonstrated that the full scale IQ correlates inversely
with (he percentage of hypermethylation of the CpG-island but not with the CGG repeat
length. This provided clinical evidence that hypermethylation of the CpG island is an
important clement in the phenotype. It has been shown that unmethylated CGG repeats in the
full mutation range cause slower transcription to mRNA. but do not completely block it [Feng
ct al., 1995]. Hypermethylation of the CpG island blocks transcription of the FA/Ä/-gene.
Unfortunately, we did not have the opportunity to measure the FMR1-protein levels in these
subjects.
The second study focused on female premutation carriers (Chapter 7). The finding that
women with the fragile X premutation have an unexpectedly high prevalence of premature
ovarian failure (POF) [Allingham-Hawkins et al., 1999], showed that the phenotype is not
necessarily normal in the premutation, as had been assumed before. We found minor
neurocognitivc anomalies in a minority of female premutation carriers, that none of the
control subjects displayed, neither any of the other premutation carriers. There was a bimodal
distribution within the group of premutation carriers. Although performed in a completely
different area than the POF-study, our finding is in line with it: we also found an abnormal
phenotype in about one in five female premutation carriers. This suggests that factors other
than the fragile X premutation have an additional effect on anomalies in the premutation
phenotype. Increased levels of FA/Ä/-mRNA have been observed in some premutation
subjects and could be one such factor. FMRP-levels are generally normal in premutation
subjects. In the subjects of this study, we did not have the opportunity to measure FMRP and
FA/Ä7 -mRNA levels.
Onera/ Dücussiow (141)
The existence of a phenotype associated with the fragile X premutation needs further
confirmation. Unlike the problem of possible POP, the observed neurocognitive
characteristics do no( seem to cause significant impairment in premutation carriers. However,
the observed characteristics are a sign that "something different" happens in the neurons of
the affected subjects Further research on the molecular mechanisms implicated here may give
new insights in the functioning of the FA/Ä/-gcne and its product, and on how a mutation in
one gene may affect a whole range of intracellular pathways.
3. Myotonie dystrophy
Myotonie Dystrophy (Dystrophia Myotonica, DM) is another dynamic repeat disorder with a
wide variability in the phenotype. DM has a progressive course, and both the age of onset and
the course of the disease vary. These variables correlate partly with the trinucleotidc repeal
length [Harper, 2001]. As part of ongoing research in the departments of clinical genetics in
Maastricht and Leuven, we focused on children and adolescents with the childhood onset type
of DM. At this age, the subjects do not have significant muscle impairment [de Die-Smulden
C, 2000], while families mention a diversity of mild cognitive and behavioural problems in
these children. In an initial group containing 14 subjects with the childhood onset type, we
demonstrated that these subjects have a general cognitive impairment: all the childhood onset
subjects had an intelligence level below the average (Chapter 9), while this had previously
only been described in subjects with the congenital type of DM.
In the two children with congenital type of DM included in the study, we found a cognitive
decline over a two-year period. This was an incidental finding which should be studied further
through longitudinal study in a larger group of congenital DM subjects. Confirmation of the
latter finding would have consequences in the academic management of children with
congenital DM.
Another finding was that an unexpected number of these children have social problems, and
symptoms relating to Attention Deficit Hyperactivity Disorder (ADHD), and to Anxiety
Disorder. This was confirmed in a subsequent study on 24 subjects with childhood onset DM,
that were recruited with less or no referral bias and with the participation of the Dutch
organisation for muscle disease patients (Chapter 10).
These findings on cognitive and behavioural problems in subjects with childhood onset DM
who have no or minimal muscular impairment are additional evidence that DM is not only a
progressive muscle disease but also a brain disorder, as has been proposed by others
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(Ashizawa, 1998). Our hypothesis is thai executive functions are most impaired. Evidence for
this are the fact that ADHD in children reflects weakness of some executive functions, and the
fact that apathy and even loss of decorum can be observed in DM subjects prior to significant
muscle impairment (Harper, 2001]. The latter symptoms are generally associated with frontal
lobe dysfunction. This hypothesis needs further research on the behavioural phenotype in
DM. combined with functional brain imaging.
An important consequence of both studies is that clinicians should give the childhood type of
DM the necessary attention. Ii should be differentiated from congenital DM in children, as
the needs of children with childhood onset DM are in the domain of behaviour and academic
performance, rather than in the domain of motor development. Another consequence of these
studies is that the absence of significant muscle impairment is not sufficient to categorise
children with a family risk for DM as not affected. Behavioural and/or cognitive complaints in
children at risk should receive the necessary medical and psychological attention, as these
may be early signs of the disease.
Clinical experience suggests that the course of childhood onset DM in the years after its onset
may be different from that in congenital DM. While children with congenital DM catch up in
several developmental areas in the first decades of life, the development of children with
childhood onset seems to diverge more and more from an initially normal development.
Longitudinal research on the behavioural phenotype is required in this and other types of DM.
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Summary
a; /*orf /' mfrtx/wc/Kwt am/ /i/rra/urc
Behavioural genetics developed as a new science in the 20* century. It links quantitative,
molecular and clinical genetics with behavioural sciences. One aim of behavioural genetics is
to unravel the genetic mechanisms that underlie neuropsychiatric disorders, such as autism,
mental retardation and others. Only a few pathofysiological pathways between gene and
behaviour have been demonstrated until now. Quantitative genetics point at the important role
of polygenic heredity in combination with environmental factors in the development of most
behaviour characteristics and neuropsychialnc disorders According to this model, an array of
genes (Quantitative Trait Loci. QTL) each partly contribute to the development of a (rait or
disorder. Molecular genetic research based on QTL models has not yet been able to expose
much of the molecular mechanisms underlying neuropsychiatric disorders and the
phenotypical variance observed in these disorders Dc expression of a single gene is very
complex en can in some genes vary widely. In models involving a large number of genes, the
complexity and variance will increase in an exponential way. This problem will only increase
if most of the involved genes are still unknown. In chapter 3 of this thesis, we advocate that
research on the effect of single genes on pathology of behaviour and the variance herein, is
fundamental for research with polygenic models in combination with environmental factors.
The impact of one gene (defect) on neuropsychiatric disorders is almost never a none-or-all
phenomenon. Molecular mechanisms and stochastic effects in the development of the brain
may result in a wide variance in the impact of a single gene (defect) on the phenotype.
Z>yna/m'c ffiu/o/;'o/w are one of these molecular mechanisms. These consist of an abnormal
expansion of a poly-, mostly tri- nucleotide repeat. Such trinucleotide repeats are present at
several sites in the genome of normal individuals. Different abnormal repeat lengths can be
associated with differences in the severity of the disorder, a different age at onset of the
disorder, or even to different disorders. Consequently, in dynamic mutation disorders, the
same type of mutation in the same gene may be associated with important differences in the
phenotype.
We studied the effect of dynamic mutations on the behavioural phenotype in two genetic
conditions: Fragile X Syndrome (FXS) and Myotonie Dystrophy (Dystrophia myotonica,
DM). In FXS (chapter 4), there are two different forms of the dynamic mutation in the FA/Ä7
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gene on Xq27 3: the premutation and the full mutation. The premutation consists of an
abnormal expansion of a trinuclcolide repeat (55-200 CGG repeats), which does not stop
transcription and translation of the gene. Until recently, it was supposed that the premutation
did not affect (he phenoiype. In the full mutation (> 200 CGG repeats), hypermethylation
occurs in the promoter region of the gene, and transcription stops. The FMR1 protein cannot
be produced anymore. This protein has an important role in growth and differentiation of
neurones and dendntes. Male carriers of Ihe full mutation will usually have the classical
fragile X phenotype: moderate mental retardation, craniofacial features, and macro-orchidism.
More than 50% of the female full mutation carriers have a milder expression of the same
phenotype.
D M (chapter 5) IN a progressive muscle disorder with multisystemic involvement. It has an
autosomal dominant inheritance. Progressive muscle wasting and myotonia are associated
with symptoms in (he eye. (he heart, the gastro-intestinal tract and other systems. The
dynamic mutation in an untranslated region of the DA//7C gene on chromosome 19q 13
consists of a CTG innuclcotidc repeat of variable length. Four subtypes or phenotypes are
differentiated, based on age-at-onsei and severity. To some extent, these phenotypes correlate
with different CTG repeal lengths. The four phenoiypes are: de congenital form of D M , the
juvenile or childhood form, the adult or classical form, and the late onset or mild form. The
congenital form is systematically associated with mental retardation, and the adult form with
increasing apathy and somnolence. These findings suggested that in D M the central nervous
system is probably affected.
/>,) /\vrf //.
In chapter 6 to 8, we report research findings that have led to new insights in the gene-
behaviour relation in FXS. (1) In a group of 11 obligate carriers of the fragile X gene (chapter
6), we found a discrepancy between measured intelligence and level of education and job, as
well as a number of mild cognitive deficits. This sugges(s that even in clinically non-affected
female carriers, the gene defect may influence the central nervous system. (2) In chapter 7, we
describe seven boys with (he full mutation, but with a milder cognitive impairment than what
is usually observed. Hypertnelhylation of the promoter region of the FA/Ä/ gene proved to be
incomplete in these boys, and (he degree of hypermethylation correlated negatively with full
scale IQ. This finding demonstrated indirectly that there is a relation between degree of
transcription of the FA//?/ gene into messenger RNA and IQ in males with FXS.
Unfortunately, we did not have the opportunity to measure FMRI protein production in these
<£ SiMMMrics 0 63)
subjects. (3> In chapter 8, we describe a group of female earners of the fragile X premutation
who display neurocognilive characteristics that are both different from what is observed in
normal female controls and in full mutation earners. We observed differences in controlled
information processing requiring focused attention in approximately 18% of these
premutation earners Although these characteristics do not seem to have clinical implications,
they suggest that in a substantial part of the female earners the premutaiion has an efteel on
the development of the central nervous system. These findings are in line with recent
gynaecological findings, which show that in approximately 2 0 * of the female carriers the
premutaiion leads to premature ovarian failure. This suggests that expansions of the COG
repeat in the /•'A/Ä/ gene may result in two different phenotypes: one associated with the
premutation. and one with the full mutation.
<7 /"or/ //. rwearcA i« Afyofonic D
In chapter 9 we report the results of standardized cognitive and behaviour testing in a referred
group of 14 youngsters with juvenile D M and two youngsters with congenital D M . All
subjects had an IQ below average. A significant number of them are socially withdrawn
and/or have attention problems. We observed a mild decline of intelligence in the two subjecti
with congenital D M . In chapter 10 we report a replication and refinement ol the previous
study in 24 not clinically referred subjects with juvenile DM. A significant number of these
subjects have behaviour problems in the child psychiatric range, principally ADHD and
anxiety disorders. In this group too, average intelligence was significantly below the
population mean, and 17 of the 21 youngsters who were still at school, had been placed in
special education programs because of academic problems. In almost all these youngsters,
academic problems had preceded neuromuscular symptoms. Unlike the predominantly
maternal inheritance of the mutation found in congenital D M , in these subjects with juvenile
D M paternal inheritance was as frequent as maternal inheritance. Remarkably, a number of
subjects had inherited the mutation from an unaffected parent with a relatively small
mutation. In some of these cases, D M had not been diagnosed in the core family yet, but only
in more distant relatives. All these findings are quite different from the clinical picture in
classical type DM. Referral bias is unlikely the cause of this as the group consisted of non-
clinical subjects. The findings demonstrate the wide variance in the D M phenotype. It draws
attention to the fact that one should always think of the possibility of juvenile D M when there
is a family history of the condition, even if the parents are unaffected. On the other hand,
learning and behaviour difficulties should receive the necessary attention in youngsters in
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whom juvenile DM has been diagnosed, even if their neuromuscular symptoms are still
minimal. The finding that behaviour and cognitive problems often come before
neuromuscular complaints is a strong argument that suggest that DM affects the brain
directly. Not much is known about the pathofysiology of brain involvement in DM, en to
clarify this further, molecular research, brain imaging and longitudinal studies in DM are
necessary.
> /. Conc/u5/'o/u
The research presented in this thesis illustrates the phenotypical variation that may exist in the
expression of a mutation in a single gene. In FXS, molecular differences in the mutation have
important effects on the phenotype: female carriers have two different phenotypes depending
on the length of the mutation - premutation or full mutation-, and each of these phenotypes is
different from what is found in the normal population. In male FXS full mutation carriers,
cognitive impairment is strongly determined by another molecular variable: the degree of
methylation in the promoter region of the gene. In DM, we saw that juvenile DM has a
different presentation than the classical form of DM. The effect of the mutation length on the
occurrence of two different phenotypes is not so distinct as in FXS. It is likely that other
molecular, stochastic, or perhaps environmental factors play a role in the development
towards the one or the other phenotype.
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Samenvatting
e> Der/ /
In de twintigste eeuw ontstond dc gcdragsgenetica als nieuwe wetenschap. Zij vorml een brug
tussen de kwantitaiieve. de molcculaire en de klinische genetic« enerzijds, en de
gedragswetenschappen anderzijds Een belangnjk doel van de gedragsgenetica is net
ontrafelen van genetische mechanismen die een rol spelen in het ontstaan van
neuropsychiatnsche aandocningen. o.m. psychiatrische ontwikkelingsMoornissen bij kinderen.
Tot op heden werden slechts een beperfct aantal pathofysiologische mechanismen tusscn
genen en gedrag aangetoond De bevindingen van de kwantitatieve genetica wijr.en in dc
nchting van een hoofdzakelijk polygene overerving van de meeste gedragskenmcrken en -
stoornissen, in combinatie met milieu-invloeden. Verschillende genen (Quantitative Trait
Loci. QTL) zouden een deel van het ontstaan van een kenmerk of stoornis verklären.
Moleculair genetisch onderzoek dat op dergelijke modellen gcbaseerd is heefi tot nu echter
weinig kunnen verklären van het ontstaan van en de vanantic binnen ncuropsychiatnsche
ziektebeelden De expressie van e>n enkel gen is al zeer complex en kan hi| ccn aantal genen
erg wisselend zijn. In een model met een groot aantal genen zullen complexiteit en variantie
exponentieel toenemen met het aantal genen. Dit probleem wordt nog groter wanneer de
meerderheid van de genen in een dergelijk model nog onbekend zijn. Wij betogen dan ook
(hoofdstuk 3) dat onderzoek naar de invloeden van 66n enkel gen op het gedrag en de
ontwikkeling, en naar de oorzaken van de variantie hierin, een onmisbaar fundament is voor
het onderzoek van complexe modellen met meerdere genen in combinatie met milieufactoren.
De invloed van een gen op het ontstaan van neuropsychiatnsche stoornissen, is meestal geen
alles-of-niets fenomeen. Diverse moleculaire mechanismen en stochastische effecten in dc
ontwikkeling van de hersenen leiden tot grote verschillen in de impact van een genafwijking
op het fenotype. Een van deze mechanismen vormen de zogenaamde </ymwm5c/7e mw/af/ej:
pathologische mutaties in een gen die bestaan uit een abnormale expansie van een anderzijds
normale poly- en meestal tri-nucleotide repeat. Verschillende expansielengtes kunnen leiden
tot verschillen in de ernst van het fenotype, verschillen in de beginlceftijd waarop de stoornis
zieh manifesteert, of soms tot totaal verschillende pathologische fenotypes. Kn type mutatie
in hetzelfde gen is hier dus geassocieerd met belangrijke verschillen in het fenotype.
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Wij onderzochlen het effect van dynamische mutaties in twee genetische aandoeningen: het
Fragiel-X Syndroom (FXS) en Myotonc Dystrofie (Dystrophia Myotonica, DM). Bij FXS
(hoofdstuk 4) worden twee vormen van de fragicl-X mutatie in het FA//J/-gen op
chromosoom Xq27.3 onderscheiden: de premutatie en de volledige mutatie. Bij de premutatie
is er sprake van ecn abnormale expansic van de trinucleotide sequentie (SS-2OO CGG repeats),
waarbij transcriplie en translatie van het gen nog mogclijk zijn. Tot dusver werd aangenomen
dat dit geen effect had op het fenotype. Bij de volledige mutatie (>200 CGG repeats) treedt
een hypcrmclhylatie op in de promotorregio van hel gen, waardoor transcriptie niet meer
mogelijk is. Het FMRI-eiwit word! niet meer aangemaakt. Dit ciwit speelt een rol in de groei
en differentiatie van ncuroncn en hun dendneten. Nagenoeg alle mannelijke dragers van de
volledige mutahe vertonen hct klassieke FXS fenotype -matige mentale retardatie,
macroorchidic. crumofaciale kenmcrken- en ruim de helft van de vrouwelijke draagsters
hebben een mildere expressic van dit fenotype.
DM (hoofdstuk S) is een aulosomaal dominante aandoening. die gekenmerkt wordt door een
progressive spierdyslrofie gepaard met myotonie, en aantasting van verschillende Systemen:
oog, maag-darm, hart en andere. De dynamische mutatie in het DA/PAT-gen op chromosoom
I9ql3 bestaat uil een CTG-trinucleotide repeat van variabele lengte. Op basis van ernst en
aanvangsleeflijd van de aandoening worden vier verschillende fenotypes beschreven, die in
beperkte mate corrcleren met de expansielengte van de CTG-repeat. Deze fenotypes zijn: de
congenitale vorm, de juveniele vorm, de adulte vorm (of klassiek fenotype), en de laattijdige
of milde vorm. Bckcnd was dat de congenitale vorm gepaard gaat met mentale retardatie, en
dat bij de volwasscn vorm meestal toenemende apathie en somnolentie optreden. Deze
bevindingen wijzen crop dat er bij DM ook sprake kan zijn van een aantasting van hct
centraal zenuwstelsel.
In hoofdstukken 6 l.e.m. 8 worden een aantal onderzoeksbevindingen gerapporteerd die tot
nieuwe inzichten hebben geleid op het vlak van gen-gedragsrelaties in FXS. (I) Bij een groep
van 11 obligate draagsters van het fragiel-X gen vonden wij een discrepantie tussen gemeten
intelligentie en niveau van scholing en functioneren, evenals een aantal milde cognitieve
afwijkingen. Dit suggerecrde dat ook bij klinisch niet-aangetaste draagsters het gen toch een
invloed kan hebben op het centraal zenuwstelsel. (2) In hoofdstuk 7 beschreven wij 7 jongens
met de volledige fragiel-X mutatie, maar met mildere cognitieve aantasting dan wat
doorgaans vastgesteld wordt. Bij hen bleek dat er geen of slechts gedeeltehjke
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hypennethylatie in de promotorregio van FA/Ä/-gen was. en dat de gemeten intelligent«
negatief corrclecrde met de graad van hypennethylatie. Dezc bevinding plcittc ervoor dat een
verband bestaat tussen de transcnptie van het FA/Ä/-gen naar messenger RNA. en de
intelligent«: van personen met FXS Wij waren helaas met in de gelegenheid om het FMRI-
eiwit bij deze jongens tc bepalen (3) In hoofdstuk 8 beschreven wij een groep vrouwelijke
draagsters van de frag ic IX premutatic. die neurocognilieve kenmerken hebben die zowel
verschillen van wat vastgesteld wordt bij de normale vrouwelijke populatie. als van wat
vastgesleld wordt bij draagsters van de volledige mutatie Dezc afwijkingcn waren op het vlak
van gecomroleerde informatieverwerking met gefocuste aandacht, en we troffen zc aan bij
circa 18% van de draagsters van dc premutatic AI hoe we I het hier ging om een afwijking die
niet onmiddellijk klinische implicates hjkt te hebben. suggereerden deze bevindingen dat bij
een substantieel deel van de draagsters. de premutatie een invloed heeft op dc ontwikkeltng
van net centraal zenuwstelsel. Deze bevinding ligt in de lijn van eerdere gynecologische
bevindingen, die aantonen dat bij circa 20% van de draagsters de premutatic Icidt tot
vroegtijdige menopauze. Dit suggcreen dat expansies van dc CGG-rcpeat in hei FA/Ä/gen
kunnen leiden tot twee verschillendc fenotypes: een geassociecrd aan de premutatic, en con
feassocieerd aan de volledige mutatie.
g) Z)ee///: om/erzoeAsftev/Wmge« Ay A/yo/owe Dys/ro/ie • • '-.
In hoofdstuk 9 rapporteerden we het gestandaardiseerd cognitief en gedragsonderzoek bij een
klinische groep van 14 jongeren met juveniele DM en twee jongeren met congenitale DM. De
gemeten intelligence was bij alle subjeeten bcncdengemiddeld. Een significant aantal
subjecten was sociaal teruggetrokken en/of heeft aandachtsstoomissen. Bij de twee subjecten
met congenitale DM werd longitudinaal een lichte dating van de gemeten intelligence
vastgesteld. In hoofdstuk 10 beschreven we een verfijning van dit onderzoek, waarbij het
gedrag bij een niet-klinische groep van 24 subjecten met juveniele DM onderzocht werd.
Hierbij bleek dat een belangrijk aantal subjecten gedragsproblemen had in de
kinderpsychiatrische range, voornamelijk ADHD of angststoornissen. Ook bij deze groep was
de gemiddelde intelligence significant beneden het populatiegemiddelde, en 17 van de 21
jongeren die nog onderwijs volgden, waren wegens leermoeilijkheden naar speciaal onderwijs
verwezen. Bij nagenoeg al deze jongeren gingen leerproblemen vooraf aan enige
ncuromusculaire klachten. In tegenstelling tot wat doorgaans wordt vastgesteld bij congenitale
DM, was er bij deze groep geen overwegend maternele overerving van de mutatie, maar was
deze even frequent van paternele oorsprong. Opvallend was dat in deze groep een aantal
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jüngeren de mutatie overerfden van een niet-aangeiaste ouder mei een rclatief kleine mutatie.
De aandoemng was dan niet eerder bekend in het gezin, maar alleen in de verdere familie.
De combinatie van deze bevindingen verschilt erg van de klassieke prcscntatie van DM. Het
is onwaarschijnlijk dat dit aan referral bias kan worden tocgeschreven, aangezien de groep
niet-klinisch was gerekruteerd. Een en ander toont de grote variatie in het DM-fenotype aan.
en onderstreept dat aan de mogelijkheid van juveniele DM gedacht moet worden in
risieofamilics. Bij jongeren met juveniele DM dient aandacht te worden besteed aan
psychologische, psychiatrische en leerproblemen, ook als zij nog maar minimale
neuromusculaire Symptomen hebben. De bevindingen bij juveniele DM, in het bijzonder de
bevinding dal leerproblemen de spierklachten vaak voorafgaan, tonen aan dat DM het centraal
zenuwstelsel aantast onafhankelijk van de spiersymptomen. Er is nog maar weinig bekend
over het pathofysiologisch mechanisme van deze aantasting, en om dit verder te onderzoeken
zijn molcculair onderzoek, brain imaging en longitudinaal onderzoek bij DM nodig.
///
Het onderzoek beschreven in dil proefschrift onderstreept de fenotypische variatie die bestaat
in de cxpressie van mutaties in een enkel gen. Bij FXS zien we dat moleculaire verschillen in
een gcnafwijking belanghjke gevolgen kunnen hebben op het fenotype: bij vrouwelijkc
draagsters van de fragiel-X mutatie zijn er twee kwalitatief verschillende fenotypes in funetie
van de lengte van de mutatie (prcmuatic versus volledigc mutatie), die elk verschillen van het
fenotype bij de normale populatie. Bij mannelijke dragers van de volledige mutatie zijn de
cognitieve beperkingen sterk afhankelijk van een andere moleculaire variabele: de graad van
hypermethylatie in de promotor van het gen. Bij DM zien we dat een bepaalde fenotypische
vorm van de aandoening, met name de juveniele vorm, een beduidend verschillende klinische
presentatic heeft vergeleken met de klassieke vorm van DM. Andere moleculaire,
slochustische, en eventueel omgevingsfactoren speien hier wellicht een rol in het ontstaan van
het een of hct andere fenotype.
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dankbaar.
Collega's in Leuven en Maastricht, in het bijzonder Martine Borghgraef, Diane Willekens, en Eric
Legius, mijn dank voor jullie inhoudelijke bijdragen aan het onderzoek. Jullie zorgden met zijn alien
echter ook voor een goed sfeer, waardoor de dagen op genetica een soort wekelijks uitstapje zijn, hoe
hard er ook gewerkt wordt.
Mijn dank aan Elly Pijkels, Maureen Holvoet, en Vera Hovers, die de families contacteerden die aan
het onderzoek deelnamen.
Bijzondere dank aan de families met fragiel X syndroom of myolone dystrofie, die steeds met
belangslelling deelnamen aan onderzoek.
Thorny de Ravel, je las dit proefschrift door en voorzag het waar nodig van taalkundige en andere
commentaar. Rita Logist, dank voor je goede zorgen voor de manuscripten en alle administratie die
erbij hoort.
Mijn vader en moeder, vaak heb ik aan jullie gedacht. Jullie geloof heeft mij hier gebracht.
Marie, vaak was ik niet helemaal bij als je mij nodig had, enje aanvaardde het.
Charlotte, ...jij was erde laatste jaren steeds.
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